1	Open	VB	MISC	open	_	0	SENT_1	[p1l8t88r186b175],

1	The	DT	O	the	det	3	SENT_2	[p1l1104t88r1148b110],
2	Pharmacogenomics	NNP	MISC	Pharmacogenomics	nn	3	SENT_2	[p1l1157t88r1386b117],
3	journal	NN	O	journal	_	0	SENT_2	[p1l1394t88r1479b115],
4	(	CD	NUMBER	(	num	5	SENT_2	[p1l1489t88r1565b116],
5	2012	CD	DATE	2012	dep	3	SENT_2	[p1l1489t88r1565b116],
6	)	CD	NUMBER	)	number	7	SENT_2	[p1l1489t88r1565b116],
7	12	CD	NUMBER	12	dep	5	SENT_2	[p1l1576t89r1609b114],
8	,	,	O	,	_	0	SENT_2	[p1l1576t89r1609b114],
9	233-237	CD	NUMBER	233-237	appos	5	SENT_2	[p1l1619t89r1713b110],
10	©	CD	NUMBER	©	num	11	SENT_2	[p1l1105t120r1121b140],
11	2012	CD	DATE	2012	dep	3	SENT_2	[p1l1129t120r1175b139],
12	Macmillan	NNP	ORGANIZATION	Macmillan	nn	14	SENT_2	[p1l1185t119r1279b139],
13	Publishers	NNPS	ORGANIZATION	Publishers	nn	14	SENT_2	[p1l1289t119r1380b139],
14	Limited	NNP	ORGANIZATION	Limited	dep	11	SENT_2	[p1l1389t119r1461b139],
15	.	.	O	.	_	0	SENT_2	[p1l1389t119r1461b139],

1	All	DT	O	all	det	2	SENT_3	[p1l1470t119r1492b139],
2	rights	NNS	O	rights	nsubj	3	SENT_3	[p1l1501t119r1552b145],
3	reserved	VBD	O	reserve	_	0	SENT_3	[p1l1561t119r1636b139],
4	1470-269X	NN	O	1470-269x	dobj	3	SENT_3	[p1l1646t119r1781b142],
5	/	:	O	/	punct	7	SENT_3	[p1l1646t119r1781b142],
6	12	CD	NUMBER	12	num	7	SENT_3	[p1l1646t119r1781b142],
7	www.nature.com/tp]	NN	O	www.nature.com/tp]	dep	4	SENT_3	[p1l1105t166r1300b191],

1	ORIGINAL	JJ	O	original	amod	2	SENT_4	[p1l1665t230r1919b270],
2	ARTICLE	NN	O	article	_	0	SENT_4	[p1l1939t230r2149b270],

1	Differential	JJ	O	differential	amod	2	SENT_5	[p1l16t364r482b439],
2	effect	NN	O	effect	_	0	SENT_5	[p1l527t364r765b439],
3	of	IN	O	of	dep	2	SENT_5	[p1l802t364r885b439],
4	the	DT	O	the	det	6	SENT_5	[p1l919t364r1056b439],
5	rs4149056	NN	O	rs4149056	nn	6	SENT_5	[p1l1101t366r1561b439],
6	variant	NN	O	variant	pobj	3	SENT_5	[p1l1599t365r1898b439],
7	in	IN	O	in	dep	2	SENT_5	[p1l1937t365r2006b438],

1	SLCOlBl	NN	O	slcolbl	_	0	SENT_6	[p1l15t491r390b563],
2	on	IN	O	on	dep	1	SENT_6	[p1l440t511r545b563],
3	myopathy	NN	O	myopathy	pobj	2	SENT_6	[p1l592t489r1031b587],
4	associated	VBN	O	associate	partmod	3	SENT_6	[p1l1069t489r1508b563],
5	with	IN	O	with	_	0	SENT_6	[p1l1548t489r1735b563],
6	simvastatin	NN	O	simvastatin	prep_with	4	SENT_6	[p1l11t614r490b688],
7	and	CC	O	and	_	0	SENT_6	[p1l534t613r690b688],
8	atorvastatin	NN	O	atorvastatin	prep_with	4	SENT_6	[p1l734t614r1236b688],

1	LR	NNP	ORGANIZATION	LR	nn	2	SENT_7	[p1l12t776r57b810],
2	Brunham	NNP	ORGANIZATION	Brunham	dep	7	SENT_7	[p1l77t770r297b818],
3	‘	NN	O	‘	dep	2	SENT_7	[p1l77t770r297b818],
4	,	,	O	,	_	0	SENT_7	[p1l77t770r297b818],
5	P	NN	O	p	appos	3	SENT_7	[p1l321t776r352b819],
6	]	CD	NUMBER	]	dep	7	SENT_7	[p1l321t776r352b819],
7	Lansberg2	NN	O	lansberg2	dep	13	SENT_7	[p1l376t770r624b822],
8	'	''	O	'	_	0	SENT_7	[p1l376t770r624b822],
9	-3	CD	NUMBER	-3	dep	7	SENT_7	[p1l376t770r624b822],
10	,	,	O	,	_	0	SENT_7	[p1l376t770r624b822],
11	L	NN	O	l	appos	9	SENT_7	[p1l12t834r31b868],
12	Zhang	NNP	PERSON	Zhang	nn	13	SENT_7	[p1l49t828r215b880],
13	‘	NNP	O	‘	dep	38	SENT_7	[p1l49t828r215b880],
14	,	,	O	,	_	0	SENT_7	[p1l49t828r215b880],
15	F	NN	O	f	nn	17	SENT_7	[p1l238t834r255b868],
16	Miao	NNP	O	Miao	nn	17	SENT_7	[p1l277t828r411b876],
17	‘	NNP	O	‘	appos	13	SENT_7	[p1l277t828r411b876],
18	,	,	O	,	_	0	SENT_7	[p1l277t828r411b876],
19	C	NNP	O	C	nn	21	SENT_7	[p1l433t834r462b869],
20	Carter	NNP	PERSON	Carter	nn	21	SENT_7	[p1l482t828r640b876],
21	‘	NN	O	‘	appos	13	SENT_7	[p1l482t828r640b876],
22	,	,	O	,	_	0	SENT_7	[p1l482t828r640b876],
23	GK	NNP	PERSON	GK	nn	24	SENT_7	[p1l10t892r72b927],
24	Hovinghz	NNP	PERSON	Hovinghz	appos	13	SENT_7	[p1l92t886r298b938],
25	,	,	O	,	_	0	SENT_7	[p1l92t886r298b938],
26	H	NNP	O	H	nn	31	SENT_7	[p1l322t892r348b926],
27	Visscher	NNP	PERSON	Visscher	nn	31	SENT_7	[p1l368t886r566b934],
28	‘	NNP	O	‘	nn	31	SENT_7	[p1l368t886r566b934],
29	,	,	O	,	_	0	SENT_7	[p1l368t886r566b934],
30	JW	NNP	O	JW	appos	31	SENT_7	[p1l9t950r66b993],
31	lukema3	NN	O	lukema3	appos	13	SENT_7	[p1l82t944r297b993],
32	'	''	O	'	_	0	SENT_7	[p1l82t944r297b993],
33	4	CD	NUMBER	4	dep	31	SENT_7	[p1l82t944r297b993],
34	,	,	O	,	_	0	SENT_7	[p1l82t944r297b993],
35	AF	NN	O	af	nn	36	SENT_7	[p1l317t951r367b984],
36	Sta	NN	O	sta	appos	13	SENT_7	[p1l388t945r638b993],
37	|	CD	NUMBER	|	num	38	SENT_7	[p1l388t945r638b993],
38	enhoef5	NN	O	enhoef5	dep	50	SENT_7	[p1l388t945r638b993],
39	,	,	O	,	_	0	SENT_7	[p1l388t945r638b993],
40	CJD	NNP	O	CJD	nn	42	SENT_7	[p1l10t1008r87b1052],
41	Ross	NNP	PERSON	Ross	nn	42	SENT_7	[p1l109t1002r226b1051],
42	‘	NNP	O	‘	appos	38	SENT_7	[p1l109t1002r226b1051],
43	,	,	O	,	_	0	SENT_7	[p1l109t1002r226b1051],
44	BC	NNP	ORGANIZATION	BC	nn	45	SENT_7	[p1l250t1008r305b1043],
45	Carletoné	NNP	ORGANIZATION	Carletoné	appos	38	SENT_7	[p1l324t1002r533b1051],
46	,	,	O	,	_	0	SENT_7	[p1l324t1002r533b1051],
47	]	CD	NUMBER	]	num	48	SENT_7	[p1l9t1067r58b1110],
48	]	CD	NUMBER	]	appos	38	SENT_7	[p1l9t1067r58b1110],
49	P	NN	O	p	nn	50	SENT_7	[p1l9t1067r58b1110],
50	Kasteleinz	NN	PERSON	kasteleinz	_	0	SENT_7	[p1l79t1061r281b1101],
51	and	CC	O	and	_	0	SENT_7	[p1l300t1065r375b1101],
52	MR	NN	PERSON	mr	conj_and	50	SENT_7	[p1l397t1067r464b1101],
53	Hayden	NNP	PERSON	Hayden	dep	50	SENT_7	[p1l484t1060r692b1112],
54	”	CD	NUMBER	”	num	53	SENT_7	[p1l484t1060r692b1112],

1	1	CD	NUMBER	1	_	0	SENT_8	[p1l10t1156r17b1171],
2	Centre	NNP	O	Centre	dep	1	SENT_8	[p1l26t1160r115b1184],
3	for	IN	O	for	_	0	SENT_8	[p1l124t1159r162b1184],
4	Molecular	JJ	O	molecular	amod	5	SENT_8	[p1l169t1159r308b1184],
5	Medicine	NN	O	medicine	prep_for	2	SENT_8	[p1l315t1159r439b1184],
6	and	CC	O	and	_	0	SENT_8	[p1l447t1159r501b1184],
7	Therapeutics	NNS	O	therapeutics	prep_for	2	SENT_8	[p1l511t1159r691b1192],
8	,	,	O	,	_	0	SENT_8	[p1l511t1159r691b1192],
9	Child	NN	O	child	prep_for	2	SENT_8	[p1l11t1196r82b1222],
10	and	CC	O	and	_	0	SENT_8	[p1l92t1196r146b1222],
11	Family	NNP	ORGANIZATION	Family	nn	13	SENT_8	[p1l157t1196r247b1229],
12	Research	NNP	ORGANIZATION	Research	nn	13	SENT_8	[p1l257t1196r377b1222],
13	Institute	NNP	ORGANIZATION	Institute	prep_for	2	SENT_8	[p1l390t1197r508b1227],
14	,	,	O	,	_	0	SENT_8	[p1l390t1197r508b1227],
15	University	NNP	ORGANIZATION	University	appos	5	SENT_8	[p1l524t1197r659b1229],
16	of	IN	ORGANIZATION	of	_	0	SENT_8	[p1l669t1196r698b1222],
17	British	NNP	ORGANIZATION	British	dep	23	SENT_8	[p1l11t1234r94b1259],
18	Columbia	NNP	ORGANIZATION	Columbia	nn	17	SENT_8	[p1l108t1234r246b1265],
19	,	,	O	,	_	0	SENT_8	[p1l108t1234r246b1265],
20	Vancouver	NNP	LOCATION	Vancouver	dep	17	SENT_8	[p1l264t1235r412b1265],
21	,	,	O	,	_	0	SENT_8	[p1l264t1235r412b1265],
22	British	NNP	LOCATION	British	nn	23	SENT_8	[p1l428t1234r511b1259],
23	Columbia	NNP	LOCATION	Columbia	prep_of	15	SENT_8	[p1l525t1234r663b1265],
24	,	,	O	,	_	0	SENT_8	[p1l525t1234r663b1265],
25	Canada	NNP	LOCATION	Canada	appos	23	SENT_8	[p1l11t1271r128b1302],
26	;	:	O	;	_	0	SENT_8	[p1l11t1271r128b1302],
27	2Academic	NNP	O	2Academic	nn	29	SENT_8	[p1l139t1268r287b1297],
28	Medical	NNP	O	Medical	nn	29	SENT_8	[p1l297t1271r407b1297],
29	Centre	NNP	O	Centre	dep	15	SENT_8	[p1l417t1272r512b1302],
30	,	,	O	,	_	0	SENT_8	[p1l417t1272r512b1302],
31	Amsterdam	NNP	LOCATION	Amsterdam	appos	29	SENT_8	[p1l525t1271r691b1302],
32	,	,	O	,	_	0	SENT_8	[p1l525t1271r691b1302],
33	The	DT	LOCATION	the	det	34	SENT_8	[p1l13t1309r61b1334],
34	Netherlands	NNP	LOCATION	Netherlands	appos	29	SENT_8	[p1l73t1309r249b1339],
35	;	:	O	;	_	0	SENT_8	[p1l73t1309r249b1339],
36	3Durrer	NNP	O	3Durrer	nn	37	SENT_8	[p1l263t1306r367b1334],
37	Center	NNP	O	Center	dep	15	SENT_8	[p1l378t1310r470b1334],
38	for	IN	O	for	_	0	SENT_8	[p1l480t1309r518b1334],
39	Cardiogenetic	NNP	ORGANIZATION	Cardiogenetic	nn	40	SENT_8	[p1l11t1346r202b1379],
40	Research	NNP	ORGANIZATION	Research	prep_for	37	SENT_8	[p1l213t1346r340b1377],
41	,	,	O	,	_	0	SENT_8	[p1l213t1346r340b1377],
42	Amsterdam	NNP	LOCATION	Amsterdam	appos	40	SENT_8	[p1l354t1346r520b1377],
43	,	,	O	,	_	0	SENT_8	[p1l354t1346r520b1377],
44	The	DT	LOCATION	the	det	45	SENT_8	[p1l538t1346r586b1372],
45	Netherlands	NNP	LOCATION	Netherlands	appos	42	SENT_8	[p1l10t1384r187b1414],
46	;	:	O	;	_	0	SENT_8	[p1l10t1384r187b1414],
47	4Leiden	NNP	O	4Leiden	nn	48	SENT_8	[p1l199t1381r302b1409],
48	University	NNP	ORGANIZATION	University	dep	15	SENT_8	[p1l316t1384r451b1417],
49	Medical	NNP	ORGANIZATION	Medical	nn	50	SENT_8	[p1l462t1384r571b1409],
50	Center	NNP	ORGANIZATION	Center	dep	48	SENT_8	[p1l583t1385r678b1414],
51	,	,	O	,	_	0	SENT_8	[p1l583t1385r678b1414],

1	Department	NNP	ORGANIZATION	Department	_	0	SENT_9	[p1l11t1497r178b1529],
2	of	IN	ORGANIZATION	of	_	0	SENT_9	[p1l189t1496r218b1521],
3	Cardiology	NNP	ORGANIZATION	Cardiology	prep_of	1	SENT_9	[p1l228t1496r381b1529],
4	,	,	O	,	_	0	SENT_9	[p1l228t1496r381b1529],
5	Leiden	NNP	LOCATION	Leiden	prep_of	1	SENT_9	[p1l398t1496r491b1527],
6	,	,	O	,	_	0	SENT_9	[p1l398t1496r491b1527],
7	The	DT	LOCATION	the	det	8	SENT_9	[p1l509t1496r557b1521],
8	Netherlands	NNP	LOCATION	Netherlands	conj_and	3	SENT_9	[p1l10t1533r187b1564],
9	;	:	O	;	_	0	SENT_9	[p1l10t1533r187b1564],
10	5Radboud	NNP	O	5Radboud	nn	14	SENT_9	[p1l199t1531r340b1559],
11	University	NNP	ORGANIZATION	University	nn	14	SENT_9	[p1l353t1534r488b1567],
12	Ni/megen	NNP	ORGANIZATION	Ni/megen	nn	14	SENT_9	[p1l498t1534r630b1567],
13	Medical	NNP	ORGANIZATION	Medical	nn	14	SENT_9	[p1l10t1571r119b1597],
14	Centre	NNP	ORGANIZATION	Centre	dep	8	SENT_9	[p1l132t1572r226b1602],
15	,	,	O	,	_	0	SENT_9	[p1l132t1572r226b1602],
16	Nijmegen	NNP	ORGANIZATION	Nijmegen	conj_and	14	SENT_9	[p1l242t1572r381b1605],
17	,	,	O	,	_	0	SENT_9	[p1l242t1572r381b1605],
18	The	DT	LOCATION	the	det	19	SENT_9	[p1l399t1571r447b1597],
19	Netherlands	NNP	LOCATION	Netherlands	conj_and	14	SENT_9	[p1l459t1571r627b1597],
20	and	CC	O	and	_	0	SENT_9	[p1l640t1571r694b1597],
21	‘	NNP	O	‘	nn	23	SENT_9	[p1l9t1605r240b1634],
22	Pharmaceutical	NNP	O	Pharmaceutical	nn	23	SENT_9	[p1l9t1605r240b1634],
23	Outcomes	NNPS	O	Outcomes	conj_and	14	SENT_9	[p1l252t1609r389b1634],
24	and	CC	O	and	_	0	SENT_9	[p1l402t1609r456b1634],
25	Policy	NNP	O	Policy	nn	27	SENT_9	[p1l468t1609r547b1642],
26	Innovations	NNPS	O	Innovations	nn	27	SENT_9	[p1l11t1647r171b1671],
27	Program	NNP	O	Program	prep_of	1	SENT_9	[p1l185t1647r308b1679],
28	,	,	O	,	_	0	SENT_9	[p1l185t1647r308b1679],
29	Department	NNP	ORGANIZATION	Department	prep_of	1	SENT_9	[p1l325t1647r492b1679],
30	of	IN	ORGANIZATION	of	_	0	SENT_9	[p1l503t1646r532b1671],
31	Pediatrics	NNPS	ORGANIZATION	Pediatrics	prep_of	29	SENT_9	[p1l541t1646r672b1671],
32	and	CC	O	and	_	0	SENT_9	[p1l10t1683r64b1709],
33	Faculty	NNP	ORGANIZATION	Faculty	prep_of	1	SENT_9	[p1l76t1683r174b1716],
34	of	IN	ORGANIZATION	of	_	0	SENT_9	[p1l184t1683r213b1709],
35	Pharmaceutical	NNP	ORGANIZATION	Pharmaceutical	nn	36	SENT_9	[p1l223t1683r437b1709],
36	Sciences	NNPS	ORGANIZATION	Sciences	prep_of	33	SENT_9	[p1l449t1684r567b1714],
37	,	,	O	,	_	0	SENT_9	[p1l449t1684r567b1714],
38	University	NNP	ORGANIZATION	University	appos	36	SENT_9	[p1l12t1721r147b1754],
39	of	IN	ORGANIZATION	of	_	0	SENT_9	[p1l157t1721r186b1746],
40	British	NNP	ORGANIZATION	British	dep	46	SENT_9	[p1l195t1721r279b1746],
41	Columbia	NNP	ORGANIZATION	Columbia	nn	40	SENT_9	[p1l292t1721r431b1751],
42	,	,	O	,	_	0	SENT_9	[p1l292t1721r431b1751],
43	Vancouver	NNP	LOCATION	Vancouver	dep	40	SENT_9	[p1l448t1722r597b1751],
44	,	,	O	,	_	0	SENT_9	[p1l448t1722r597b1751],
45	British	NNP	LOCATION	British	nn	46	SENT_9	[p1l11t1758r94b1783],
46	Columbia	NNP	LOCATION	Columbia	prep_of	38	SENT_9	[p1l108t1758r246b1789],
47	,	,	O	,	_	0	SENT_9	[p1l108t1758r246b1789],
48	Canada	NNP	LOCATION	Canada	dep	1	SENT_9	[p1l262t1758r370b1783],

1	Correspondence	NN	O	correspondence	_	0	SENT_10	[p1l10t1841r271b1875],
2	:	:	O	:	_	0	SENT_10	[p1l10t1841r271b1875],
3	Dr	NNP	O	Dr	nn	5	SENT_10	[p1l11t1880r45b1904],
4	MR	NN	PERSON	mr	nn	5	SENT_10	[p1l58t1880r104b1904],
5	Hayden	NNP	PERSON	Hayden	dep	1	SENT_10	[p1l118t1879r235b1912],
6	,	,	O	,	_	0	SENT_10	[p1l118t1879r235b1912],
7	Department	NNP	ORGANIZATION	Department	appos	1	SENT_10	[p1l251t1880r426b1912],
8	of	IN	ORGANIZATION	of	_	0	SENT_10	[p1l438t1879r466b1904],
9	Medical	NNP	ORGANIZATION	Medical	nn	10	SENT_10	[p1l479t1879r590b1904],
10	Genetics	NNP	ORGANIZATION	Genetics	prep_of	7	SENT_10	[p1l10t1917r141b1947],
11	,	,	O	,	_	0	SENT_10	[p1l10t1917r141b1947],
12	University	NNP	ORGANIZATION	University	appos	1	SENT_10	[p1l157t1917r298b1950],
13	of	IN	ORGANIZATION	of	_	0	SENT_10	[p1l310t1916r338b1942],
14	British	NNP	ORGANIZATION	British	nn	15	SENT_10	[p1l351t1916r436b1942],
15	Columbia	NNP	ORGANIZATION	Columbia	prep_of	12	SENT_10	[p1l451t1916r599b1947],
16	,	,	O	,	_	0	SENT_10	[p1l451t1916r599b1947],
17	CMMT	NNP	O	CMMT	appos	1	SENT_10	[p1l10t1955r118b1985],
18	,	,	O	,	_	0	SENT_10	[p1l10t1955r118b1985],
19	950	CD	NUMBER	950	appos	1	SENT_10	[p1l133t1955r187b1979],
20	West	NNP	O	West	dep	19	SENT_10	[p1l199t1955r271b1979],
21	28th	JJ	ORDINAL	28th	amod	22	SENT_10	[p1l283t1954r349b1979],
22	Avenue	NNP	O	Avenue	dep	1	SENT_10	[p1l362t1955r478b1984],
23	,	,	O	,	_	0	SENT_10	[p1l362t1955r478b1984],
24	Vancouver	NNP	LOCATION	Vancouver	dep	29	SENT_10	[p1l491t1955r652b1985],
25	,	,	O	,	_	0	SENT_10	[p1l491t1955r652b1985],
26	British	NNP	LOCATION	British	dep	24	SENT_10	[p1l11t1991r96b2017],
27	Columbia	NNP	LOCATION	Columbia	dep	24	SENT_10	[p1l110t1991r250b2017],
28	V5Z	NN	O	v5z	nn	29	SENT_10	[p1l262t1992r321b2017],
29	4H4	NN	O	4h4	appos	22	SENT_10	[p1l333t1993r401b2022],
30	,	,	O	,	_	0	SENT_10	[p1l333t1993r401b2022],
31	Canada	NNP	LOCATION	Canada	appos	1	SENT_10	[p1l416t1991r533b2017],
32	.	.	O	.	_	0	SENT_10	[p1l416t1991r533b2017],

1	E-mail	NN	O	e-mail	_	0	SENT_11	[p1l11t2029r105b2054],
2	:	:	O	:	_	0	SENT_11	[p1l11t2029r105b2054],
3	mrh@cmmt.ubc.ca	NN	O	mrh@cmmt.ubc.ca	dep	1	SENT_11	[p1l121t2029r397b2054],

1	7MRH	NN	O	7mrh	nsubj	8	SENT_12	[p1l11t2538r92b2566],
2	is	VBZ	O	be	cop	6	SENT_12	[p1l105t2542r123b2566],
3	a	DT	O	a	det	6	SENT_12	[p1l133t2549r147b2566],
4	University	NNP	O	University	nn	6	SENT_12	[p1l159t2542r300b2574],
5	Killam	NNP	PERSON	Killam	nn	6	SENT_12	[p1l311t2541r396b2566],
6	professor	NN	O	professor	_	0	SENT_12	[p1l408t2541r539b2574],
7	and	CC	O	and	_	0	SENT_12	[p1l548t2541r600b2566],
8	holds	VBZ	O	hold	conj_and	6	SENT_12	[p1l613t2541r688b2566],
9	a	DT	O	a	det	12	SENT_12	[p1l9t2590r23b2608],
10	Canada	NNP	ORGANIZATION	Canada	nn	12	SENT_12	[p1l37t2583r146b2608],
11	Research	NNP	ORGANIZATION	Research	nn	12	SENT_12	[p1l161t2583r284b2608],
12	Chair	NNP	ORGANIZATION	Chair	dobj	8	SENT_12	[p1l299t2583r376b2608],
13	in	IN	O	in	_	0	SENT_12	[p1l388t2583r412b2608],
14	Medical	NNP	O	Medical	nn	15	SENT_12	[p1l427t2583r538b2608],
15	Genetics	NNP	O	Genetics	prep_in	12	SENT_12	[p1l553t2583r684b2608],
16	.	.	O	.	_	0	SENT_12	[p1l553t2583r684b2608],

1	Received	VBN	O	receive	_	0	SENT_13	[p1l11t2747r145b2772],
2	4	CD	DATE	4	dobj	1	SENT_13	[p1l165t2748r183b2772],
3	May	NNP	DATE	May	tmod	1	SENT_13	[p1l204t2748r268b2780],
4	2010	CD	DATE	2010	num	3	SENT_13	[p1l287t2747r369b2777],
5	;	:	O	;	_	0	SENT_13	[p1l287t2747r369b2777],
6	revised	VBN	O	revise	parataxis	1	SENT_13	[p1l392t2747r499b2772],
7	24	CD	DATE	24	dobj	6	SENT_13	[p1l520t2747r557b2772],
8	October	NNP	DATE	October	tmod	6	SENT_13	[p1l576t2747r702b2772],
9	2010	CD	DATE	2010	num	8	SENT_13	[p1l9t2785r92b2815],
10	;	:	O	;	_	0	SENT_13	[p1l9t2785r92b2815],
11	accepted	VBN	O	accept	parataxis	1	SENT_13	[p1l105t2784r242b2817],
12	2	CD	DATE	2	dobj	11	SENT_13	[p1l256t2785r273b2809],
13	December	NNP	DATE	December	tmod	11	SENT_13	[p1l286t2784r444b2809],
14	2010	CD	DATE	2010	num	13	SENT_13	[p1l455t2785r537b2815],
15	;	:	O	;	_	0	SENT_13	[p1l455t2785r537b2815],
16	published	VBN	O	publish	parataxis	1	SENT_13	[p1l551t2784r700b2817],
17	online	NN	O	online	prep	16	SENT_13	[p1l9t2822r104b2847],
18	18	CD	DATE	18	dep	17	SENT_13	[p1l119t2822r154b2847],
19	January	NNP	DATE	January	tmod	16	SENT_13	[p1l165t2823r282b2855],
20	2011	CD	DATE	2011	num	19	SENT_13	[p1l294t2822r363b2847],

1	Statins	NNS	MISC	statin	nsubj	2	SENT_14	[p1l750t766r867b796],
2	reduce	VBP	O	reduce	_	0	SENT_14	[p1l900t765r1021b796],
3	cardiovascular	JJ	O	cardiovascular	amod	4	SENT_14	[p1l1053t765r1312b796],
4	morbidity	NN	O	morbidity	dobj	2	SENT_14	[p1l1344t765r1520b806],
5	and	CC	O	and	_	0	SENT_14	[p1l1551t765r1617b796],
6	mortality	NN	O	mortality	dobj	2	SENT_14	[p1l1651t765r1813b806],
7	in	IN	O	in	_	0	SENT_14	[p1l1845t766r1874b796],
8	appropriately	RB	O	appropriately	advmod	10	SENT_14	[p1l1908t765r2150b806],
9	selected	VBN	O	select	amod	10	SENT_14	[p1l748t812r893b843],
10	patients	NNS	O	patient	prep_in	2	SENT_14	[p1l916t812r1068b853],
11	.	.	O	.	_	0	SENT_14	[p1l916t812r1068b853],

1	However	RB	O	however	advmod	10	SENT_15	[p1l1092t813r1260b850],
2	,	,	O	,	_	0	SENT_15	[p1l1092t813r1260b850],
3	statin	NN	O	statin	nn	4	SENT_15	[p1l1283t812r1580b843],
4	—	NN	O	—	nsubj	10	SENT_15	[p1l1283t812r1580b843],
5	associated	VBN	O	associate	partmod	4	SENT_15	[p1l1283t812r1580b843],
6	myopathy	NN	O	myopathy	dobj	5	SENT_15	[p1l1603t812r1786b853],
7	is	VBZ	O	be	cop	10	SENT_15	[p1l1807t812r1829b843],
8	a	DT	O	a	det	10	SENT_15	[p1l1850t821r1867b843],
9	significant	JJ	O	significant	amod	10	SENT_15	[p1l1887t812r2073b853],
10	risk	NN	O	risk	_	0	SENT_15	[p1l2093t812r2150b843],
11	associated	VBN	O	associate	partmod	10	SENT_15	[p1l749t858r932b890],
12	with	IN	O	with	_	0	SENT_15	[p1l951t858r1029b890],
13	these	DT	O	these	det	14	SENT_15	[p1l1049t858r1143b890],
14	agents	NNS	O	agent	prep_with	11	SENT_15	[p1l1162t862r1291b900],
15	.	.	O	.	_	0	SENT_15	[p1l1162t862r1291b900],

1	Recently	RB	DATE	recently	advmod	9	SENT_16	[p1l1313t858r1473b900],
2	,	,	O	,	_	0	SENT_16	[p1l1313t858r1473b900],
3	variation	NN	O	variation	nsubjpass	9	SENT_16	[p1l1493t859r1648b890],
4	in	IN	O	in	_	0	SENT_16	[p1l1670t859r1699b889],
5	the	DT	O	the	det	7	SENT_16	[p1l1718t858r1776b890],
6	SLCOlBl	NN	O	slcolbl	nn	7	SENT_16	[p1l1796t859r1953b890],
7	gene	NN	O	gene	prep_in	3	SENT_16	[p1l1976t868r2064b900],
8	was	VBD	O	be	auxpass	9	SENT_16	[p1l2082t868r2149b890],
9	reported	VBN	O	report	_	0	SENT_16	[p1l750t905r903b946],
10	to	TO	O	to	aux	11	SENT_16	[p1l922t909r958b936],
11	predict	VB	O	predict	xcomp	9	SENT_16	[p1l977t905r1103b946],
12	simvastatin-associated	JJ	O	simvastatin-associated	amod	13	SENT_16	[p1l1119t905r1521b936],
13	myopathy	NN	O	myopathy	dobj	11	SENT_16	[p1l1542t905r1735b946],
14	.	.	O	.	_	0	SENT_16	[p1l1542t905r1735b946],

1	The	DT	O	the	det	2	SENT_17	[p1l1753t905r1820b936],
2	aim	NN	O	aim	nsubj	6	SENT_17	[p1l1839t906r1902b936],
3	of	IN	O	of	_	0	SENT_17	[p1l1922t905r1957b936],
4	this	DT	O	this	det	5	SENT_17	[p1l1972t905r2035b936],
5	study	NN	O	study	prep_of	2	SENT_17	[p1l2052t905r2150b946],
6	was	VBD	O	be	_	0	SENT_17	[p1l747t961r815b983],
7	to	TO	O	to	aux	8	SENT_17	[p1l829t955r865b983],
8	replicate	VB	O	replicate	ccomp	6	SENT_17	[p1l881t952r1033b993],
9	association	NN	O	association	dobj	8	SENT_17	[p1l1047t953r1243b983],
10	of	IN	O	of	_	0	SENT_17	[p1l1259t952r1294b983],
11	the	DT	O	the	det	13	SENT_17	[p1l1306t952r1363b983],
12	rs4149056	NN	O	rs4149056	nn	13	SENT_17	[p1l1379t953r1572b983],
13	variant	NN	O	variant	prep_of	9	SENT_17	[p1l1585t953r1710b983],
14	in	IN	O	in	_	0	SENT_17	[p1l1724t953r1753b983],
15	$	$	MONEY	$	prep_in	8	SENT_17	[p1l1770t953r1927b983],
16	LCOlBl	JJ	MONEY	lcolbl	dep	15	SENT_17	[p1l1770t953r1927b983],
17	with	IN	O	with	_	0	SENT_17	[p1l1944t952r2022b983],
18	severe	JJ	O	severe	amod	20	SENT_17	[p1l2037t961r2149b983],
19	statin-associated	JJ	O	statin-associated	amod	20	SENT_17	[p1l748t998r1046b1030],
20	myopathy	NN	O	myopathy	prep_with	15	SENT_17	[p1l1068t998r1251b1040],
21	in	IN	O	in	_	0	SENT_17	[p1l1271t999r1300b1029],
22	a	DT	O	a	det	23	SENT_17	[p1l1320t1008r1338b1030],
23	cohort	NN	O	cohort	prep_in	20	SENT_17	[p1l1358t998r1476b1030],
24	of	IN	O	of	_	0	SENT_17	[p1l1495t998r1530b1030],
25	patients	NNS	O	patient	prep_of	23	SENT_17	[p1l1549t999r1690b1040],
26	using	VBG	O	use	xcomp	8	SENT_17	[p1l1711t999r1804b1040],
27	a	DT	O	a	det	28	SENT_17	[p1l1824t1008r1842b1030],
28	variety	NN	O	variety	dobj	26	SENT_17	[p1l1860t999r1981b1040],
29	of	IN	O	of	_	0	SENT_17	[p1l2000t998r2035b1030],
30	statin	NN	O	statin	nn	31	SENT_17	[p1l2052t999r2148b1030],
31	medications	NNS	O	medication	prep_of	28	SENT_17	[p1l750t1045r968b1076],
32	and	CC	O	and	_	0	SENT_17	[p1l993t1045r1058b1076],
33	to	TO	O	to	aux	34	SENT_17	[p1l1083t1049r1119b1076],
34	investigate	VB	O	investigate	conj_and	8	SENT_17	[p1l1144t1046r1337b1086],
35	the	DT	O	the	det	36	SENT_17	[p1l1361t1045r1418b1076],
36	association	NN	O	association	dobj	34	SENT_17	[p1l1443t1046r1638b1076],
37	with	IN	O	with	_	0	SENT_17	[p1l1663t1045r1741b1076],
38	specific	JJ	O	specific	amod	40	SENT_17	[p1l1766t1045r1898b1086],
39	statin	NN	O	statin	nn	40	SENT_17	[p1l1921t1046r2017b1076],
40	types	NNS	O	type	prep_with	34	SENT_17	[p1l2042t1049r2147b1086],
41	.	.	O	.	_	0	SENT_17	[p1l2042t1049r2147b1086],

1	We	PRP	O	we	nsubj	2	SENT_18	[p1l747t1093r806b1123],
2	identified	VBD	O	identify	_	0	SENT_18	[p1l822t1092r989b1123],
3	25	CD	NUMBER	25	num	4	SENT_18	[p1l1007t1093r1050b1123],
4	cases	NNS	O	case	dobj	2	SENT_18	[p1l1067t1101r1158b1123],
5	of	IN	O	of	_	0	SENT_18	[p1l1174t1092r1209b1123],
6	severe	JJ	O	severe	amod	8	SENT_18	[p1l1222t1101r1334b1123],
7	statin-associated	JJ	O	statin-associated	amod	8	SENT_18	[p1l1349t1092r1646b1123],
8	myopathy	NN	O	myopathy	prep_of	4	SENT_18	[p1l1665t1092r1848b1133],
9	and	CC	O	and	_	0	SENT_18	[p1l1863t1092r1928b1123],
10	84	CD	NUMBER	84	num	11	SENT_18	[p1l1946t1093r1990b1123],
11	controls	NNS	O	control	conj_and	4	SENT_18	[p1l2006t1092r2149b1123],
12	matched	VBN	O	match	partmod	11	SENT_18	[p1l750t1138r907b1170],
13	for	IN	O	for	_	0	SENT_18	[p1l927t1138r978b1170],
14	age	NN	O	age	nn	19	SENT_18	[p1l997t1148r1071b1180],
15	,	,	O	,	_	0	SENT_18	[p1l997t1148r1071b1180],
16	gender	NN	O	gender	prep_for	12	SENT_18	[p1l1094t1138r1231b1180],
17	,	,	O	,	_	0	SENT_18	[p1l1094t1138r1231b1180],
18	statin	NN	O	statin	prep_for	12	SENT_18	[p1l1254t1139r1349b1170],
19	type	NN	O	type	prep_for	12	SENT_18	[p1l1371t1142r1450b1180],
20	and	CC	O	and	_	0	SENT_18	[p1l1471t1138r1536b1170],
21	dose	NN	O	dose	prep_for	12	SENT_18	[p1l1558t1138r1651b1170],
22	.	.	O	.	_	0	SENT_18	[p1l1558t1138r1651b1170],

1	The	DT	O	the	det	3	SENT_19	[p1l1673t1138r1740b1170],
2	rs4149056	NN	O	rs4149056	nn	3	SENT_19	[p1l1762t1139r1954b1170],
3	variant	NN	O	variant	nsubjpass	10	SENT_19	[p1l1974t1139r2098b1170],
4	in	IN	O	in	_	0	SENT_19	[p1l2119t1139r2148b1170],
5	$	$	MONEY	$	prep_in	3	SENT_19	[p1l750t1186r907b1217],
6	LCOlBl	JJ	MONEY	lcolbl	dep	5	SENT_19	[p1l750t1186r907b1217],
7	was	VBD	O	be	auxpass	10	SENT_19	[p1l928t1195r995b1217],
8	not	RB	O	not	neg	10	SENT_19	[p1l1015t1189r1074b1217],
9	significantly	RB	O	significantly	advmod	10	SENT_19	[p1l1091t1185r1306b1227],
10	associated	VBN	O	associate	_	0	SENT_19	[p1l1323t1185r1506b1217],
11	with	IN	O	with	_	0	SENT_19	[p1l1525t1185r1603b1217],
12	myopathy	NN	O	myopathy	prep_with	10	SENT_19	[p1l1624t1185r1807b1227],
13	in	IN	O	in	_	0	SENT_19	[p1l1825t1186r1854b1217],
14	this	DT	O	this	det	15	SENT_19	[p1l1873t1185r1935b1217],
15	group	NN	O	group	prep_in	12	SENT_19	[p1l1953t1195r2061b1227],
16	as	IN	O	as	_	0	SENT_19	[p1l2079t1195r2113b1217],
17	a	DT	O	a	det	18	SENT_19	[p1l2131t1195r2148b1217],
18	whole	NN	O	whole	prep_as	15	SENT_19	[p1l748t1232r868b1264],
19	.	.	O	.	_	0	SENT_19	[p1l748t1232r868b1264],

1	However	RB	O	however	advmod	18	SENT_20	[p1l889t1234r1057b1271],
2	,	,	O	,	_	0	SENT_20	[p1l889t1234r1057b1271],
3	when	WRB	O	when	advmod	6	SENT_20	[p1l1076t1232r1175b1264],
4	subjects	NNS	O	subject	nsubjpass	6	SENT_20	[p1l1193t1232r1337b1274],
5	were	VBD	O	be	auxpass	6	SENT_20	[p1l1353t1242r1441b1264],
6	stratified	VBN	O	stratify	advcl	18	SENT_20	[p1l1458t1232r1612b1264],
7	by	IN	O	by	_	0	SENT_20	[p1l1632t1232r1674b1274],
8	statin	NN	O	statin	nn	9	SENT_20	[p1l1690t1233r1786b1264],
9	type	NN	O	type	agent	6	SENT_20	[p1l1804t1236r1893b1274],
10	,	,	O	,	_	0	SENT_20	[p1l1804t1236r1893b1274],
11	the	DT	O	the	det	15	SENT_20	[p1l1912t1232r1970b1264],
12	$	$	MONEY	$	amod	15	SENT_20	[p1l1988t1233r2145b1264],
13	LCOlBl	JJ	MONEY	lcolbl	dep	12	SENT_20	[p1l1988t1233r2145b1264],
14	rs4149056	NN	O	rs4149056	nn	15	SENT_20	[p1l750t1280r943b1311],
15	genotype	NN	O	genotype	nsubjpass	18	SENT_20	[p1l960t1283r1132b1321],
16	was	VBD	O	be	auxpass	18	SENT_20	[p1l1147t1289r1215b1311],
17	significantly	RB	O	significantly	advmod	18	SENT_20	[p1l1231t1279r1446b1321],
18	associated	VBN	O	associate	_	0	SENT_20	[p1l1462t1279r1646b1311],
19	with	IN	O	with	_	0	SENT_20	[p1l1662t1279r1740b1311],
20	myopathy	NN	O	myopathy	prep_with	18	SENT_20	[p1l1760t1279r1943b1321],
21	in	IN	O	in	_	0	SENT_20	[p1l1960t1280r1989b1310],
22	patients	NNS	O	patient	prep_in	18	SENT_20	[p1l2008t1280r2149b1321],
23	who	WP	O	who	nsubj	24	SENT_20	[p1l748t1326r826b1357],
24	received	VBD	O	receive	rcmod	22	SENT_20	[p1l852t1326r999b1357],
25	simvastatin	NN	O	simvastatin	dobj	24	SENT_20	[p1l1024t1327r1235b1364],
26	,	,	O	,	_	0	SENT_20	[p1l1024t1327r1235b1364],
27	but	CC	O	but	_	0	SENT_20	[p1l1263t1326r1323b1357],
28	not	RB	O	not	_	0	SENT_20	[p1l1347t1330r1406b1357],
29	in	IN	O	in	_	0	SENT_20	[p1l1430t1327r1458b1357],
30	patients	NNS	O	patient	prep_in	18	SENT_20	[p1l1485t1327r1627b1367],
31	who	WP	O	who	nsubj	32	SENT_20	[p1l1649t1326r1728b1357],
32	received	VBD	O	receive	rcmod	30	SENT_20	[p1l1753t1326r1901b1357],
33	atorvastatin	NN	O	atorvastatin	dobj	32	SENT_20	[p1l1926t1327r2147b1357],
34	.	.	O	.	_	0	SENT_20	[p1l1926t1327r2147b1357],

1	Our	PRP$	O	we	poss	2	SENT_21	[p1l749t1374r819b1404],
2	findings	NNS	O	finding	nsubj	18	SENT_21	[p1l838t1373r983b1414],
3	provide	VBP	O	provide	_	0	SENT_21	[p1l1007t1373r1141b1414],
4	further	JJ	O	further	amod	5	SENT_21	[p1l1162t1373r1287b1404],
5	support	NN	O	support	dobj	3	SENT_21	[p1l1307t1377r1448b1414],
6	for	IN	O	for	_	0	SENT_21	[p1l1468t1373r1518b1404],
7	a	DT	O	a	det	8	SENT_21	[p1l1539t1382r1557b1404],
8	role	NN	O	role	prep_for	3	SENT_21	[p1l1581t1373r1646b1404],
9	for	IN	O	for	_	0	SENT_21	[p1l1667t1373r1718b1404],
10	$	$	MONEY	$	amod	12	SENT_21	[p1l1740t1374r1897b1404],
11	LCOlBl	JJ	MONEY	lcolbl	dep	10	SENT_21	[p1l1740t1374r1897b1404],
12	genotype	NN	O	genotype	prep_for	8	SENT_21	[p1l1923t1377r2095b1414],
13	in	IN	O	in	_	0	SENT_21	[p1l2119t1374r2148b1404],
14	simvastatin-associated	JJ	O	simvastatin-associated	amod	15	SENT_21	[p1l748t1495r1150b1526],
15	myopathy	NN	O	myopathy	prep_in	12	SENT_21	[p1l1172t1495r1364b1536],
16	,	,	O	,	_	0	SENT_21	[p1l1172t1495r1364b1536],
17	and	CC	O	and	_	0	SENT_21	[p1l1385t1495r1450b1526],
18	suggest	VBP	O	suggest	conj_and	3	SENT_21	[p1l1470t1499r1609b1536],
19	that	IN	O	that	complm	24	SENT_21	[p1l1626t1495r1699b1526],
20	this	DT	O	this	det	21	SENT_21	[p1l1715t1495r1778b1526],
21	association	NN	O	association	nsubj	24	SENT_21	[p1l1796t1496r1992b1526],
22	may	MD	O	may	aux	24	SENT_21	[p1l2013t1504r2089b1536],
23	be	VB	O	be	cop	24	SENT_21	[p1l2108t1495r2149b1526],
24	stronger	JJR	O	stronger	ccomp	18	SENT_21	[p1l749t1545r901b1583],
25	for	IN	O	for	_	0	SENT_21	[p1l914t1541r965b1573],
26	simvastatin	NN	O	simvastatin	prep_for	24	SENT_21	[p1l979t1542r1179b1573],
27	compared	VBN	O	compare	_	0	SENT_21	[p1l1198t1541r1380b1583],
28	with	IN	O	with	prepc_compared_with	24	SENT_21	[p1l1397t1541r1475b1573],
29	atorvastatin	NN	O	atorvastatin	pobj	24	SENT_21	[p1l1493t1542r1714b1573],
30	.	.	O	.	_	0	SENT_21	[p1l1493t1542r1714b1573],

1	The	DT	O	the	det	3	SENT_22	[p1l753t1588r812b1620],
2	Pharmacogenomics	NNP	MISC	Pharmacogenomics	nn	3	SENT_22	[p1l826t1588r1157b1630],
3	journal	NN	O	journal	dep	6	SENT_22	[p1l1167t1588r1293b1627],
4	(	CD	NUMBER	(	dep	3	SENT_22	[p1l1304t1589r1423b1628],
5	2012	CD	DATE	2012	dep	6	SENT_22	[p1l1304t1589r1423b1628],
6	)	CD	NUMBER	)	dep	12	SENT_22	[p1l1304t1589r1423b1628],
7	12	CD	NUMBER	12	dep	6	SENT_22	[p1l1440t1589r1491b1626],
8	,	,	O	,	_	0	SENT_22	[p1l1440t1589r1491b1626],
9	233-237	CD	NUMBER	233-237	appos	7	SENT_22	[p1l1508t1589r1676b1626],
10	;	:	O	;	_	0	SENT_22	[p1l1508t1589r1676b1626],
11	doi	FW	O	doi	dep	7	SENT_22	[p1l1693t1588r2147b1630],
12	:10.1038	CD	NUMBER	:10.1038	_	0	SENT_22	[p1l1693t1588r2147b1630],
13	/	:	O	/	punct	14	SENT_22	[p1l1693t1588r2147b1630],
14	tpj	NN	O	tpj	dep	12	SENT_22	[p1l1693t1588r2147b1630],
15	.2010.92	CD	NUMBER	.2010.92	num	14	SENT_22	[p1l1693t1588r2147b1630],
16	;	:	O	;	_	0	SENT_22	[p1l1693t1588r2147b1630],
17	published	VBN	O	publish	partmod	12	SENT_22	[p1l750t1635r921b1677],
18	online	NN	O	online	prep	17	SENT_22	[p1l938t1635r1047b1667],
19	18	CD	DATE	18	dep	18	SENT_22	[p1l1065t1636r1107b1667],
20	January	NNP	DATE	January	tmod	17	SENT_22	[p1l1122t1637r1254b1677],
21	2011	CD	DATE	2011	num	20	SENT_22	[p1l1270t1636r1353b1667],

1	Keywords	NNPS	O	Keywords	_	0	SENT_23	[p1l749t1732r920b1765],
2	:	:	O	:	_	0	SENT_23	[p1l749t1732r920b1765],
3	statin	NN	O	statin	dep	1	SENT_23	[p1l939t1732r1025b1762],
4	;	:	O	;	_	0	SENT_23	[p1l939t1732r1025b1762],
5	myopathy	NN	O	myopathy	dep	3	SENT_23	[p1l1040t1732r1194b1765],
6	;	:	O	;	_	0	SENT_23	[p1l1040t1732r1194b1765],
7	SLCOlBl	NN	O	slcolbl	dep	5	SENT_23	[p1l1209t1732r1340b1757],

1	Introduction	NN	O	introduction	_	0	SENT_24	[p1l749t1883r987b1912],

1	Despite	IN	O	despite	_	0	SENT_25	[p1l749t1977r876b2013],
2	their	PRP$	O	they	poss	4	SENT_25	[p1l898t1976r980b2004],
3	significant	JJ	O	significant	amod	4	SENT_25	[p1l1003t1976r1184b2013],
4	effects	NNS	O	effect	prep_despite	28	SENT_25	[p1l1206t1976r1314b2004],
5	on	IN	O	on	_	0	SENT_25	[p1l1337t1984r1381b2004],
6	reducing	VBG	O	reduce	prepc_on	4	SENT_25	[p1l1403t1976r1555b2013],
7	cardiovascular	JJ	O	cardiovascular	amod	8	SENT_25	[p1l1577t1976r1825b2004],
8	mortality	NN	O	mortality	dobj	6	SENT_25	[p1l1846t1976r2014b2013],
9	,	,	O	,	_	0	SENT_25	[p1l1846t1976r2014b2013],
10	statins	NNS	O	statin	nsubj	28	SENT_25	[p1l2039t1978r2149b2004],
11	remain	VBP	O	remain	cop	28	SENT_25	[p1l748t2024r870b2051],
12	underused	JJ	O	underused	acomp	28	SENT_25	[p1l880t2023r1062b2051],
13	in	IN	O	in	prep	12	SENT_25	[p1l1073t2024r1107b2051],
14	at	IN	O	at	pcomp	13	SENT_25	[p1l1119t2023r1225b2051],
15	—	CD	NUMBER	—	num	17	SENT_25	[p1l1119t2023r1225b2051],
16	risk	NN	O	risk	nn	17	SENT_25	[p1l1119t2023r1225b2051],
17	patients	NNS	O	patient	pobj	14	SENT_25	[p1l1235t2019r1398b2060],
18	}	RB	O	}	advmod	28	SENT_25	[p1l1235t2019r1398b2060],
19	in	IN	O	in	_	0	SENT_25	[p1l1411t2024r1445b2051],
20	part	NN	O	part	prep_in	28	SENT_25	[p1l1456t2027r1525b2060],
21	because	IN	O	because	_	0	SENT_25	[p1l1534t2023r1668b2051],
22	of	IN	O	of	_	0	SENT_25	[p1l1680t2023r1714b2051],
23	concerns	NNS	O	concern	prep_because_of	28	SENT_25	[p1l1724t2031r1877b2051],
24	of	IN	O	of	_	0	SENT_25	[p1l1889t2023r1924b2051],
25	adverse	JJ	O	adverse	amod	27	SENT_25	[p1l1933t2023r2060b2051],
26	drug	NN	O	drug	nn	27	SENT_25	[p1l2072t2023r2150b2060],
27	reactions	NNS	O	reaction	prep_of	23	SENT_25	[p1l748t2071r904b2098],
28	affecting	VBG	O	affect	_	0	SENT_25	[p1l927t2069r1078b2107],
29	the	DT	O	the	det	31	SENT_25	[p1l1099t2069r1154b2098],
30	musculoskeletal	JJ	O	musculoskeletal	amod	31	SENT_25	[p1l1177t2069r1453b2098],
31	system	NN	O	system	dobj	28	SENT_25	[p1l1476t2073r1602b2107],
32	.	.	O	.	_	0	SENT_25	[p1l1476t2073r1602b2107],

1	Statins	NNS	O	statin	nsubjpass	3	SENT_26	[p1l1626t2070r1741b2098],
2	are	VBP	O	be	auxpass	3	SENT_26	[p1l1764t2078r1813b2098],
3	associated	VBN	O	associate	_	0	SENT_26	[p1l1837t2070r2010b2098],
4	with	IN	O	with	_	0	SENT_26	[p1l2031t2069r2111b2098],
5	a	DT	O	a	det	6	SENT_26	[p1l2133t2078r2150b2098],
6	spectrum	NN	O	spectrum	prep_with	3	SENT_26	[p1l749t2125r908b2158],
7	of	IN	O	of	_	0	SENT_26	[p1l923t2121r957b2149],
8	muscle	NN	O	muscle	nn	9	SENT_26	[p1l970t2121r1090b2149],
9	pain	NN	O	pain	prep_of	6	SENT_26	[p1l1104t2123r1181b2158],
10	and	CC	O	and	_	0	SENT_26	[p1l1195t2121r1260b2149],
11	damage	NN	O	damage	prep_with	3	SENT_26	[p1l1274t2121r1406b2158],
12	varying	VBG	O	vary	amod	11	SENT_26	[p1l1420t2123r1552b2158],
13	in	IN	O	in	_	0	SENT_26	[p1l1566t2123r1600b2149],
14	severity	NN	O	severity	prep_in	11	SENT_26	[p1l1615t2123r1748b2158],
15	and	CC	O	and	_	0	SENT_26	[p1l1761t2121r1825b2149],
16	frequency	NN	O	frequency	conj_and	14	SENT_26	[p1l1840t2121r2017b2158],
17	.	.	O	.	_	0	SENT_26	[p1l1840t2121r2017b2158],

1	At	IN	O	at	_	0	SENT_27	[p1l2033t2122r2072b2149],
2	one	CD	NUMBER	one	num	3	SENT_27	[p1l2087t2129r2149b2149],
3	end	NN	O	end	prep_at	7	SENT_27	[p1l749t2174r812b2203],
4	of	IN	O	of	_	0	SENT_27	[p1l825t2174r860b2203],
5	this	DT	O	this	det	6	SENT_27	[p1l870t2174r934b2203],
6	spectrum	NN	O	spectrum	prep_of	3	SENT_27	[p1l947t2178r1106b2212],
7	is	VBZ	O	be	_	0	SENT_27	[p1l1118t2176r1143b2203],
8	rhabdomyolysis	NN	O	rhabdomyolysis	nsubj	7	SENT_27	[p1l1156t2174r1440b2212],
9	,	,	O	,	_	0	SENT_27	[p1l1156t2174r1440b2212],
10	a	DT	O	a	det	15	SENT_27	[p1l1455t2182r1472b2203],
11	rare	JJ	O	rare	amod	15	SENT_27	[p1l1484t2182r1549b2203],
12	but	CC	O	but	_	0	SENT_27	[p1l1561t2174r1619b2203],
13	potentially	RB	O	potentially	advmod	14	SENT_27	[p1l1631t2174r1821b2212],
14	fatal	JJ	O	fatal	amod	15	SENT_27	[p1l1833t2174r1908b2203],
15	complication	NN	O	complication	appos	8	SENT_27	[p1l1920t2174r2150b2212],
16	that	WDT	O	that	nsubj	17	SENT_27	[p1l748t2227r818b2256],
17	occurs	VBZ	O	occur	rcmod	15	SENT_27	[p1l833t2235r941b2256],
18	in	IN	O	in	_	0	SENT_27	[p1l956t2229r990b2255],
19	fewer	JJR	O	fewer	mwe	20	SENT_27	[p1l1005t2227r1098b2256],
20	than	IN	O	than	quantmod	21	SENT_27	[p1l1111t2227r1192b2256],
21	one	CD	NUMBER	one	prep_in	17	SENT_27	[p1l1206t2235r1269b2256],
22	in	IN	O	in	_	0	SENT_27	[p1l1284t2229r1318b2255],
23	10000	CD	NUMBER	10000	num	24	SENT_27	[p1l1335t2228r1444b2256],
24	patients	NNS	O	patient	prep_in	17	SENT_27	[p1l1458t2229r1596b2265],
25	receiving	VBG	O	receive	partmod	24	SENT_27	[p1l1610t2229r1768b2265],
26	statins	NNS	O	statin	dobj	25	SENT_27	[p1l1782t2229r1893b2256],
27	per	IN	O	per	_	0	SENT_27	[p1l1907t2235r1962b2265],
28	year	NN	DURATION	year	prep_per	26	SENT_27	[p1l1975t2224r2071b2265],
29	?	.	O	?	_	0	SENT_27	[p1l1975t2224r2071b2265],

1	The	DT	O	the	det	3	SENT_28	[p1l2084t2227r2149b2256],
2	devastating	JJ	O	devastating	amod	3	SENT_28	[p1l749t2274r947b2312],
3	consequences	NNS	O	consequence	nsubj	7	SENT_28	[p1l968t2283r1205b2312],
4	of	IN	O	of	_	0	SENT_28	[p1l1228t2274r1263b2303],
5	statin	NN	O	statin	nn	6	SENT_28	[p1l1284t2274r1533b2303],
6	—	NN	O	—	prep_of	3	SENT_28	[p1l1284t2274r1533b2303],
7	induced	VBD	O	induce	ccomp	59	SENT_28	[p1l1284t2274r1533b2303],
8	rhabdomyolysis	NN	O	rhabdomyolysis	nsubj	9	SENT_28	[p1l1555t2274r1830b2312],
9	led	VBD	O	lead	ccomp	7	SENT_28	[p1l1853t2274r1904b2303],
10	to	TO	O	to	_	0	SENT_28	[p1l1926t2278r1960b2303],
11	the	DT	O	the	det	12	SENT_28	[p1l1982t2274r2037b2303],
12	withdrawal	NN	O	withdrawal	prep_to	9	SENT_28	[p1l2059t2274r2149b2303, p1l749t2322r863b2350],
13	of	IN	O	of	_	0	SENT_28	[p1l881t2321r916b2350],
14	cerivastatin	NN	O	cerivastatin	prep_of	12	SENT_28	[p1l932t2323r1131b2350],
15	in	IN	O	in	_	0	SENT_28	[p1l1149t2323r1184b2349],
16	2001	CD	DATE	2001	prep_in	14	SENT_28	[p1l1202t2322r1283b2350],
17	after	IN	O	after	mark	23	SENT_28	[p1l1303t2321r1380b2350],
18	~	NN	O	~	nsubjpass	23	SENT_28	[p1l1403t2322r1498b2350],
19	100	CD	NUMBER	100	num	21	SENT_28	[p1l1403t2322r1498b2350],
20	rhabdomyolysis-related	JJ	O	rhabdomyolysis-related	amod	21	SENT_28	[p1l1515t2322r1922b2359],
21	deaths	NNS	O	death	dep	18	SENT_28	[p1l1941t2322r2052b2350],
22	were	VBD	O	be	auxpass	23	SENT_28	[p1l2069t2330r2149b2350],
23	associated	VBN	O	associate	advcl	9	SENT_28	[p1l749t2369r922b2397],
24	with	IN	O	with	_	0	SENT_28	[p1l938t2368r1017b2397],
25	this	DT	O	this	det	29	SENT_28	[p1l1034t2368r1097b2397],
26	drug	NN	O	drug	nn	29	SENT_28	[p1l1115t2365r1219b2406],
27	.3	NN	NUMBER	.3	nn	29	SENT_28	[p1l1115t2365r1219b2406],
28	Statin	NN	O	statin	nn	29	SENT_28	[p1l1237t2368r1525b2397],
29	—	NN	O	—	prep_with	23	SENT_28	[p1l1237t2368r1525b2397],
30	associated	VBN	O	associate	dep	29	SENT_28	[p1l1237t2368r1525b2397],
31	myopathy	NN	O	myopathy	dobj	30	SENT_28	[p1l1542t2369r1725b2406],
32	,	,	O	,	_	0	SENT_28	[p1l1542t2369r1725b2406],
33	defined	VBN	O	define	conj_and	30	SENT_28	[p1l1745t2368r1874b2397],
34	as	IN	O	as	_	0	SENT_28	[p1l1892t2377r1923b2397],
35	elevation	NN	O	elevation	prep_as	33	SENT_28	[p1l1941t2369r2100b2397],
36	of	IN	O	of	_	0	SENT_28	[p1l2117t2368r2152b2397],
37	creatine	NN	O	creatine	nn	38	SENT_28	[p1l749t2417r885b2444],
38	kinase	NN	O	kinase	prep_of	35	SENT_28	[p1l900t2415r1007b2444],
39	(	CD	NUMBER	(	num	42	SENT_28	[p1l1023t2416r1097b2451],
40	CK	NN	O	ck	nn	42	SENT_28	[p1l1023t2416r1097b2451],
41	)	NN	O	)	nn	42	SENT_28	[p1l1023t2416r1097b2451],
42	values	NNS	O	value	dep	38	SENT_28	[p1l1111t2415r1218b2444],
43	greater	JJR	O	greater	mwe	44	SENT_28	[p1l1233t2419r1351b2453],
44	than	IN	O	than	quantmod	46	SENT_28	[p1l1364t2415r1445b2444],
45	10	CD	NUMBER	10	number	46	SENT_28	[p1l1461t2416r1499b2444],
46	times	NNS	O	time	num	49	SENT_28	[p1l1513t2417r1606b2444],
47	the	DT	O	the	det	49	SENT_28	[p1l1620t2415r1675b2444],
48	upper	JJ	O	upper	amod	49	SENT_28	[p1l1689t2424r1789b2453],
49	limit	NN	O	limit	dep	42	SENT_28	[p1l1803t2415r1885b2444],
50	of	IN	O	of	_	0	SENT_28	[p1l1899t2415r1935b2444],
51	normal	JJ	O	normal	prep_of	35	SENT_28	[p1l1946t2415r2071b2444],
52	and	CC	O	and	_	0	SENT_28	[p1l2086t2415r2150b2444],
53	often	RB	O	often	advmod	54	SENT_28	[p1l749t2463r839b2491],
54	accompanied	VBN	O	accompany	dep	29	SENT_28	[p1l857t2463r1087b2500],
55	by	IN	O	by	_	0	SENT_28	[p1l1103t2463r1146b2500],
56	muscle	NN	O	muscle	nn	57	SENT_28	[p1l1163t2463r1283b2491],
57	pain	NN	O	pain	prep_by	54	SENT_28	[p1l1300t2464r1385b2500],
58	,	,	O	,	_	0	SENT_28	[p1l1300t2464r1385b2500],
59	occurs	VBZ	O	occur	conj_and	59	SENT_28	[p1l1406t2471r1515b2491],
60	in	IN	O	in	advmod	59	SENT_28	[p1l1533t2464r1567b2491],
61	up	RB	O	up	advmod	60	SENT_28	[p1l1584t2471r1628b2500],
62	to	TO	O	to	_	0	SENT_28	[p1l1646t2466r1680b2491],
63	0.4	CD	PERCENT	0.4	num	64	SENT_28	[p1l1698t2463r1784b2491],
64	%	NN	PERCENT	%	prep_to	59	SENT_28	[p1l1698t2463r1784b2491],
65	of	IN	O	of	_	0	SENT_28	[p1l1802t2463r1837b2491],
66	patients	NNS	O	patient	prep_of	64	SENT_28	[p1l1852t2464r1990b2500],
67	on	IN	O	on	_	0	SENT_28	[p1l2008t2471r2053b2491],
68	high	JJ	O	high	amod	69	SENT_28	[p1l2071t2463r2150b2500],
69	doses	NNS	O	dose	prep_on	66	SENT_28	[p1l749t2510r840b2538],
70	of	IN	O	of	_	0	SENT_28	[p1l858t2510r892b2538],
71	simvastatin	NN	O	simvastatin	nn	72	SENT_28	[p1l908t2506r1122b2538],
72	“	NN	O	“	prep_of	69	SENT_28	[p1l908t2506r1122b2538],
73	and	CC	O	and	_	0	SENT_28	[p1l1139t2510r1203b2538],
74	in	IN	O	in	_	0	SENT_28	[p1l1220t2511r1254b2538],
75	0.01	CD	PERCENT	0.01	num	76	SENT_28	[p1l1271t2511r1451b2538],
76	—	CD	PERCENT	—	prep_in	59	SENT_28	[p1l1271t2511r1451b2538],
77	0.1	CD	PERCENT	0.1	num	78	SENT_28	[p1l1271t2511r1451b2538],
78	%	NN	PERCENT	%	nsubj	59	SENT_28	[p1l1271t2511r1451b2538],
79	of	IN	O	of	_	0	SENT_28	[p1l1468t2510r1503b2538],
80	patients	NNS	O	patient	prep_of	78	SENT_28	[p1l1517t2511r1655b2547],
81	on	IN	O	on	_	0	SENT_28	[p1l1673t2518r1717b2538],
82	more	JJR	O	more	amod	84	SENT_28	[p1l1734t2518r1823b2538],
83	standard	JJ	O	standard	amod	84	SENT_28	[p1l1841t2510r1990b2538],
84	doses	NNS	O	dose	prep_on	80	SENT_28	[p1l2007t2506r2150b2538],
85	.	.	O	.	_	0	SENT_28	[p1l2007t2506r2150b2538],

1	“	NN	O	“	nsubj	15	SENT_29	[p1l2007t2506r2150b2538],
2	Less	RBR	O	less	advmod	3	SENT_29	[p1l748t2558r817b2585],
3	severe	JJ	O	severe	amod	5	SENT_29	[p1l836t2565r939b2585],
4	muscle	NN	O	muscle	nn	5	SENT_29	[p1l958t2557r1078b2585],
5	pain	NN	O	pain	npadvmod	1	SENT_29	[p1l1096t2558r1173b2594],
6	without	IN	O	without	_	0	SENT_29	[p1l1190t2556r1329b2585],
7	biochemical	JJ	O	biochemical	amod	8	SENT_29	[p1l1346t2556r1558b2585],
8	evidence	NN	O	evidence	prep_without	1	SENT_29	[p1l1577t2556r1728b2585],
9	of	IN	O	of	_	0	SENT_29	[p1l1747t2556r1782b2585],
10	muscle	NN	O	muscle	nn	11	SENT_29	[p1l1798t2556r1918b2585],
11	damage	NN	O	damage	prep_of	8	SENT_29	[p1l1938t2557r2070b2594],
12	is	VBZ	O	be	cop	15	SENT_29	[p1l2089t2558r2114b2585],
13	a	DT	O	a	det	15	SENT_29	[p1l2133t2565r2150b2585],
14	common	JJ	O	common	amod	15	SENT_29	[p1l749t2611r905b2631],
15	complaint	NN	O	complaint	_	0	SENT_29	[p1l930t2603r1108b2640],
16	and	CC	O	and	_	0	SENT_29	[p1l1133t2603r1197b2631],
17	occurs	VBZ	O	occur	conj_and	15	SENT_29	[p1l1223t2611r1332b2631],
18	in	IN	O	in	_	0	SENT_29	[p1l1357t2605r1392b2631],
19	up	RB	O	up	advmod	24	SENT_29	[p1l1416t2611r1460b2640],
20	to	TO	O	to	_	0	SENT_29	[p1l1486t2607r1520b2631],
21	5	CD	PERCENT	5	number	22	SENT_29	[p1l1547t2604r1661b2631],
22	—	CD	PERCENT	—	prep_to	19	SENT_29	[p1l1547t2604r1661b2631],
23	10	CD	PERCENT	10	num	24	SENT_29	[p1l1547t2604r1661b2631],
24	%	NN	PERCENT	%	prep_in	17	SENT_29	[p1l1547t2604r1661b2631],
25	of	IN	O	of	_	0	SENT_29	[p1l1686t2603r1721b2631],
26	patients	NNS	O	patient	prep_of	24	SENT_29	[p1l1744t2605r1882b2640],
27	on	IN	O	on	_	0	SENT_29	[p1l1908t2611r1953b2631],
28	statins	NNS	O	statin	prep_on	26	SENT_29	[p1l1979t2605r2090b2631],
29	in	IN	O	in	_	0	SENT_29	[p1l2115t2605r2150b2631],
30	observational	JJ	O	observational	amod	31	SENT_29	[p1l749t2725r982b2753],
31	studies	NNS	O	study	prep_in	28	SENT_29	[p1l998t2721r1167b2753],
32	.7	CD	NUMBER	.7	dobj	17	SENT_29	[p1l998t2721r1167b2753],
33	'	''	O	'	_	0	SENT_29	[p1l998t2721r1167b2753],
34	8	CD	NUMBER	8	npadvmod	55	SENT_29	[p1l998t2721r1167b2753],
35	In	IN	O	in	_	0	SENT_29	[p1l1183t2726r1219b2753],
36	a	DT	O	a	det	38	SENT_29	[p1l1235t2733r1252b2753],
37	systematic	JJ	O	systematic	amod	38	SENT_29	[p1l1269t2727r1448b2762],
38	review	NN	O	review	prep_in	55	SENT_29	[p1l1464t2727r1577b2753],
39	of	IN	O	of	_	0	SENT_29	[p1l1592t2725r1627b2753],
40	randomized	VBN	O	randomize	prepc_of	38	SENT_29	[p1l1641t2725r1848b2753],
41	trials	NNS	O	trial	nsubj	42	SENT_29	[p1l1863t2725r1947b2753],
42	comparing	VBG	O	compare	dep	40	SENT_29	[p1l1964t2726r2150b2762],
43	statin	NN	O	statin	nn	44	SENT_29	[p1l749t2773r845b2800],
44	therapy	NN	O	therapy	dobj	42	SENT_29	[p1l856t2772r990b2809],
45	with	IN	O	with	_	0	SENT_29	[p1l999t2772r1078b2800],
46	placebo	NN	O	placebo	prep_with	42	SENT_29	[p1l1089t2772r1230b2809],
47	,	,	O	,	_	0	SENT_29	[p1l1089t2772r1230b2809],
48	the	DT	O	the	det	49	SENT_29	[p1l1244t2772r1299b2800],
49	risk	NN	O	risk	nsubjpass	55	SENT_29	[p1l1310t2772r1371b2800],
50	of	IN	O	of	_	0	SENT_29	[p1l1382t2772r1417b2800],
51	myalgia	NN	O	myalgium	prep_of	49	SENT_29	[p1l1426t2772r1562b2809],
52	was	VBD	O	be	auxpass	55	SENT_29	[p1l1573t2780r1635b2800],
53	not	RB	O	not	neg	55	SENT_29	[p1l1647t2775r1706b2800],
54	significantly	RB	O	significantly	advmod	55	SENT_29	[p1l1718t2772r1933b2809],
55	increased	VBN	O	increase	rcmod	32	SENT_29	[p1l1943t2772r2104b2800],
56	in	IN	O	in	_	0	SENT_29	[p1l2115t2773r2150b2800],
57	patients	NNS	O	patient	prep_in	55	SENT_29	[p1l748t2820r886b2856],
58	administered	VBN	O	administer	partmod	57	SENT_29	[p1l901t2819r1127b2847],
59	statins	NNS	O	statin	dobj	58	SENT_29	[p1l1142t2815r1279b2847],
60	?	.	O	?	_	0	SENT_29	[p1l1142t2815r1279b2847],

1	SLCO1B1	NN	O	slco1b1	nn	4	SENT_30	[p1l1427t3023r1622b3067],
2	and	CC	O	and	_	0	SENT_30	[p1l1644t3022r1732b3067],
3	statin	NN	O	statin	nn	4	SENT_30	[p1l1751t3022r1888b3067],
4	myopathy	NN	O	myopathy	_	0	SENT_30	[p1l1909t3022r2151b3082],
5	LR	NNP	O	LR	nn	6	SENT_30	[p1l1795t3096r1840b3135],
6	Brunham	NNP	O	Brunham	dep	4	SENT_30	[p1l1860t3094r2043b3135],
7	et	FW	O	et	nn	8	SENT_30	[p1l2065t3099r2101b3135],
8	al	FW	O	al	dep	4	SENT_30	[p1l2117t3094r2153b3135],

1	The	DT	O	the	det	2	SENT_31	[p2l83t84r216b142],
2	mechanisms	NNS	O	mechanism	nsubjpass	8	SENT_31	[p2l255t84r697b142],
3	underlying	VBG	O	underlie	partmod	2	SENT_31	[p2l734t84r1126b160],
4	statin-associated	JJ	O	statin-associated	amod	5	SENT_31	[p2l1165t84r1747b142],
5	myopathy	NN	O	myopathy	dobj	3	SENT_31	[p2l1785t84r2151b160],
6	remain	VBP	O	remain	auxpass	8	SENT_31	[p2l9t181r258b236],
7	incompletely	RB	O	incompletely	advmod	8	SENT_31	[p2l297t178r767b254],
8	understood	VBN	O	understand	_	0	SENT_31	[p2l802t178r1208b236],
9	and	CC	O	and	_	0	SENT_31	[p2l1247t178r1378b236],
10	methods	NNS	O	method	nsubj	18	SENT_31	[p2l1416t178r1724b236],
11	to	TO	O	to	aux	12	SENT_31	[p2l1763t186r1833b236],
12	identify	VB	O	identify	infmod	10	SENT_31	[p2l1873t178r2151b254],
13	patients	NNS	O	patient	dobj	12	SENT_31	[p2l8t277r290b350],
14	at	IN	O	at	_	0	SENT_31	[p2l314t281r378b332],
15	high	JJ	O	high	amod	16	SENT_31	[p2l400t274r562b350],
16	risk	NN	O	risk	prep_at	12	SENT_31	[p2l585t274r710b332],
17	are	VBP	O	be	aux	18	SENT_31	[p2l731t291r832b332],
18	lacking	VBG	O	lack	conj_and	8	SENT_31	[p2l856t274r1128b350],
19	.	.	O	.	_	0	SENT_31	[p2l856t274r1128b350],

1	Recently	RB	DATE	recently	dep	115	SENT_32	[p2l1156t274r1471b350],
2	,	,	O	,	_	0	SENT_32	[p2l1156t274r1471b350],
3	genetic	JJ	O	genetic	dep	115	SENT_32	[p2l1498t277r1753b350],
4	variants	NNS	O	variant	dep	115	SENT_32	[p2l1774t277r2055b332],
5	in	IN	O	in	dep	115	SENT_32	[p2l2078t277r2149b331],
6	the	DT	O	the	dep	115	SENT_32	[p2l8t370r121b428],
7	gene	NN	O	gene	dep	115	SENT_32	[p2l172t387r336b446],
8	encoding	VBG	O	encode	dep	115	SENT_32	[p2l387t370r717b446],
9	the	DT	O	the	dep	115	SENT_32	[p2l766t370r879b428],
10	organic	JJ	O	organic	dep	115	SENT_32	[p2l931t373r1194b446],
11	anion-transporting	JJ	O	anion-transporting	dep	115	SENT_32	[p2l1245t373r1920b446],
12	polypeptide	NN	O	polypeptide	dep	115	SENT_32	[p2l1968t370r2148b446, p2l8t465r272b540],
13	OATP1B1	NN	O	oatp1b1	dep	115	SENT_32	[p2l319t466r647b522],
14	(	NN	O	(	dep	115	SENT_32	[p2l702t465r888b540],
15	gene	NN	O	gene	dep	115	SENT_32	[p2l702t465r888b540],
16	name	NN	O	name	dep	115	SENT_32	[p2l935t481r1130b522],
17	SLCO1B1	NN	O	slco1b1	dep	115	SENT_32	[p2l1176t466r1516b535],
18	,	,	O	,	_	0	SENT_32	[p2l1176t466r1516b535],
19	GeneID	NNP	O	GeneID	dep	115	SENT_32	[p2l1569t466r1856b522],
20	:	:	O	:	_	0	SENT_32	[p2l1569t466r1856b522],
21	10599	CD	NUMBER	10599	dep	115	SENT_32	[p2l1912t465r2145b537],
22	)	NN	O	)	dep	115	SENT_32	[p2l1912t465r2145b537],
23	were	VBD	O	be	dep	115	SENT_32	[p2l7t577r170b618],
24	reported	VBN	O	report	dep	115	SENT_32	[p2l201t560r500b636],
25	to	TO	O	to	dep	115	SENT_32	[p2l530t567r600b618],
26	be	VB	O	be	dep	115	SENT_32	[p2l629t560r709b618],
27	significantly	RB	O	significantly	dep	115	SENT_32	[p2l742t560r1181b636],
28	associated	VBN	O	associate	dep	115	SENT_32	[p2l1210t560r1566b618],
29	with	IN	O	with	dep	115	SENT_32	[p2l1594t560r1756b618],
30	myopathy	NN	O	myopathy	dep	115	SENT_32	[p2l1785t560r2151b636],
31	in	IN	O	in	dep	115	SENT_32	[p2l9t658r79b712],
32	two	CD	NUMBER	two	dep	115	SENT_32	[p2l137t662r267b712],
33	cohorts	NNS	O	cohort	dep	115	SENT_32	[p2l328t655r590b712],
34	of	IN	O	of	dep	115	SENT_32	[p2l651t654r722b712],
35	patients	NNS	O	patient	dep	115	SENT_32	[p2l776t658r1059b730],
36	from	IN	O	from	dep	115	SENT_32	[p2l1118t654r1288b712],
37	the	DT	O	the	dep	115	SENT_32	[p2l1347t655r1460b712],
38	United	NNP	LOCATION	United	dep	115	SENT_32	[p2l1519t655r1763b712],
39	Kingdom	NNP	LOCATION	Kingdom	dep	115	SENT_32	[p2l1822t655r2148b730],
40	receiving	VBG	O	receive	dep	115	SENT_32	[p2l9t751r331b823],
41	high	JJ	O	high	dep	115	SENT_32	[p2l386t748r548b823],
42	doses	NNS	O	dose	dep	115	SENT_32	[p2l604t748r791b805],
43	of	IN	O	of	dep	115	SENT_32	[p2l848t747r920b805],
44	simvastatin	NN	O	simvastatin	dep	115	SENT_32	[p2l973t741r1466b805],
45	.1	CD	NUMBER	.1	dep	115	SENT_32	[p2l973t741r1466b805],
46	°	CD	NUMBER	°	dep	115	SENT_32	[p2l973t741r1466b805],
47	In	IN	O	in	dep	115	SENT_32	[p2l1523t750r1595b805],
48	patients	NNS	O	patient	dep	115	SENT_32	[p2l1650t751r1933b823],
49	with	IN	O	with	dep	115	SENT_32	[p2l1987t748r2148b805],
50	‘	NN	O	‘	dep	115	SENT_32	[p2l11t844r301b902],
51	definite	JJ	O	definite	dep	115	SENT_32	[p2l11t844r301b902],
52	myopathy	NN	O	myopathy	dep	115	SENT_32	[p2l335t844r736b920],
53	’	NN	O	’	dep	115	SENT_32	[p2l335t844r736b920],
54	,	,	O	,	_	0	SENT_32	[p2l335t844r736b920],
55	defined	VBN	O	define	dep	115	SENT_32	[p2l775t844r1040b902],
56	as	IN	O	as	dep	115	SENT_32	[p2l1073t861r1138b902],
57	a	DT	O	a	dep	115	SENT_32	[p2l1172t861r1206b902],
58	CK	NN	O	ck	dep	115	SENT_32	[p2l1241t846r1345b902],
59	value	NN	O	value	dep	115	SENT_32	[p2l1373t844r1561b902],
60	greater	JJR	O	greater	dep	115	SENT_32	[p2l1594t851r1836b920],
61	than	IN	O	than	dep	115	SENT_32	[p2l1868t844r2032b902],
62	10	CD	NUMBER	10	dep	115	SENT_32	[p2l2071t846r2149b902],
63	times	NNS	O	time	dep	115	SENT_32	[p2l9t942r199b997],
64	the	DT	O	the	dep	115	SENT_32	[p2l241t939r353b997],
65	upper	JJ	O	upper	dep	115	SENT_32	[p2l395t956r601b1015],
66	limit	NN	O	limit	dep	115	SENT_32	[p2l642t939r811b997],
67	of	IN	O	of	dep	115	SENT_32	[p2l854t939r926b997],
68	normal	JJ	O	normal	dep	115	SENT_32	[p2l963t939r1238b1009],
69	,	,	O	,	_	0	SENT_32	[p2l963t939r1238b1009],
70	the	DT	O	the	dep	115	SENT_32	[p2l1284t939r1397b997],
71	minor	JJ	O	minor	dep	115	SENT_32	[p2l1440t942r1659b997],
72	allele	NN	O	allele	dep	115	SENT_32	[p2l1701t939r1882b997],
73	of	IN	O	of	dep	115	SENT_32	[p2l1926t939r1998b997],
74	the	DT	O	the	dep	115	SENT_32	[p2l2035t939r2148b997],
75	rs4149056	NN	O	rs4149056	dep	115	SENT_32	[p2l9t1035r371b1092],
76	single	JJ	O	single	dep	115	SENT_32	[p2l455t1034r658b1110],
77	nucleotide	NN	O	nucleotide	dep	115	SENT_32	[p2l740t1034r1114b1092],
78	polymorphism	NN	O	polymorphism	dep	115	SENT_32	[p2l1196t1034r1722b1110],
79	(	CD	NUMBER	(	dep	115	SENT_32	[p2l1807t1034r1993b1106],
80	SNP	NN	O	snp	dep	115	SENT_32	[p2l1807t1034r1993b1106],
81	)	NN	O	)	dep	115	SENT_32	[p2l1807t1034r1993b1106],
82	in	IN	O	in	dep	115	SENT_32	[p2l2078t1037r2149b1091],
83	SLCOJBI	NNP	O	SLCOJBI	dep	115	SENT_32	[p2l7t1130r324b1186],
84	(	CD	NUMBER	(	dep	115	SENT_32	[p2l397t1129r825b1200],
85	SLCO1B1	NN	O	slco1b1	dep	115	SENT_32	[p2l397t1129r825b1200],
86	*	CD	NUMBER	*	dep	115	SENT_32	[p2l397t1129r825b1200],
87	5	CD	NUMBER	5	dep	115	SENT_32	[p2l397t1129r825b1200],
88	genotype	NN	O	genotype	dep	115	SENT_32	[p2l892t1129r1264b1204],
89	)	NN	O	)	dep	115	SENT_32	[p2l892t1129r1264b1204],
90	,	,	O	,	_	0	SENT_32	[p2l892t1129r1264b1204],
91	which	WDT	O	which	dep	115	SENT_32	[p2l1330t1128r1550b1186],
92	results	VBZ	O	result	dep	115	SENT_32	[p2l1613t1128r1838b1186],
93	in	IN	O	in	dep	115	SENT_32	[p2l1902t1131r1973b1185],
94	the	DT	O	the	dep	115	SENT_32	[p2l2035t1128r2148b1186],
95	substitution	NN	O	substitution	dep	115	SENT_32	[p2l10t1223r435b1280],
96	of	IN	O	of	dep	115	SENT_32	[p2l484t1223r556b1280],
97	alanine	NN	O	alanine	dep	115	SENT_32	[p2l601t1223r860b1280],
98	for	IN	O	for	dep	115	SENT_32	[p2l910t1223r1008b1280],
99	valine	NN	O	valine	dep	115	SENT_32	[p2l1054t1223r1269b1280],
100	at	IN	O	at	dep	115	SENT_32	[p2l1319t1230r1382b1280],
101	amino	NN	O	amino	dep	115	SENT_32	[p2l1432t1226r1657b1280],
102	acid	NN	O	acid	dep	115	SENT_32	[p2l1707t1223r1850b1280],
103	residue	NN	O	residue	dep	115	SENT_32	[p2l1898t1223r2148b1280],
104	174	CD	NUMBER	174	dep	115	SENT_32	[p2l14t1319r154b1387],
105	,	,	O	,	_	0	SENT_32	[p2l14t1319r154b1387],
106	conferred	VBD	O	confer	dep	115	SENT_32	[p2l187t1317r524b1375],
107	an	DT	O	a	dep	115	SENT_32	[p2l552t1334r637b1375],
108	allelic	JJ	O	allelic	dep	115	SENT_32	[p2l666t1317r871b1375],
109	odds	NNS	O	odds	dep	115	SENT_32	[p2l900t1317r1064b1375],
110	ratio	NN	O	ratio	dep	115	SENT_32	[p2l1092t1320r1254b1375],
111	(	CD	NUMBER	(	dep	115	SENT_32	[p2l1286t1317r1440b1389],
112	OR	NN	O	or	dep	115	SENT_32	[p2l1286t1317r1440b1389],
113	)	NN	O	)	dep	115	SENT_32	[p2l1286t1317r1440b1389],
114	of	IN	O	of	dep	115	SENT_32	[p2l1472t1317r1544b1375],
115	4.5	CD	NUMBER	4.5	_	0	SENT_32	[p2l1568t1319r1691b1375],
116	.	.	O	.	_	0	SENT_32	[p2l1568t1319r1691b1375],

1	This	DT	O	this	det	2	SENT_33	[p2l1721t1317r1871b1375],
2	variant	NN	O	variant	nsubjpass	6	SENT_33	[p2l1898t1320r2149b1375],
3	has	VBZ	O	have	aux	6	SENT_33	[p2l9t1413r124b1470],
4	also	RB	O	also	advmod	6	SENT_33	[p2l172t1413r305b1470],
5	been	VBN	O	be	auxpass	6	SENT_33	[p2l350t1413r520b1470],
6	reported	VBN	O	report	_	0	SENT_33	[p2l565t1413r864b1488],
7	to	TO	O	to	aux	9	SENT_33	[p2l910t1420r979b1470],
8	be	VB	O	be	auxpass	9	SENT_33	[p2l1024t1413r1104b1470],
9	associated	VBN	O	associate	xcomp	6	SENT_33	[p2l1151t1413r1507b1470],
10	with	IN	O	with	_	0	SENT_33	[p2l1551t1413r1712b1470],
11	more	JJR	O	more	dep	12	SENT_33	[p2l1758t1429r1939b1470],
12	mild	JJ	O	mild	amod	15	SENT_33	[p2l1986t1413r2149b1470],
13	simvastatin-associated	JJ	O	simvastatin-associated	amod	15	SENT_33	[p2l10t1508r801b1566],
14	adverse	JJ	O	adverse	amod	15	SENT_33	[p2l840t1508r1099b1566],
15	effects	NNS	O	effect	prep_with	9	SENT_33	[p2l1139t1508r1360b1566],
16	consisting	VBG	O	consist	xcomp	9	SENT_33	[p2l1399t1511r1760b1584],
17	of	IN	O	of	_	0	SENT_33	[p2l1797t1508r1868b1566],
18	muscle	NN	O	muscle	nn	19	SENT_33	[p2l1902t1508r2148b1566],
19	pain	NN	O	pain	prep_of	16	SENT_33	[p2l8t1606r181b1678],
20	,	,	O	,	_	0	SENT_33	[p2l8t1606r181b1678],
21	drug	NN	O	drug	nn	22	SENT_33	[p2l234t1603r395b1678],
22	discontinuation	NN	O	discontinuation	conj_or	19	SENT_33	[p2l441t1603r1008b1660],
23	or	CC	O	or	_	0	SENT_33	[p2l1055t1619r1127b1660],
24	CK	NN	O	ck	nn	25	SENT_33	[p2l1174t1604r1279b1660],
25	elevation	NN	O	elevation	prep_of	16	SENT_33	[p2l1324t1603r1650b1660],
26	greater	JJR	O	greater	mwe	27	SENT_33	[p2l1697t1610r1938b1678],
27	than	IN	O	than	quantmod	29	SENT_33	[p2l1984t1603r2149b1660],
28	three	CD	NUMBER	three	number	29	SENT_33	[p2l8t1698r189b1755],
29	times	NNS	O	time	num	32	SENT_33	[p2l216t1701r406b1755],
30	the	DT	O	the	det	32	SENT_33	[p2l433t1698r546b1755],
31	upper	JJ	O	upper	amod	32	SENT_33	[p2l573t1714r779b1773],
32	limit	NN	O	limit	dobj	16	SENT_33	[p2l804t1698r974b1755],
33	of	IN	O	of	_	0	SENT_33	[p2l1001t1697r1073b1755],
34	normal	JJ	O	normal	amod	42	SENT_33	[p2l1095t1698r1352b1755],
35	with	IN	O	with	_	0	SENT_33	[p2l1376t1698r1538b1755],
36	an	DT	O	a	det	37	SENT_33	[p2l1566t1714r1650b1755],
37	OR	NN	O	or	prep_with	34	SENT_33	[p2l1678t1699r1786b1755],
38	of	IN	O	of	_	0	SENT_33	[p2l1811t1697r1883b1755],
39	1.7	CD	NUMBER	1.7	prep_of	37	SENT_33	[p2l1911t1700r2010b1755],
40	per	IN	O	per	_	0	SENT_33	[p2l2038t1714r2150b1773],
41	SLCOJBI	NNP	O	SLCOJBI	prep_per	39	SENT_33	[p2l7t1793r324b1849],
42	genotype	NN	O	genotype	prep_of	32	SENT_33	[p2l383t1784r795b1867],
43	.	.	O	.	_	0	SENT_33	[p2l383t1784r795b1867],

1	“	NN	O	“	nsubjpass	40	SENT_34	[p2l383t1784r795b1867],
2	However	RB	O	however	advmod	8	SENT_34	[p2l851t1794r1177b1861],
3	,	,	O	,	_	0	SENT_34	[p2l851t1794r1177b1861],
4	no	DT	O	no	det	5	SENT_34	[p2l1234t1808r1325b1849],
5	replication	NN	O	replication	nsubjpass	8	SENT_34	[p2l1377t1791r1760b1867],
6	has	VBZ	O	have	aux	8	SENT_34	[p2l1812t1791r1928b1849],
7	been	VBN	O	be	auxpass	8	SENT_34	[p2l1979t1791r2149b1849],
8	reported	VBN	O	report	rcmod	1	SENT_34	[p2l9t1887r307b1963],
9	for	IN	O	for	_	0	SENT_34	[p2l337t1887r435b1945],
10	the	DT	O	the	det	11	SENT_34	[p2l464t1887r576b1945],
11	association	NN	O	association	prep_for	8	SENT_34	[p2l608t1890r998b1945],
12	of	IN	O	of	_	0	SENT_34	[p2l1029t1887r1101b1945],
13	this	DT	O	this	det	20	SENT_34	[p2l1126t1887r1255b1945],
14	variant	JJ	O	variant	amod	20	SENT_34	[p2l1284t1890r1535b1945],
15	with	IN	O	with	_	0	SENT_34	[p2l1562t1887r1724b1945],
16	significant	JJ	O	significant	prep_with	14	SENT_34	[p2l1755t1887r2143b1963],
17	,	,	O	,	_	0	SENT_34	[p2l1755t1887r2143b1963],
18	biochemically	RB	O	biochemically	advmod	19	SENT_34	[p2l6t1982r510b2058],
19	determined	VBN	O	determine	amod	16	SENT_34	[p2l543t1982r951b2040],
20	myopathy	NN	O	myopathy	prep_of	11	SENT_34	[p2l986t1982r1352b2058],
21	and	CC	O	and	_	0	SENT_34	[p2l1385t1982r1533b2052],
22	,	,	O	,	_	0	SENT_34	[p2l1385t1982r1533b2052],
23	in	IN	O	in	dep	8	SENT_34	[p2l1573t1985r1643b2039],
24	addition	NN	O	addition	pobj	23	SENT_34	[p2l1679t1982r1995b2052],
25	,	,	O	,	_	0	SENT_34	[p2l1679t1982r1995b2052],
26	the	DT	O	the	det	27	SENT_34	[p2l2035t1982r2148b2040],
27	role	NN	O	role	nsubj	33	SENT_34	[p2l9t2076r141b2134],
28	of	IN	O	of	_	0	SENT_34	[p2l195t2076r267b2134],
29	this	DT	O	this	det	30	SENT_34	[p2l315t2077r444b2134],
30	variant	NN	O	variant	prep_of	27	SENT_34	[p2l496t2079r747b2134],
31	in	IN	O	in	_	0	SENT_34	[p2l800t2079r870b2133],
32	myopathy	NN	O	myopathy	prep_in	30	SENT_34	[p2l923t2076r1288b2152],
33	associated	VBN	O	associate	conj_and	8	SENT_34	[p2l1339t2077r1695b2134],
34	with	IN	O	with	_	0	SENT_34	[p2l1746t2076r1907b2134],
35	other	JJ	O	other	amod	36	SENT_34	[p2l1961t2076r2150b2134],
36	statins	NNS	O	statin	prep_with	33	SENT_34	[p2l10t2175r237b2230],
37	has	VBZ	O	have	aux	40	SENT_34	[p2l259t2172r375b2230],
38	not	RB	O	not	neg	40	SENT_34	[p2l398t2179r519b2230],
39	been	VBN	O	be	auxpass	40	SENT_34	[p2l539t2172r708b2230],
40	explored	VBN	O	explore	_	0	SENT_34	[p2l731t2172r1056b2248],
41	.	.	O	.	_	0	SENT_34	[p2l731t2172r1056b2248],

1	Here	RB	O	here	advmod	3	SENT_35	[p2l1084t2174r1245b2230],
2	we	PRP	O	we	nsubj	3	SENT_35	[p2l1267t2189r1362b2230],
3	investigate	VBP	O	investigate	_	0	SENT_35	[p2l1385t2175r1767b2248],
4	the	DT	O	the	det	5	SENT_35	[p2l1790t2172r1902b2230],
5	role	NN	O	role	dobj	3	SENT_35	[p2l1925t2172r2058b2230],
6	of	IN	O	of	_	0	SENT_35	[p2l2081t2172r2153b2230],
7	the	DT	O	the	det	9	SENT_35	[p2l8t2267r121b2325],
8	rs4149056	NN	O	rs4149056	nn	9	SENT_35	[p2l165t2269r528b2325],
9	SNP	NN	ORGANIZATION	snp	prep_of	5	SENT_35	[p2l573t2269r711b2325],
10	in	IN	O	in	_	0	SENT_35	[p2l754t2270r825b2324],
11	SLCO1B1	NN	O	slco1b1	prep_in	9	SENT_35	[p2l867t2269r1183b2325],
12	in	IN	O	in	_	0	SENT_35	[p2l1234t2270r1304b2324],
13	a	DT	O	a	det	14	SENT_35	[p2l1347t2284r1382b2325],
14	cohort	NN	O	cohort	prep_in	11	SENT_35	[p2l1426t2267r1658b2325],
15	of	IN	O	of	_	0	SENT_35	[p2l1702t2267r1774b2325],
16	European	JJ	MISC	european	amod	17	SENT_35	[p2l1814t2269r2148b2343],
17	patients	NNS	O	patient	prep_of	14	SENT_35	[p2l8t2365r290b2437],
18	with	IN	O	with	_	0	SENT_35	[p2l334t2362r495b2419],
19	statin-associated	JJ	O	statin-associated	amod	20	SENT_35	[p2l542t2362r1124b2419],
20	myopathy	NN	O	myopathy	prep_with	3	SENT_35	[p2l1168t2362r1543b2437],
21	.	.	O	.	_	0	SENT_35	[p2l1168t2362r1543b2437],

1	This	DT	O	this	det	2	SENT_36	[p2l1590t2362r1740b2419],
2	study	NN	O	study	nsubjpass	4	SENT_36	[p2l1787t2362r1980b2437],
3	was	VBD	O	be	auxpass	4	SENT_36	[p2l2020t2378r2148b2419],
4	designed	VBN	O	design	_	0	SENT_36	[p2l9t2457r321b2533],
5	to	TO	O	to	aux	6	SENT_36	[p2l352t2464r421b2515],
6	replicate	VB	O	replicate	ccomp	4	SENT_36	[p2l453t2457r753b2533],
7	the	DT	O	the	det	10	SENT_36	[p2l786t2457r899b2515],
8	previously	RB	DATE	previously	advmod	9	SENT_36	[p2l930t2457r1299b2533],
9	reported	VBN	O	report	amod	10	SENT_36	[p2l1328t2457r1627b2533],
10	association	NN	O	association	dobj	6	SENT_36	[p2l1659t2460r2049b2515],
11	of	IN	O	of	_	0	SENT_36	[p2l2081t2457r2153b2515],
12	rs4149056	NN	O	rs4149056	prep_of	10	SENT_36	[p2l9t2554r371b2610],
13	with	IN	O	with	_	0	SENT_36	[p2l419t2552r581b2610],
14	severe	JJ	O	severe	amod	15	SENT_36	[p2l631t2569r842b2610],
15	myopathy	NN	O	myopathy	prep_with	12	SENT_36	[p2l893t2552r1258b2628],
16	and	CC	O	and	_	0	SENT_36	[p2l1305t2552r1436b2610],
17	to	TO	O	to	aux	18	SENT_36	[p2l1485t2559r1555b2610],
18	investigate	VB	O	investigate	conj_and	6	SENT_36	[p2l1604t2555r1985b2628],
19	the	DT	O	the	det	20	SENT_36	[p2l2035t2552r2148b2610],
20	statin-specificity	NN	O	statin-specificity	dobj	18	SENT_36	[p2l10t2646r594b2722],
21	of	IN	O	of	_	0	SENT_36	[p2l622t2646r693b2704],
22	this	DT	O	this	det	23	SENT_36	[p2l718t2647r848b2704],
23	association	NN	O	association	prep_of	20	SENT_36	[p2l878t2650r1287b2704],
24	.	.	O	.	_	0	SENT_36	[p2l878t2650r1287b2704],

1	Patients	NNS	O	patient	_	0	SENT_37	[p2l11t2877r324b2934],
2	and	CC	O	and	_	0	SENT_37	[p2l354t2877r495b2934],
3	methods	NNS	O	method	conj_and	1	SENT_37	[p2l529t2877r863b2934],

1	Patients	NNS	O	patient	_	0	SENT_38	[p2l12t3065r264b3121],

1	Cases	NNS	O	case	nsubjpass	3	SENT_39	[p3l10t27r200b84],
2	were	VBD	O	be	auxpass	3	SENT_39	[p3l238t43r401b84],
3	identified	VBN	O	identify	_	0	SENT_39	[p3l441t26r783b84],
4	by	IN	O	by	_	0	SENT_39	[p3l820t26r908b102],
5	searching	VBG	O	search	agent	3	SENT_39	[p3l946t26r1283b102],
6	the	DT	O	the	det	8	SENT_39	[p3l1320t26r1432b84],
7	medical	JJ	O	medical	amod	8	SENT_39	[p3l1472t26r1749b84],
8	records	NNS	O	record	dobj	5	SENT_39	[p3l1788t26r2041b84],
9	of	IN	O	of	_	0	SENT_39	[p3l2081t26r2153b84],
10	two	CD	NUMBER	two	num	13	SENT_39	[p3l8t128r139b178],
11	large	JJ	O	large	amod	13	SENT_39	[p3l174t120r341b196],
12	lipid	NN	O	lipid	nn	13	SENT_39	[p3l377t120r537b196],
13	clinics	NNS	O	clinic	prep_of	8	SENT_39	[p3l572t120r794b178],
14	in	IN	O	in	_	0	SENT_39	[p3l830t123r900b177],
15	the	DT	O	the	det	18	SENT_39	[p3l934t120r1047b178],
16	Netherlands	NNP	LOCATION	Netherlands	nn	18	SENT_39	[p3l1081t120r1514b178],
17	(	NNP	O	(	nn	18	SENT_39	[p3l1552t120r1982b193],
18	Amsterdam	NNP	LOCATION	Amsterdam	prep_in	13	SENT_39	[p3l1552t120r1982b193],
19	and	CC	O	and	_	0	SENT_39	[p3l2018t120r2149b178],
20	Slotervaartziekenhuis	NNP	O	Slotervaartziekenhuis	prep_in	13	SENT_39	[p3l9t216r814b288],
21	)	CD	NUMBER	)	num	20	SENT_39	[p3l9t216r814b288],
22	.	.	O	.	_	0	SENT_39	[p3l9t216r814b288],

1	As	IN	O	as	mark	7	SENT_40	[p3l847t218r928b274],
2	muscle	NN	O	muscle	nn	3	SENT_40	[p3l958t216r1203b274],
3	symptoms	NNS	O	symptom	nsubjpass	15	SENT_40	[p3l1236t223r1600b292],
4	are	VBP	O	be	cop	7	SENT_40	[p3l1631t233r1732b274],
5	an	DT	O	a	det	7	SENT_40	[p3l1764t233r1849b274],
6	insensitive	JJ	O	insensitive	amod	7	SENT_40	[p3l1878t219r2147b274, p3l8t312r137b367],
7	marker	NN	O	marker	advcl	22	SENT_40	[p3l177t309r425b367],
8	of	IN	O	of	_	0	SENT_40	[p3l465t309r536b367],
9	myopathy	NN	O	myopathy	prep_of	7	SENT_40	[p3l572t309r937b385],
10	and	CC	O	and	_	0	SENT_40	[p3l975t309r1106b367],
11	rhabdomyolysislz	NN	O	rhabdomyolysislz	prep_of	7	SENT_40	[p3l1145t302r1776b385],
12	and	CC	O	and	_	0	SENT_40	[p3l1815t309r1946b367],
13	were	VBD	O	be	auxpass	15	SENT_40	[p3l1984t326r2148b367],
14	inconsistently	RB	O	inconsistently	advmod	15	SENT_40	[p3l9t405r513b480],
15	reported	VBN	O	report	conj_and	7	SENT_40	[p3l552t405r851b480],
16	in	IN	O	in	_	0	SENT_40	[p3l892t408r962b462],
17	the	DT	O	the	det	19	SENT_40	[p3l1004t405r1117b462],
18	clinical	JJ	O	clinical	amod	19	SENT_40	[p3l1161t405r1415b462],
19	records	NNS	O	record	prep_in	15	SENT_40	[p3l1458t405r1729b475],
20	,	,	O	,	_	0	SENT_40	[p3l1458t405r1729b475],
21	we	PRP	O	we	nsubj	22	SENT_40	[p3l1774t421r1870b462],
22	used	VBD	O	use	_	0	SENT_40	[p3l1912t405r2072b462],
23	a	DT	O	a	det	25	SENT_40	[p3l2114t421r2149b462],
24	biochemical	JJ	O	biochemical	amod	25	SENT_40	[p3l7t500r441b558],
25	definition	NN	O	definition	dobj	22	SENT_40	[p3l483t500r836b558],
26	of	IN	O	of	_	0	SENT_40	[p3l878t500r949b558],
27	myopathy	NN	O	myopathy	prep_of	25	SENT_40	[p3l986t500r1352b576],
28	consisting	VBG	O	consist	xcomp	22	SENT_40	[p3l1391t503r1751b576],
29	of	IN	O	of	_	0	SENT_40	[p3l1792t500r1863b558],
30	plasma	NN	O	plasma	nn	33	SENT_40	[p3l1900t500r2149b576],
31	creatine	NN	O	creatine	nn	33	SENT_40	[p3l9t598r289b653],
32	kinase	NN	O	kinase	nn	33	SENT_40	[p3l315t595r535b653],
33	values	NNS	O	value	prep_of	28	SENT_40	[p3l559t595r778b653],
34	greater	JJR	O	greater	mwe	35	SENT_40	[p3l804t602r1045b671],
35	than	IN	O	than	quantmod	37	SENT_40	[p3l1069t595r1234b653],
36	ten	CD	NUMBER	ten	number	37	SENT_40	[p3l1258t602r1372b653],
37	times	NNS	O	time	num	40	SENT_40	[p3l1397t598r1587b653],
38	the	DT	O	the	det	40	SENT_40	[p3l1613t595r1725b653],
39	upper	JJ	O	upper	amod	40	SENT_40	[p3l1750t612r1956b671],
40	limit	NN	O	limit	dobj	28	SENT_40	[p3l1980t595r2149b653],
41	of	IN	O	of	_	0	SENT_40	[p3l9t688r81b746],
42	normal	JJ	O	normal	amod	51	SENT_40	[p3l118t688r375b746],
43	for	IN	O	for	_	0	SENT_40	[p3l417t688r515b746],
44	the	DT	O	the	det	46	SENT_40	[p3l556t688r668b746],
45	reference	NN	O	reference	nn	46	SENT_40	[p3l711t688r1032b746],
46	laboratory	NN	O	laboratory	prep_for	42	SENT_40	[p3l1075t688r1441b764],
47	(	CD	NUMBER	(	tmod	42	SENT_40	[p3l1485t681r1867b760],
48	15OUl	NN	O	15oul	nn	51	SENT_40	[p3l1485t681r1867b760],
49	‘	NN	O	‘	nn	51	SENT_40	[p3l1485t681r1867b760],
50	1	CD	NUMBER	1	num	51	SENT_40	[p3l1485t681r1867b760],
51	)	NN	O	)	prep_of	40	SENT_40	[p3l1485t681r1867b760],
52	,	,	O	,	_	0	SENT_40	[p3l1485t681r1867b760],
53	as	RB	O	as	advmod	55	SENT_40	[p3l1915t705r1979b746],
54	was	VBD	O	be	auxpass	55	SENT_40	[p3l2020t705r2148b746],
55	used	VBN	O	use	dep	22	SENT_40	[p3l7t782r168b840],
56	in	IN	O	in	_	0	SENT_40	[p3l208t785r279b839],
57	the	DT	O	the	det	59	SENT_40	[p3l319t782r431b840],
58	SEARCH	NN	O	search	nn	59	SENT_40	[p3l474t784r769b840],
59	study	NN	O	study	prep_in	55	SENT_40	[p3l813t775r1085b858],
60	.	.	O	.	_	0	SENT_40	[p3l813t775r1085b858],

1	”	NN	O	”	nn	2	SENT_41	[p3l813t775r1085b858],
2	Patients	NNS	O	patient	nsubjpass	20	SENT_41	[p3l1126t785r1405b840],
3	with	IN	O	with	_	0	SENT_41	[p3l1445t782r1606b840],
4	CK	NN	O	ck	nn	5	SENT_41	[p3l1649t784r1753b840],
5	elevations	NNS	O	elevation	prep_with	2	SENT_41	[p3l1792t782r2148b840],
6	that	WDT	O	that	nsubj	7	SENT_41	[p3l8t878r152b936],
7	occurred	VBD	O	occur	rcmod	5	SENT_41	[p3l181t878r487b936],
8	in	IN	O	in	_	0	SENT_41	[p3l516t881r587b935],
9	the	DT	O	the	det	10	SENT_41	[p3l615t878r728b936],
10	setting	NN	O	setting	prep_in	7	SENT_41	[p3l759t881r997b954],
11	of	IN	O	of	_	0	SENT_41	[p3l1026t878r1098b936],
12	an	DT	O	a	det	15	SENT_41	[p3l1123t895r1208b936],
13	acute	JJ	O	acute	amod	15	SENT_41	[p3l1237t885r1422b936],
14	coronary	JJ	O	coronary	amod	15	SENT_41	[p3l1453t895r1770b954],
15	syndrome	NN	O	syndrome	prep_of	10	SENT_41	[p3l1798t878r2147b954],
16	or	CC	O	or	_	0	SENT_41	[p3l9t990r81b1031],
17	myocardial	JJ	O	myocardial	amod	18	SENT_41	[p3l116t973r511b1049],
18	infarction	NN	O	infarction	prep_of	10	SENT_41	[p3l547t973r898b1031],
19	were	VBD	O	be	auxpass	20	SENT_41	[p3l932t990r1096b1031],
20	excluded	VBN	O	exclude	_	0	SENT_41	[p3l1133t973r1468b1031],
21	.	.	O	.	_	0	SENT_41	[p3l1133t973r1468b1031],

1	For	IN	O	for	_	0	SENT_42	[p3l1509t975r1620b1031],
2	each	DT	O	each	det	3	SENT_42	[p3l1656t973r1817b1031],
3	case	NN	O	case	prep_for	6	SENT_42	[p3l1854t990r2013b1043],
4	,	,	O	,	_	0	SENT_42	[p3l1854t990r2013b1043],
5	we	PRP	O	we	nsubj	6	SENT_42	[p3l2052t990r2148b1031],
6	identified	VBD	O	identify	_	0	SENT_42	[p3l9t1067r351b1125],
7	between	IN	O	between	_	0	SENT_42	[p3l384t1067r682b1125],
8	two	CD	NUMBER	two	nn	12	SENT_42	[p3l717t1075r847b1125],
9	and	CC	NUMBER	and	_	0	SENT_42	[p3l884t1067r1015b1125],
10	four	CD	NUMBER	four	nn	12	SENT_42	[p3l1051t1067r1196b1125],
11	control	NN	O	control	nn	12	SENT_42	[p3l1230t1067r1486b1125],
12	patients	NNS	O	patient	prep_between	6	SENT_42	[p3l1521t1070r1804b1143],
13	matched	VBN	O	match	partmod	12	SENT_42	[p3l1840t1067r2149b1125],
14	for	IN	O	for	_	0	SENT_42	[p3l9t1163r107b1221],
15	age	NN	O	age	nn	20	SENT_42	[p3l144t1180r276b1239],
16	,	,	O	,	_	0	SENT_42	[p3l144t1180r276b1239],
17	gender	NN	O	gender	conj_and	20	SENT_42	[p3l318t1163r573b1239],
18	,	,	O	,	_	0	SENT_42	[p3l318t1163r573b1239],
19	statin	NN	O	statin	conj_and	20	SENT_42	[p3l617t1166r813b1221],
20	type	NN	O	type	prep_for	13	SENT_42	[p3l850t1170r1001b1239],
21	and	CC	O	and	_	0	SENT_42	[p3l1041t1163r1172b1221],
22	dose	NN	O	dose	prep_for	13	SENT_42	[p3l1209t1163r1384b1221],
23	.	.	O	.	_	0	SENT_42	[p3l1209t1163r1384b1221],

1	All	DT	O	all	det	2	SENT_43	[p3l1425t1163r1523b1220],
2	patients	NNS	O	patient	nsubj	3	SENT_43	[p3l1560t1166r1842b1239],
3	were	VBD	O	be	_	0	SENT_43	[p3l1878t1180r2042b1221],
4	of	IN	O	of	_	0	SENT_43	[p3l2081t1163r2153b1221],
5	Dutch	JJ	MISC	dutch	amod	6	SENT_43	[p3l9t1258r228b1316],
6	ancestry	NN	O	ancestry	prep_of	3	SENT_43	[p3l276t1265r581b1334],
7	.	.	O	.	_	0	SENT_43	[p3l276t1265r581b1334],

1	This	DT	O	this	det	2	SENT_44	[p3l631t1258r781b1316],
2	study	NN	O	study	nsubjpass	4	SENT_44	[p3l831t1258r1023b1334],
3	was	VBD	O	be	auxpass	4	SENT_44	[p3l1066t1275r1194b1316],
4	approved	VBN	O	approve	_	0	SENT_44	[p3l1244t1258r1572b1334],
5	by	IN	O	by	_	0	SENT_44	[p3l1617t1258r1705b1334],
6	the	DT	O	the	det	9	SENT_44	[p3l1750t1258r1862b1316],
7	ethical	JJ	O	ethical	amod	9	SENT_44	[p3l1912t1258r2148b1316],
8	review	NN	O	review	nn	9	SENT_44	[p3l9t1356r240b1410],
9	boards	NNS	O	board	agent	4	SENT_44	[p3l287t1353r520b1410],
10	of	IN	O	of	_	0	SENT_44	[p3l573t1352r645b1410],
11	the	DT	O	the	det	12	SENT_44	[p3l691t1353r804b1410],
12	University	NNP	ORGANIZATION	University	prep_of	9	SENT_44	[p3l857t1355r1226b1428],
13	of	IN	ORGANIZATION	of	_	0	SENT_44	[p3l1275t1352r1347b1410],
14	Amsterdam	NNP	ORGANIZATION	Amsterdam	prep_of	12	SENT_44	[p3l1393t1353r1800b1410],
15	and	CC	O	and	_	0	SENT_44	[p3l1853t1353r1984b1410],
16	the	DT	O	the	det	17	SENT_44	[p3l2035t1353r2148b1410],
17	University	NNP	ORGANIZATION	University	conj_and	12	SENT_44	[p3l8t1451r377b1524],
18	of	IN	ORGANIZATION	of	_	0	SENT_44	[p3l405t1448r476b1506],
19	British	NNP	ORGANIZATION	British	nn	20	SENT_44	[p3l502t1448r732b1506],
20	Columbia	NNP	ORGANIZATION	Columbia	prep_of	17	SENT_44	[p3l763t1448r1129b1506],
21	.	.	O	.	_	0	SENT_44	[p3l763t1448r1129b1506],

1	Genotyping	VBG	O	genotype	amod	3	SENT_45	[p3l14t1673r382b1748],
2	DNA	NN	O	dna	nn	3	SENT_45	[p3l9t1770r179b1825],
3	extraction	NN	O	extraction	nsubjpass	7	SENT_45	[p3l227t1771r587b1826],
4	and	CC	O	and	_	0	SENT_45	[p3l637t1768r768b1826],
5	genotyping	NN	O	genotyping	conj_and	3	SENT_45	[p3l817t1771r1222b1844],
6	were	VBD	O	be	auxpass	7	SENT_45	[p3l1267t1785r1431b1826],
7	performed	VBN	O	perform	_	0	SENT_45	[p3l1480t1768r1850b1844],
8	as	IN	O	as	mark	10	SENT_45	[p3l1899t1785r1963b1826],
9	previously	RB	DATE	previously	advmod	10	SENT_45	[p3l2012t1785r2148b1844, p3l6t1863r263b1939],
10	described	VBN	O	describe	advcl	7	SENT_45	[p3l303t1856r720b1921],
11	.	.	O	.	_	0	SENT_45	[p3l303t1856r720b1921],

1	”	NN	O	”	nsubj	3	SENT_46	[p3l303t1856r720b1921],
2	We	PRP	O	we	nsubj	3	SENT_46	[p3l762t1866r872b1921],
3	designed	VBD	O	design	_	0	SENT_46	[p3l915t1863r1227b1939],
4	an	DT	O	a	det	8	SENT_46	[p3l1269t1880r1354b1921],
5	Illumina	NNP	ORGANIZATION	Illumina	nn	8	SENT_46	[p3l1395t1863r1699b1921],
6	Goldengate	NNP	ORGANIZATION	Goldengate	nn	8	SENT_46	[p3l1742t1863r2147b1939],
7	genotyping	VBG	O	genotype	amod	8	SENT_46	[p3l9t1963r414b2036],
8	assay	NN	O	assay	dobj	3	SENT_46	[p3l480t1977r660b2036],
9	using	VBG	O	use	partmod	8	SENT_46	[p3l722t1963r915b2036],
10	a	DT	O	a	det	13	SENT_46	[p3l981t1977r1015b2018],
11	custom	NN	O	custom	nn	13	SENT_46	[p3l1082t1967r1339b2018],
12	oligo	JJ	O	oligo	amod	13	SENT_46	[p3l1407t1960r1581b2036],
13	pool	NN	O	pool	dobj	9	SENT_46	[p3l1648t1960r1806b2036],
14	for	IN	O	for	_	0	SENT_46	[p3l1872t1960r1970b2018],
15	the	DT	O	the	det	17	SENT_46	[p3l2035t1960r2148b2018],
16	rs4149056	NN	O	rs4149056	nn	17	SENT_46	[p3l9t2057r371b2113],
17	variant	NN	O	variant	prep_for	13	SENT_46	[p3l403t2059r654b2113],
18	at	IN	O	at	_	0	SENT_46	[p3l687t2063r751b2113],
19	the	DT	O	the	det	21	SENT_46	[p3l783t2056r896b2113],
20	SLCO1B1	NN	O	slco1b1	nn	21	SENT_46	[p3l928t2057r1244b2113],
21	locus	NN	O	locus	prep_at	9	SENT_46	[p3l1285t2056r1484b2113],
22	.	.	O	.	_	0	SENT_46	[p3l1285t2056r1484b2113],

1	All	DT	O	all	det	4	SENT_47	[p3l1520t2056r1617b2113],
2	SNP	NN	O	snp	nn	4	SENT_47	[p3l1651t2057r1789b2113],
3	genotype	NN	O	genotype	nn	4	SENT_47	[p3l1821t2063r2147b2131],
4	data	NNS	O	datum	nsubjpass	7	SENT_47	[p3l9t2152r158b2210],
5	were	VBD	O	be	auxpass	7	SENT_47	[p3l205t2169r369b2210],
6	manually	RB	O	manually	advmod	7	SENT_47	[p3l419t2152r756b2228],
7	clustered	VBN	O	cluster	_	0	SENT_47	[p3l803t2152r1120b2210],
8	using	VBG	O	use	xcomp	7	SENT_47	[p3l1167t2155r1360b2228],
9	BeadStudio	NNP	O	BeadStudio	nsubj	12	SENT_47	[p3l1409t2152r1804b2210],
10	software	NN	O	software	nn	12	SENT_47	[p3l1855t2152r2147b2210],
11	(	CD	NUMBER	(	num	12	SENT_47	[p3l12t2248r357b2320],
12	Illumina	NNP	ORGANIZATION	Illumina	xcomp	8	SENT_47	[p3l12t2248r357b2320],
13	,	,	O	,	_	0	SENT_47	[p3l12t2248r357b2320],
14	San	NNP	LOCATION	San	nn	19	SENT_47	[p3l386t2250r509b2306],
15	Diego	NNP	LOCATION	Diego	nn	19	SENT_47	[p3l534t2251r756b2324],
16	,	,	O	,	_	0	SENT_47	[p3l534t2251r756b2324],
17	CA	NNP	LOCATION	CA	appos	19	SENT_47	[p3l786t2250r908b2318],
18	,	,	O	,	_	0	SENT_47	[p3l786t2250r908b2318],
19	USA	NNP	LOCATION	USA	appos	12	SENT_47	[p3l936t2248r1128b2320],
20	)	CD	NUMBER	)	num	19	SENT_47	[p3l936t2248r1128b2320],
21	.	.	O	.	_	0	SENT_47	[p3l936t2248r1128b2320],

1	The	DT	O	the	det	5	SENT_48	[p3l1154t2248r1287b2306],
2	average	JJ	O	average	amod	5	SENT_48	[p3l1313t2265r1575b2324],
3	genotyping	NN	O	genotyping	nn	5	SENT_48	[p3l1600t2251r2006b2324],
4	call	NN	O	call	nn	5	SENT_48	[p3l2029t2248r2148b2306],
5	rate	NN	O	rate	nsubj	10	SENT_48	[p3l9t2351r139b2402],
6	for	IN	O	for	_	0	SENT_48	[p3l170t2344r268b2402],
7	all	DT	O	all	det	8	SENT_48	[p3l297t2344r379b2402],
8	samples	NNS	O	sample	prep_for	5	SENT_48	[p3l411t2344r687b2420],
9	was	VBD	O	be	cop	10	SENT_48	[p3l715t2361r843b2402],
10	>	JJR	O	>	_	0	SENT_48	[p3l885t2345r1120b2402],
11	98	CD	PERCENT	98	num	12	SENT_48	[p3l885t2345r1120b2402],
12	%	NN	PERCENT	%	dep	10	SENT_48	[p3l885t2345r1120b2402],
13	.	.	O	.	_	0	SENT_48	[p3l885t2345r1120b2402],

1	The	DT	O	the	det	3	SENT_49	[p3l7t2612r109b2657],
2	Pharmacogenomics	NNP	O	Pharmacogenomics	nn	3	SENT_49	[p3l136t2612r677b2671],
3	Journal	NNP	O	Journal	_	0	SENT_49	[p3l699t2612r893b2667],

1	Power	NNP	O	Power	nn	2	SENT_50	[p3l12t2826r208b2882],
2	calculation	NN	O	calculation	nsubj	38	SENT_50	[p3l232t2824r577b2882],
3	and	CC	O	and	_	0	SENT_50	[p3l607t2824r732b2882],
4	statistical	JJ	O	statistical	amod	5	SENT_50	[p3l756t2824r1061b2882],
5	analysis	NN	O	analysis	conj_and	2	SENT_50	[p3l1088t2824r1338b2899],
6	We	PRP	O	we	nsubj	7	SENT_50	[p3l7t2921r117b2976],
7	calculated	VBD	O	calculate	rcmod	2	SENT_50	[p3l184t2918r541b2976],
8	that	IN	O	that	complm	10	SENT_50	[p3l606t2918r749b2976],
9	to	TO	O	to	aux	10	SENT_50	[p3l815t2926r884b2976],
10	identify	VB	O	identify	ccomp	7	SENT_50	[p3l951t2918r1230b2994],
11	an	DT	O	a	det	12	SENT_50	[p3l1293t2935r1378b2976],
12	association	NN	O	association	dobj	10	SENT_50	[p3l1445t2921r1835b2976],
13	of	IN	O	of	_	0	SENT_50	[p3l1902t2918r1974b2976],
14	the	DT	O	the	det	16	SENT_50	[p3l2035t2918r2147b2976],
15	rs4149056	NN	O	rs4149056	nn	16	SENT_50	[p3l8t3015r371b3071],
16	SNP	NN	O	snp	prep_of	12	SENT_50	[p3l404t3015r542b3071],
17	with	IN	O	with	_	0	SENT_50	[p3l570t3013r732b3071],
18	myopathy	NN	O	myopathy	prep_with	16	SENT_50	[p3l763t3014r1128b3089],
19	with	IN	O	with	_	0	SENT_50	[p3l1155t3013r1316b3071],
20	an	DT	O	a	det	22	SENT_50	[p3l1348t3030r1433b3071],
21	effect	NN	O	effect	nn	22	SENT_50	[p3l1464t3013r1655b3071],
22	size	NN	O	size	prep_with	10	SENT_50	[p3l1687t3016r1810b3071],
23	of	IN	O	of	_	0	SENT_50	[p3l1842t3013r1914b3071],
24	3.0	CD	NUMBER	3.0	prep_of	22	SENT_50	[p3l1942t3015r2047b3071],
25	or	CC	O	or	_	0	SENT_50	[p3l2078t3030r2150b3071],
26	greater	JJR	O	greater	amod	27	SENT_50	[p3l8t3116r250b3185],
27	(	NN	O	(	prep_with	10	SENT_50	[p3l303t3109r568b3181],
28	similar	JJ	O	similar	amod	27	SENT_50	[p3l303t3109r568b3181],
29	to	TO	O	to	_	0	SENT_50	[p3l618t3116r687b3167],
30	that	DT	O	that	prep_to	28	SENT_50	[p3l739t3109r882b3167],
31	observed	VBN	O	observe	partmod	30	SENT_50	[p3l933t3109r1246b3167],
32	in	IN	O	in	_	0	SENT_50	[p3l1296t3112r1367b3166],
33	the	DT	O	the	det	36	SENT_50	[p3l1417t3109r1530b3167],
34	SEARCH	NN	O	search	nn	36	SENT_50	[p3l1582t3111r1878b3167],
35	study	NN	O	study	nn	36	SENT_50	[p3l1932t3109r2145b3185],
36	)	NN	O	)	prep_in	31	SENT_50	[p3l1932t3109r2145b3185],
37	would	MD	O	would	aux	38	SENT_50	[p3l7t3204r228b3261],
38	require	VB	O	require	_	0	SENT_50	[p3l269t3207r517b3279],
39	at	IN	O	at	quantmod	41	SENT_50	[p3l559t3211r623b3261],
40	least	JJS	O	least	mwe	39	SENT_50	[p3l664t3204r821b3261],
41	20	CD	NUMBER	20	num	42	SENT_50	[p3l863t3205r945b3261],
42	cases	NNS	O	case	dobj	38	SENT_50	[p3l987t3220r1158b3261],
43	assuming	VBG	O	assume	xcomp	38	SENT_50	[p3l1201t3207r1534b3279],
44	a	DT	O	a	det	48	SENT_50	[p3l1574t3220r1609b3261],
45	similar	JJ	O	similar	amod	48	SENT_50	[p3l1651t3204r1891b3261],
46	minor	JJ	O	minor	amod	48	SENT_50	[p3l1930t3207r2149b3261],
47	allele	NN	O	allele	nn	48	SENT_50	[p3l9t3299r191b3356],
48	frequency	NN	O	frequency	dobj	43	SENT_50	[p3l229t3298r594b3374],
49	.	.	O	.	_	0	SENT_50	[p3l229t3298r594b3374],

1	The	DT	O	the	det	4	SENT_51	[p3l634t3299r766b3356],
2	primary	JJ	O	primary	amod	4	SENT_51	[p3l804t3302r1087b3374],
3	end	NN	O	end	nn	4	SENT_51	[p3l1123t3299r1253b3356],
4	point	NN	O	point	nsubj	9	SENT_51	[p3l1290t3302r1482b3374],
5	of	IN	O	of	_	0	SENT_51	[p3l1520t3298r1592b3356],
6	this	DT	O	this	det	7	SENT_51	[p3l1625t3299r1754b3356],
7	study	NN	O	study	prep_of	4	SENT_51	[p3l1794t3299r1986b3374],
8	was	VBD	O	be	cop	9	SENT_51	[p3l2020t3315r2148b3356],
9	replication	NN	O	replication	_	0	SENT_51	[p3l8t3394r391b3470],
10	of	IN	O	of	_	0	SENT_51	[p3l425t3394r496b3452],
11	the	DT	O	the	det	12	SENT_51	[p3l525t3394r637b3452],
12	association	NN	O	association	prep_of	9	SENT_51	[p3l672t3397r1063b3452],
13	of	IN	O	of	_	0	SENT_51	[p3l1096t3394r1168b3452],
14	rs4149056	NN	O	rs4149056	prep_of	12	SENT_51	[p3l1196t3396r1559b3452],
15	with	IN	O	with	_	0	SENT_51	[p3l1591t3394r1752b3452],
16	myopathy	NN	O	myopathy	prep_with	14	SENT_51	[p3l1786t3394r2151b3470],
17	in	IN	O	in	_	0	SENT_51	[p3l8t3494r79b3548],
18	an	DT	O	a	det	21	SENT_51	[p3l128t3508r212b3549],
19	appropriately	RB	O	appropriately	advmod	20	SENT_51	[p3l261t3491r738b3567],
20	powered	VBN	O	power	amod	21	SENT_51	[p3l783t3491r1084b3567],
21	sample	NN	O	sample	prep_in	16	SENT_51	[p3l1134t3491r1379b3567],
22	of	IN	O	of	_	0	SENT_51	[p3l1429t3491r1500b3549],
23	patients	NNS	O	patient	prep_of	21	SENT_51	[p3l1544t3494r1826b3567],
24	using	VBG	O	use	partmod	23	SENT_51	[p3l1874t3494r2066b3567],
25	a	DT	O	a	det	26	SENT_51	[p3l2114t3508r2149b3549],
26	variety	NN	O	variety	dobj	24	SENT_51	[p3l6t3589r251b3662],
27	of	IN	O	of	_	0	SENT_51	[p3l274t3586r345b3644],
28	statins	NNS	O	statin	prep_of	26	SENT_51	[p3l367t3589r613b3644],
29	.	.	O	.	_	0	SENT_51	[p3l367t3589r613b3644],

1	Secondary	JJ	O	secondary	amod	3	SENT_52	[p3l642t3586r1008b3662],
2	end	NN	O	end	nn	3	SENT_52	[p3l1031t3586r1161b3644],
3	points	NNS	O	point	nsubj	6	SENT_52	[p3l1184t3589r1406b3662],
4	were	VBD	O	be	cop	6	SENT_52	[p3l1430t3603r1593b3644],
5	the	DT	O	the	det	6	SENT_52	[p3l1619t3586r1731b3644],
6	association	NN	O	association	_	0	SENT_52	[p3l1757t3589r2148b3644],
7	of	IN	O	of	_	0	SENT_52	[p3l9t3680r80b3738],
8	myopathy	NN	O	myopathy	prep_of	6	SENT_52	[p3l127t3680r492b3756],
9	with	IN	O	with	_	0	SENT_52	[p3l538t3680r699b3738],
10	rs4149056	NN	O	rs4149056	prep_with	8	SENT_52	[p3l749t3682r1112b3738],
11	in	IN	O	in	_	0	SENT_52	[p3l1163t3683r1233b3737],
12	patients	NNS	O	patient	prep_in	10	SENT_52	[p3l1283t3683r1565b3756],
13	taking	VBG	O	take	partmod	12	SENT_52	[p3l1616t3680r1839b3756],
14	specific	JJ	O	specific	amod	16	SENT_52	[p3l1889t3680r2148b3756],
15	statin	NN	O	statin	nn	16	SENT_52	[p4l10t20r206b75],
16	types	NNS	O	type	dobj	13	SENT_52	[p4l253t24r454b93],
17	.	.	O	.	_	0	SENT_52	[p4l253t24r454b93],

1	Genotype	NN	O	genotype	nn	2	SENT_53	[p4l506t18r849b93],
2	frequencies	NNS	O	frequency	nsubjpass	8	SENT_53	[p4l897t17r1299b93],
3	in	IN	O	in	_	0	SENT_53	[p4l1346t20r1416b74],
4	cases	NNS	O	case	prep_in	2	SENT_53	[p4l1463t34r1635b75],
5	and	CC	O	and	_	0	SENT_53	[p4l1683t17r1815b75],
6	controls	NNS	O	control	prep_in	2	SENT_53	[p4l1861t17r2147b75],
7	were	VBD	O	be	auxpass	8	SENT_53	[p4l7t128r170b169],
8	compared	VBN	O	compare	_	0	SENT_53	[p4l202t111r553b187],
9	using	VBG	O	use	xcomp	8	SENT_53	[p4l582t114r774b187],
10	a	DT	O	a	det	13	SENT_53	[p4l804t128r839b169],
11	genotypic	JJ	O	genotypic	amod	13	SENT_53	[p4l869t114r1220b187],
12	dominant	JJ	O	dominant	amod	13	SENT_53	[p4l1250t111r1602b169],
13	model	NN	O	model	dobj	9	SENT_53	[p4l1633t111r1873b169],
14	.	.	O	.	_	0	SENT_53	[p4l1633t111r1873b169],

1	As	IN	O	as	mark	4	SENT_54	[p4l1907t113r1987b169],
2	this	DT	O	this	nsubjpass	4	SENT_54	[p4l2018t111r2148b169],
3	was	VBD	O	be	auxpass	4	SENT_54	[p4l7t223r134b264],
4	designed	VBN	O	design	advcl	28	SENT_54	[p4l187t206r498b282],
5	as	IN	O	as	_	0	SENT_54	[p4l549t223r614b264],
6	a	DT	O	a	det	8	SENT_54	[p4l666t223r701b264],
7	replication	NN	O	replication	nn	8	SENT_54	[p4l751t206r1134b282],
8	study	NN	O	study	prep_as	4	SENT_54	[p4l1186t206r1378b282],
9	under	IN	O	under	_	0	SENT_54	[p4l1425t207r1635b264],
10	the	DT	O	the	det	12	SENT_54	[p4l1684t206r1797b264],
11	previous	JJ	O	previous	amod	12	SENT_54	[p4l1848t209r2148b282],
12	hypothesis	NN	O	hypothesis	prep_under	4	SENT_54	[p4l8t302r391b378],
13	that	IN	O	that	complm	21	SENT_54	[p4l415t302r559b360],
14	the	DT	O	the	det	15	SENT_54	[p4l581t302r694b360],
15	rs4149056	NN	O	rs4149056	nsubj	21	SENT_54	[p4l718t304r1081b360],
16	minor	JJ	O	minor	amod	18	SENT_54	[p4l1105t305r1324b360],
17	allele	NN	O	allele	nn	18	SENT_54	[p4l1348t302r1529b360],
18	frequency	NN	O	frequency	dep	15	SENT_54	[p4l1554t302r1908b378],
19	would	MD	O	would	aux	21	SENT_54	[p4l1927t302r2148b360],
20	be	VB	O	be	cop	21	SENT_54	[p4l6t397r86b454],
21	higher	JJR	O	higher	ccomp	4	SENT_54	[p4l115t397r346b472],
22	in	IN	O	in	_	0	SENT_54	[p4l374t400r444b454],
23	cases	NNS	O	case	prep_in	21	SENT_54	[p4l472t413r644b454],
24	than	IN	O	than	_	0	SENT_54	[p4l673t397r837b454],
25	controls	NNS	O	control	prep_than	23	SENT_54	[p4l867t397r1171b467],
26	,	,	O	,	_	0	SENT_54	[p4l867t397r1171b467],
27	we	PRP	O	we	nsubj	28	SENT_54	[p4l1202t413r1298b454],
28	used	VBD	O	use	_	0	SENT_54	[p4l1326t397r1486b454],
29	a	DT	O	a	det	32	SENT_54	[p4l1515t413r1550b454],
30	1-tailed	JJ	O	1-tailed	amod	32	SENT_54	[p4l1583t397r1843b454],
31	P	NN	O	p	nn	32	SENT_54	[p4l1868t399r1914b454],
32	value	NN	O	value	dobj	28	SENT_54	[p4l1938t397r2144b454],
33	.	.	O	.	_	0	SENT_54	[p4l1938t397r2144b454],

1	Under	IN	O	under	_	0	SENT_55	[p4l8t492r230b549],
2	the	DT	O	the	det	3	SENT_55	[p4l292t492r404b549],
3	assumptions	NNS	O	assumption	prep_under	23	SENT_55	[p4l469t495r910b567],
4	of	IN	O	of	_	0	SENT_55	[p4l974t491r1046b549],
5	this	DT	O	this	det	6	SENT_55	[p4l1105t492r1234b549],
6	test	NN	O	test	prep_of	3	SENT_55	[p4l1298t499r1421b549],
7	a	DT	O	a	det	8	SENT_55	[p4l1485t508r1519b549],
8	finding	NN	O	finding	nsubjpass	23	SENT_55	[p4l1582t491r1842b567],
9	of	IN	O	of	_	0	SENT_55	[p4l1905t491r1976b549],
10	the	DT	O	the	det	13	SENT_55	[p4l2035t492r2147b549],
11	rs4149056	NN	O	rs4149056	nn	13	SENT_55	[p4l8t589r371b645],
12	risk	NN	O	risk	nn	13	SENT_55	[p4l406t587r531b645],
13	allele	NN	O	allele	prep_of	8	SENT_55	[p4l563t587r745b645],
14	being	VBG	O	be	cop	16	SENT_55	[p4l777t587r976b663],
15	more	RBR	O	more	advmod	16	SENT_55	[p4l1008t604r1189b645],
16	frequent	JJ	O	frequent	partmod	13	SENT_55	[p4l1224t587r1525b663],
17	in	IN	O	in	_	0	SENT_55	[p4l1558t590r1628b644],
18	controls	NNS	O	control	prep_in	16	SENT_55	[p4l1663t587r1949b645],
19	than	IN	O	than	_	0	SENT_55	[p4l1984t587r2148b645],
20	cases	NNS	O	case	prep_than	18	SENT_55	[p4l9t697r180b738],
21	would	MD	O	would	aux	23	SENT_55	[p4l211t681r433b738],
22	be	VB	O	be	auxpass	23	SENT_55	[p4l462t681r542b738],
23	considered	VBN	O	consider	_	0	SENT_55	[p4l576t681r958b738],
24	erroneous	JJ	O	erroneous	acomp	23	SENT_55	[p4l991t697r1359b738],
25	.	.	O	.	_	0	SENT_55	[p4l991t697r1359b738],

1	A	DT	O	a	det	2	SENT_56	[p4l1393t682r1444b737],
2	P	NN	O	p	nsubjpass	7	SENT_56	[p4l1471t683r1518b737],
3	value	NN	O	value	dep	2	SENT_56	[p4l1544t681r1732b738],
4	<	JJR	O	<	dobj	3	SENT_56	[p4l1776t682r1986b738],
5	0.05	CD	NUMBER	0.05	advmod	3	SENT_56	[p4l1776t682r1986b738],
6	was	VBD	O	be	auxpass	7	SENT_56	[p4l2020t697r2148b738],
7	considered	VBN	O	consider	_	0	SENT_56	[p4l9t776r391b834],
8	significant	JJ	O	significant	acomp	7	SENT_56	[p4l422t776r811b852],
9	.	.	O	.	_	0	SENT_56	[p4l422t776r811b852],

1	Results	NNS	O	result	_	0	SENT_57	[p4l11t1006r279b1063],

1	We	PRP	O	we	nsubj	2	SENT_58	[p4l7t1197r117b1253],
2	examined	VBD	O	examine	_	0	SENT_58	[p4l148t1195r496b1253],
3	the	DT	O	the	det	4	SENT_58	[p4l527t1195r639b1253],
4	records	NNS	O	record	dobj	2	SENT_58	[p4l671t1195r923b1253],
5	of	IN	O	of	_	0	SENT_58	[p4l955t1195r1027b1253],
6	nearly	RB	O	nearly	advmod	8	SENT_58	[p4l1053t1195r1275b1271],
7	9000	CD	DATE	9000	num	8	SENT_58	[p4l1303t1197r1474b1253],
8	patients	NNS	O	patient	prep_of	4	SENT_58	[p4l1504t1198r1786b1271],
9	from	IN	O	from	_	0	SENT_58	[p4l1817t1195r1987b1253],
10	two	CD	NUMBER	two	num	12	SENT_58	[p4l2018t1202r2148b1253],
11	lipid	NN	O	lipid	nn	12	SENT_58	[p4l8t1290r169b1365],
12	clinics	NNS	O	clinic	prep_from	2	SENT_58	[p4l206t1290r428b1347],
13	in	IN	O	in	_	0	SENT_58	[p4l467t1293r537b1347],
14	the	DT	O	the	det	15	SENT_58	[p4l574t1290r686b1347],
15	Netherlands	NNP	LOCATION	Netherlands	prep_in	12	SENT_58	[p4l722t1290r1174b1347],
16	.	.	O	.	_	0	SENT_58	[p4l722t1290r1174b1347],

1	Twenty-five	CD	NUMBER	twenty-five	num	2	SENT_59	[p4l1213t1289r1632b1365],
2	patients	NNS	O	patient	nsubj	34	SENT_59	[p4l1669t1293r1951b1365],
3	with	IN	O	with	_	0	SENT_59	[p4l1987t1290r2148b1347],
4	statin	NN	O	statin	nn	5	SENT_59	[p4l10t1383r592b1440],
5	—	NN	O	—	prep_with	2	SENT_59	[p4l10t1383r592b1440],
6	associated	VBN	O	associate	partmod	5	SENT_59	[p4l10t1383r592b1440],
7	myopathy	NN	O	myopathy	dobj	6	SENT_59	[p4l640t1383r1014b1458],
8	,	,	O	,	_	0	SENT_59	[p4l640t1383r1014b1458],
9	defined	VBN	O	define	partmod	7	SENT_59	[p4l1067t1382r1332b1440],
10	as	IN	O	as	mark	19	SENT_59	[p4l1380t1400r1445b1440],
11	a	DT	O	a	det	12	SENT_59	[p4l1494t1400r1529b1440],
12	CK	NN	O	ck	nsubjpass	19	SENT_59	[p4l1577t1384r1744b1440],
13	>	JJR	O	>	dep	12	SENT_59	[p4l1577t1384r1744b1440],
14	1500	CD	DATE	1500	num	15	SENT_59	[p4l1766t1384r1931b1440],
15	Ul	NNP	O	Ul	dep	12	SENT_59	[p4l1979t1376r2145b1440],
16	‘	CD	NUMBER	‘	num	15	SENT_59	[p4l1979t1376r2145b1440],
17	1	CD	NUMBER	1	dep	15	SENT_59	[p4l1979t1376r2145b1440],
18	were	VBD	O	be	auxpass	19	SENT_59	[p4l7t1496r170b1537],
19	identified	VBN	O	identify	advcl	9	SENT_59	[p4l223t1479r582b1549],
20	,	,	O	,	_	0	SENT_59	[p4l223t1479r582b1549],
21	yielding	VBG	O	yield	partmod	7	SENT_59	[p4l637t1479r927b1555],
22	a	DT	O	a	det	23	SENT_59	[p4l978t1496r1013b1537],
23	prevalence	NN	O	prevalence	dobj	21	SENT_59	[p4l1063t1479r1442b1555],
24	of	IN	O	of	_	0	SENT_59	[p4l1496t1479r1567b1537],
25	0.26	CD	PERCENT	0.26	num	26	SENT_59	[p4l1615t1481r1851b1549],
26	%	NN	PERCENT	%	prep_of	23	SENT_59	[p4l1615t1481r1851b1549],
27	,	,	O	,	_	0	SENT_59	[p4l1615t1481r1851b1549],
28	similar	JJ	O	similar	amod	26	SENT_59	[p4l1910t1479r2149b1537],
29	to	TO	O	to	_	0	SENT_59	[p4l8t1579r78b1630],
30	rates	NNS	O	rate	prep_to	28	SENT_59	[p4l107t1579r269b1630],
31	reported	VBN	O	report	partmod	30	SENT_59	[p4l299t1572r597b1648],
32	for	IN	O	for	prep	31	SENT_59	[p4l626t1572r724b1630],
33	equivalently	RB	O	equivalently	advmod	34	SENT_59	[p4l753t1572r1195b1648],
34	defined	VBN	O	define	_	0	SENT_59	[p4l1222t1572r1487b1630],
35	phenotypes	NNS	O	phenotype	dobj	34	SENT_59	[p4l1515t1564r2148b1648],
36	.5	CD	NUMBER	.5	num	35	SENT_59	[p4l1515t1564r2148b1648],
37	'	''	O	'	_	0	SENT_59	[p4l1515t1564r2148b1648],
38	1	CD	NUMBER	1	number	39	SENT_59	[p4l1515t1564r2148b1648],
39	°	CD	NUMBER	°	num	40	SENT_59	[p4l1515t1564r2148b1648],
40	'14	NN	O	'14	nsubj	48	SENT_59	[p4l1515t1564r2148b1648],
41	For	IN	O	for	_	0	SENT_59	[p4l9t1670r120b1725],
42	each	DT	O	each	det	43	SENT_59	[p4l157t1667r318b1725],
43	case	NN	O	case	prep_for	45	SENT_59	[p4l355t1684r496b1725],
44	we	PRP	O	we	nsubj	45	SENT_59	[p4l532t1684r628b1725],
45	identified	VBD	O	identify	rcmod	40	SENT_59	[p4l666t1667r1009b1725],
46	2-4	CD	NUMBER	2-4	num	47	SENT_59	[p4l1047t1669r1167b1724],
47	controls	NNS	O	control	dobj	45	SENT_59	[p4l1206t1667r1492b1725],
48	matched	VBN	O	match	rcmod	35	SENT_59	[p4l1531t1667r1840b1725],
49	for	IN	O	for	_	0	SENT_59	[p4l1877t1667r1975b1725],
50	age	NN	O	age	nn	55	SENT_59	[p4l2012t1684r2144b1743],
51	,	,	O	,	_	0	SENT_59	[p4l2012t1684r2144b1743],
52	gender	NN	O	gender	prep_for	48	SENT_59	[p4l8t1762r262b1838],
53	,	,	O	,	_	0	SENT_59	[p4l8t1762r262b1838],
54	statin	NN	O	statin	prep_for	48	SENT_59	[p4l302t1765r498b1820],
55	type	NN	O	type	prep_for	48	SENT_59	[p4l531t1770r682b1838],
56	and	CC	O	and	_	0	SENT_59	[p4l716t1763r848b1820],
57	dose	NN	O	dose	conj_and	55	SENT_59	[p4l881t1762r1056b1820],
58	.	.	O	.	_	0	SENT_59	[p4l881t1762r1056b1820],

1	The	DT	O	the	det	3	SENT_60	[p4l1090t1762r1223b1820],
2	clinical	JJ	O	clinical	amod	3	SENT_60	[p4l1258t1762r1513b1820],
3	characteristics	NNS	O	characteristic	nsubjpass	10	SENT_60	[p4l1547t1763r2047b1820],
4	of	IN	O	of	_	0	SENT_60	[p4l2081t1762r2153b1820],
5	the	DT	O	the	det	6	SENT_60	[p4l8t1857r121b1914],
6	cases	NNS	O	case	prep_of	3	SENT_60	[p4l152t1874r324b1914],
7	and	CC	O	and	_	0	SENT_60	[p4l355t1857r486b1914],
8	controls	NNS	O	control	prep_of	3	SENT_60	[p4l516t1857r802b1914],
9	are	VBP	O	be	auxpass	10	SENT_60	[p4l834t1874r935b1914],
10	shown	VBN	O	show	_	0	SENT_60	[p4l968t1857r1200b1914],
11	in	IN	O	in	_	0	SENT_60	[p4l1229t1860r1300b1913],
12	Table	NNP	O	Table	prep_in	10	SENT_60	[p4l1327t1857r1512b1914],
13	1	CD	NUMBER	1	num	12	SENT_60	[p4l1549t1859r1601b1914],
14	.	.	O	.	_	0	SENT_60	[p4l1549t1859r1601b1914],

1	There	EX	O	there	expl	2	SENT_61	[p4l1633t1857r1833b1914],
2	were	VBD	O	be	_	0	SENT_61	[p4l1862t1874r2026b1914],
3	no	DT	O	no	nsubj	2	SENT_61	[p4l2057t1874r2148b1914],

1	Table	NNP	O	Table	_	0	SENT_62	[p4l7t2068r196b2125],
2	1	CD	NUMBER	1	num	3	SENT_62	[p4l244t2070r267b2124],
3	Characteristics	NNS	O	characteristic	dep	1	SENT_62	[p4l357t2070r845b2125],
4	of	IN	O	of	_	0	SENT_62	[p4l888t2070r956b2125],
5	statin-associated	JJ	O	statin-associated	amod	7	SENT_62	[p4l995t2070r1553b2125],
6	myopathy	NN	O	myopathy	nn	7	SENT_62	[p4l1600t2070r1937b2142],
7	cases	NNS	O	case	prep_of	3	SENT_62	[p4l1978t2086r2148b2125],
8	and	CC	O	and	_	0	SENT_62	[p4l9t2154r130b2209],
9	controls	NNS	O	control	prep_of	3	SENT_62	[p4l162t2154r430b2209],

1	Cases	NNS	O	case	_	0	SENT_63	[p4l1166t2329r1332b2382],
2	Controls	NNP	O	Controls	nn	5	SENT_63	[p4l1520t2327r1766b2382],
3	X2	NN	O	x2	nn	5	SENT_63	[p4l1833t2321r1901b2396],
4	P	NN	O	p	nn	5	SENT_63	[p4l1932t2330r1962b2381],
5	value	NN	O	value	dep	1	SENT_63	[p4l1995t2327r2152b2382],
6	(	CD	NUMBER	(	num	7	SENT_63	[p4l1123t2416r1181b2484],
7	n	NN	O	n	dep	1	SENT_63	[p4l1123t2416r1181b2484],
8	=	JJ	O	=	quantmod	10	SENT_63	[p4l1201t2443r1250b2460],
9	25	CD	NUMBER	25	number	10	SENT_63	[p4l1268t2416r1372b2484],
10	)	CD	NUMBER	)	num	15	SENT_63	[p4l1268t2416r1372b2484],
11	(	NN	O	(	nn	15	SENT_63	[p4l1517t2416r1574b2484],
12	n	NN	O	n	nn	15	SENT_63	[p4l1517t2416r1574b2484],
13	=	JJ	O	=	amod	15	SENT_63	[p4l1595t2443r1643b2460],
14	83	CD	NUMBER	83	num	15	SENT_63	[p4l1664t2416r1766b2484],
15	)	NN	O	)	dep	7	SENT_63	[p4l1664t2416r1766b2484],

1	Age	NNP	O	Age	_	0	SENT_64	[p4l6t2600r145b2670],
2	,	,	O	,	_	0	SENT_64	[p4l6t2600r145b2670],
3	years	NNS	DURATION	year	appos	1	SENT_64	[p4l175t2614r335b2670],
4	53	CD	NUMBER	53	num	3	SENT_64	[p4l1129t2600r1205b2653],
5	i	FW	O	i	dep	1	SENT_64	[p4l1227t2604r1264b2653],
6	13	CD	NUMBER	13	number	7	SENT_64	[p4l1288t2600r1360b2653],
7	57	CD	NUMBER	57	dep	5	SENT_64	[p4l1523t2600r1600b2653],
8	1	LS	NUMBER	1	dep	7	SENT_64	[p4l1621t2604r1658b2653],
9	-	:	O	-	_	0	SENT_64	[p4l1621t2604r1658b2653],
10	12	CD	NUMBER	12	num	11	SENT_64	[p4l1681t2600r1754b2652],
11	0.4	CD	NUMBER	0.4	dep	5	SENT_64	[p4l1915t2600r2013b2653],
12	Female	JJ	O	female	amod	13	SENT_64	[p4l12t2684r231b2739],
13	gender	NN	O	gender	dep	11	SENT_64	[p4l260t2684r498b2756],
14	,	,	O	,	_	0	SENT_64	[p4l260t2684r498b2756],
15	%	NN	O	%	appos	13	SENT_64	[p4l532t2686r594b2739],
16	21.7	CD	NUMBER	21.7	number	15	SENT_64	[p4l1176t2686r1315b2739],
17	27.4	CD	NUMBER	27.4	number	15	SENT_64	[p4l1569t2686r1708b2739],
18	1.0	CD	NUMBER	1.0	number	15	SENT_64	[p4l1918t2686r2013b2739],

1	Patients	NNS	O	patient	_	0	SENT_65	[p4l12t2860r249b2913],
2	per	IN	O	per	_	0	SENT_65	[p4l273t2874r375b2930],
3	statin	NN	O	statin	nn	5	SENT_65	[p4l396t2860r565b2913],
4	1.0	CD	NUMBER	1.0	num	5	SENT_65	[p4l1918t2860r2013b2913],
5	type	NN	O	type	prep_per	1	SENT_65	[p4l13t2951r150b3016],
6	,	,	O	,	_	0	SENT_65	[p4l13t2951r150b3016],
7	n	NN	O	n	appos	5	SENT_65	[p4l185t2961r217b2999],
8	(	CD	PERCENT	(	num	9	SENT_65	[p4l252t2945r357b3013],
9	%	NN	PERCENT	%	dep	1	SENT_65	[p4l252t2945r357b3013],
10	)	CD	NUMBER	)	dep	9	SENT_65	[p4l252t2945r357b3013],

1	Simvastatin	NNP	O	Simvastatin	_	0	SENT_66	[p4l83t3032r438b3085],
2	12	CD	NUMBER	12	num	1	SENT_66	[p4l1131t3032r1204b3085],
3	(	CD	NUMBER	(	number	4	SENT_66	[p4l1236t3031r1363b3099],
4	48	CD	NUMBER	48	num	5	SENT_66	[p4l1236t3031r1363b3099],
5	)	NN	O	)	dep	1	SENT_66	[p4l1236t3031r1363b3099],
6	39	CD	NUMBER	39	num	7	SENT_66	[p4l1525t3032r1598b3085],
7	(	CD	NUMBER	(	dep	31	SENT_66	[p4l1629t3031r1757b3099],
8	48	CD	NUMBER	48	num	9	SENT_66	[p4l1629t3031r1757b3099],
9	)	NN	O	)	dep	7	SENT_66	[p4l1629t3031r1757b3099],
10	—	CD	NUMBER	—	num	27	SENT_66	[p4l1954t3064r2027b3069],
11	Atorvastatin	NNP	O	Atorvastatin	nn	27	SENT_66	[p4l79t3119r454b3172],
12	10	CD	NUMBER	10	num	27	SENT_66	[p4l1131t3119r1205b3172],
13	(	CD	NUMBER	(	num	27	SENT_66	[p4l1236t3118r1363b3186],
14	40	CD	NUMBER	40	num	27	SENT_66	[p4l1236t3118r1363b3186],
15	)	NN	O	)	nn	27	SENT_66	[p4l1236t3118r1363b3186],
16	35	CD	NUMBER	35	num	27	SENT_66	[p4l1525t3119r1597b3172],
17	(	CD	NUMBER	(	num	27	SENT_66	[p4l1629t3118r1757b3186],
18	42	CD	NUMBER	42	num	27	SENT_66	[p4l1629t3118r1757b3186],
19	)	NN	O	)	nn	27	SENT_66	[p4l1629t3118r1757b3186],
20	—	CD	NUMBER	—	num	27	SENT_66	[p4l1954t3151r2027b3156],
21	Pravastatin	NN	O	pravastatin	nn	27	SENT_66	[p4l84t3206r418b3259],
22	2	CD	NUMBER	2	num	27	SENT_66	[p4l1169t3206r1204b3259],
23	(	CD	NUMBER	(	num	27	SENT_66	[p4l1236t3205r1321b3273],
24	8	CD	NUMBER	8	num	27	SENT_66	[p4l1236t3205r1321b3273],
25	)	NN	O	)	nn	27	SENT_66	[p4l1236t3205r1321b3273],
26	8	CD	NUMBER	8	num	27	SENT_66	[p4l1533t3206r1567b3259],
27	(	NN	O	(	rcmod	9	SENT_66	[p4l1598t3205r1746b3273],
28	9.5	CD	NUMBER	9.5	dep	31	SENT_66	[p4l1598t3205r1746b3273],
29	)	CD	NUMBER	)	num	31	SENT_66	[p4l1598t3205r1746b3273],
30	—	NN	O	—	nn	31	SENT_66	[p4l1954t3238r2027b3243],
31	Rosuvastatin	NN	ORGANIZATION	rosuvastatin	dep	35	SENT_66	[p4l84t3293r468b3346],
32	1	CD	NUMBER	1	number	33	SENT_66	[p4l1172t3293r1191b3346],
33	(	CD	NUMBER	(	dep	31	SENT_66	[p4l1236t3292r1321b3360],
34	4	CD	NUMBER	4	dep	33	SENT_66	[p4l1236t3292r1321b3360],
35	)	NN	O	)	dep	48	SENT_66	[p4l1236t3292r1321b3360],
36	1	CD	NUMBER	1	num	35	SENT_66	[p4l1535t3293r1554b3346],
37	(	CD	NUMBER	(	number	38	SENT_66	[p4l1598t3292r1746b3360],
38	1.2	CD	NUMBER	1.2	nsubj	48	SENT_66	[p4l1598t3292r1746b3360],
39	)	NN	O	)	nn	42	SENT_66	[p4l1598t3292r1746b3360],
40	—	CD	NUMBER	—	num	42	SENT_66	[p4l1954t3325r2027b3330],
41	Mean	NN	O	mean	nn	42	SENT_66	[p4l12t3382r184b3434],
42	dose	NN	O	dose	dep	38	SENT_66	[p4l215t3379r376b3445],
43	,	,	O	,	_	0	SENT_66	[p4l215t3379r376b3445],
44	mg	NN	O	mg	appos	38	SENT_66	[p4l412t3395r530b3451],
45	,	,	O	,	_	0	SENT_66	[p4l412t3395r530b3451],
46	(	NN	O	(	nn	47	SENT_66	[p4l563t3379r819b3451],
47	range	NN	O	range	appos	44	SENT_66	[p4l563t3379r819b3451],
48	)	VBD	O	)	dep	1	SENT_66	[p4l563t3379r819b3451],
49	a	DT	O	a	det	51	SENT_66	[p4l563t3379r819b3451],
50	31	CD	NUMBER	31	num	51	SENT_66	[p4l1133t3381r1193b3434],
51	i	FW	O	i	dobj	48	SENT_66	[p4l1227t3385r1264b3433],
52	23	CD	NUMBER	23	number	53	SENT_66	[p4l1285t3381r1360b3434],
53	36	CD	NUMBER	36	dep	51	SENT_66	[p4l1526t3381r1600b3434],
54	i	FW	O	i	tmod	48	SENT_66	[p4l1621t3385r1658b3433],
55	25	CD	NUMBER	25	num	56	SENT_66	[p4l1678t3381r1753b3434],
56	0.4	CD	NUMBER	0.4	dep	54	SENT_66	[p4l1915t3381r2013b3434],

1	Creatine	NN	O	creatine	dep	7	SENT_67	[p4l10t3552r273b3606],
2	kinase	NN	O	kinase	dep	1	SENT_67	[p4l304t3551r509b3617],
3	,	,	O	,	_	0	SENT_67	[p4l304t3551r509b3617],
4	U	NNP	O	U	nn	5	SENT_67	[p4l545t3554r585b3606],
5	I-1	NNP	O	I-1	appos	2	SENT_67	[p4l606t3545r679b3605],
6	2376	CD	DATE	2376	dep	7	SENT_67	[p4l1047t3553r1206b3606],
7	i	FW	DATE	i	dep	13	SENT_67	[p4l1227t3557r1265b3606],
8	1067	CD	DATE	1067	number	9	SENT_67	[p4l1288t3553r1444b3606],
9	86.3	CD	NUMBER	86.3	dep	7	SENT_67	[p4l1492t3553r1629b3606],
10	i	FW	O	i	dep	9	SENT_67	[p4l1652t3557r1689b3606],
11	36	CD	NUMBER	36	number	12	SENT_67	[p4l1713t3553r1786b3606],
12	<	JJR	O	<	amod	9	SENT_67	[p4l1853t3553r2123b3606],
13	0.0001	CD	NUMBER	0.0001	_	0	SENT_67	[p4l1853t3553r2123b3606],

1	Concomitant	JJ	O	concomitant	_	0	SENT_68	[p4l13t3727r403b3780],
2	medications	NNS	O	medication	dep	1	SENT_68	[p4l429t3725r803b3792],
3	,	,	O	,	_	0	SENT_68	[p4l429t3725r803b3792],

1	n	NN	O	n	_	0	SENT_69	[p5l11t32r44b70],
2	(	CD	PERCENT	(	num	3	SENT_69	[p5l78t17r183b85],
3	%	NN	PERCENT	%	dep	1	SENT_69	[p5l78t17r183b85],
4	)	CD	NUMBER	)	dep	1	SENT_69	[p5l78t17r183b85],

1	Amiodarone	NNP	O	Amiodarone	nn	4	SENT_70	[p5l79t103r468b158],
2	o	NN	O	o	nn	4	SENT_70	[p5l1169t105r1205b158],
3	(	NN	O	(	nn	4	SENT_70	[p5l1236t104r1321b172],
4	o	NN	O	o	dep	17	SENT_70	[p5l1236t104r1321b172],
5	)	CD	NUMBER	)	num	8	SENT_70	[p5l1236t104r1321b172],
6	o	NN	O	o	nn	8	SENT_70	[p5l1563t105r1599b158],
7	(	NN	O	(	nn	8	SENT_70	[p5l1629t104r1715b172],
8	o	NN	O	o	dep	4	SENT_70	[p5l1629t104r1715b172],
9	)	CD	NUMBER	)	number	10	SENT_70	[p5l1629t104r1715b172],
10	—	CD	NUMBER	—	num	14	SENT_70	[p5l1954t137r2027b142],
11	Niacin	NN	O	niacin	nn	14	SENT_70	[p5l84t192r278b245],
12	o	NN	O	o	nn	14	SENT_70	[p5l1169t192r1205b245],
13	(	CD	NUMBER	(	num	14	SENT_70	[p5l1236t191r1321b259],
14	o	NN	O	o	dep	8	SENT_70	[p5l1236t191r1321b259],
15	)	CD	NUMBER	)	dep	17	SENT_70	[p5l1236t191r1321b259],
16	5	CD	NUMBER	5	num	17	SENT_70	[p5l1532t193r1565b245],
17	(	NN	O	(	dep	27	SENT_70	[p5l1598t191r1746b259],
18	6.0	CD	NUMBER	6.0	num	21	SENT_70	[p5l1598t191r1746b259],
19	)	CD	NUMBER	)	num	21	SENT_70	[p5l1598t191r1746b259],
20	0.2	CD	NUMBER	0.2	num	21	SENT_70	[p5l1915t192r2012b245],
21	Fibrates	NNS	O	fibrate	dep	17	SENT_70	[p5l84t278r322b333],
22	8	CD	NUMBER	8	number	23	SENT_70	[p5l1118t280r1153b333],
23	(	CD	NUMBER	(	num	25	SENT_70	[p5l1183t278r1373b347],
24	32.0	CD	NUMBER	32.0	number	25	SENT_70	[p5l1183t278r1373b347],
25	)	CD	NUMBER	)	dep	21	SENT_70	[p5l1183t278r1373b347],
26	13	CD	NUMBER	13	num	27	SENT_70	[p5l1493t280r1565b333],
27	(	NN	O	(	dep	34	SENT_70	[p5l1598t278r1787b346],
28	15.5	CD	NUMBER	15.5	number	29	SENT_70	[p5l1598t278r1787b346],
29	)	CD	NUMBER	)	dep	27	SENT_70	[p5l1598t278r1787b346],
30	0.06	CD	NUMBER	0.06	num	33	SENT_70	[p5l1915t280r2054b333],
31	Calcium	NN	O	calcium	nn	33	SENT_70	[p5l82t365r334b420],
32	channel	NN	O	channel	nn	33	SENT_70	[p5l367t365r611b420],
33	antagonists	NNS	O	antagonist	dep	29	SENT_70	[p5l643t366r1001b437],
34	o	NN	O	o	dep	36	SENT_70	[p5l1169t367r1205b420],
35	(	CD	NUMBER	(	num	34	SENT_70	[p5l1236t365r1321b433],
36	o	NN	O	o	dep	38	SENT_70	[p5l1236t365r1321b433],
37	)	CD	NUMBER	)	num	36	SENT_70	[p5l1236t365r1321b433],
38	10	CD	NUMBER	10	dep	39	SENT_70	[p5l1493t367r1567b420],
39	(	NN	O	(	dep	42	SENT_70	[p5l1597t365r1787b433],
40	11.9	CD	NUMBER	11.9	num	39	SENT_70	[p5l1597t365r1787b433],
41	)	CD	NUMBER	)	num	42	SENT_70	[p5l1597t365r1787b433],
42	0.07	CD	NUMBER	0.07	_	0	SENT_70	[p5l1915t367r2054b420],

1	Data	NNS	O	datum	nsubjpass	3	SENT_71	[p5l11t537r127b579],
2	are	VBP	O	be	auxpass	3	SENT_71	[p5l153t548r229b579],
3	shown	VBN	O	show	_	0	SENT_71	[p5l252t535r420b579],
4	as	IN	O	as	mark	6	SENT_71	[p5l446t548r495b579],
5	mean	NN	O	mean	nsubj	6	SENT_71	[p5l521t548r661b579],
6	is	VBZ	O	be	advcl	3	SENT_71	[p5l680t535r813b579],
7	.	.	O	.	_	0	SENT_71	[p5l680t535r813b579],

1	d.	NN	O	d.	_	0	SENT_72	[p5l680t535r813b579],
2	where	WRB	O	where	advmod	3	SENT_72	[p5l838t535r998b579],
3	applicable	JJ	O	applicable	amod	1	SENT_72	[p5l1023t535r1301b593],
4	.	.	O	.	_	0	SENT_72	[p5l1023t535r1301b593],

1	aExpressed	VBN	O	aexpress	_	0	SENT_73	[p5l8t596r283b655],
2	in	IN	O	in	_	0	SENT_73	[p5l311t598r352b641],
3	equivalent	JJ	O	equivalent	amod	5	SENT_73	[p5l379t596r650b655],
4	simvastatin	NN	O	simvastatin	nn	5	SENT_73	[p5l671t598r958b641],
5	dose	NN	O	dose	prep_in	1	SENT_73	[p5l984t596r1117b641],
6	.	.	O	.	_	0	SENT_73	[p5l984t596r1117b641],

1	Table	NNP	O	Table	_	0	SENT_74	[p5l7t686r196b742],
2	2	CD	NUMBER	2	num	1	SENT_74	[p5l273t687r311b741],
3	Association	NNP	O	Association	dep	1	SENT_74	[p5l387t688r765b742],
4	between	IN	O	between	_	0	SENT_74	[p5l845t687r1132b742],
5	rs4149056	CD	NUMBER	rs4149056	num	6	SENT_74	[p5l1211t689r1555b742],
6	genotype	NN	O	genotype	prep_between	3	SENT_74	[p5l1630t693r1948b759],
7	and	CC	O	and	_	0	SENT_74	[p5l2025t687r2146b742],
8	myopathy	NN	O	myopathy	prep_between	3	SENT_74	[p5l11t783r348b855],

1	Statin-type	JJ	O	statin-type	amod	2	SENT_75	[p5l11t958r342b1028],
2	Cases	NNS	O	case	_	0	SENT_75	[p5l537t958r704b1011],
3	Controls	NNP	O	Controls	nn	4	SENT_75	[p5l996t957r1242b1011],
4	C	NNP	O	C	dep	2	SENT_75	[p5l1507t958r1550b1011],
5	allele	NN	O	allele	nn	6	SENT_75	[p5l1574t956r1727b1011],
6	frequency	NN	O	frequency	dep	2	SENT_75	[p5l1753t957r2047b1028],

1	T/T	NN	O	t/t	nn	3	SENT_76	[p5l404t1139r508b1200],
2	T/C	NN	O	t/c	nn	3	SENT_76	[p5l565t1139r671b1200],
3	C/C	NN	O	c/c	_	0	SENT_76	[p5l728t1139r843b1200],
4	T/T	NN	O	t/t	nn	7	SENT_76	[p5l903t1139r1006b1200],
5	T/C	NN	O	t/c	nn	7	SENT_76	[p5l1064t1139r1170b1200],
6	C/C	NN	O	c/c	nn	7	SENT_76	[p5l1227t1139r1342b1200],
7	Cases	NNS	O	case	dep	3	SENT_76	[p5l1399t1141r1565b1193],
8	Controls	NNP	O	Controls	nn	10	SENT_76	[p5l1626t1139r1872b1193],
9	P	NN	O	p	nn	10	SENT_76	[p5l1931t1142r1962b1192],
10	value	NN	O	value	dep	3	SENT_76	[p5l1995t1139r2153b1193],

1	All	DT	O	all	det	3	SENT_77	[p5l6t1321r81b1374],
2	15	CD	NUMBER	15	num	3	SENT_77	[p5l413t1322r484b1375],
3	8	CD	NUMBER	8	dep	13	SENT_77	[p5l595t1322r629b1375],
4	2	CD	NUMBER	2	number	5	SENT_77	[p5l762t1322r797b1374],
5	57	CD	NUMBER	57	num	7	SENT_77	[p5l908t1323r985b1375],
6	20	CD	NUMBER	20	number	7	SENT_77	[p5l1072t1322r1148b1375],
7	6	CD	NUMBER	6	dep	3	SENT_77	[p5l1262t1322r1297b1375],
8	0.24	CD	NUMBER	0.24	num	9	SENT_77	[p5l1409t1322r1547b1375],
9	0.19	CD	NUMBER	0.19	dep	7	SENT_77	[p5l1676t1322r1814b1375],
10	0.21	CD	NUMBER	0.21	num	11	SENT_77	[p5l1948t1322r2073b1375],
11	Simva	NN	O	simva	dep	13	SENT_77	[p5l10t1408r195b1461],
12	5	CD	NUMBER	5	num	13	SENT_77	[p5l451t1409r485b1461],
13	6	CD	NUMBER	6	dep	21	SENT_77	[p5l595t1408r629b1461],
14	1	CD	NUMBER	1	number	15	SENT_77	[p5l765t1408r785b1460],
15	27	CD	NUMBER	27	num	17	SENT_77	[p5l908t1408r985b1461],
16	10	CD	NUMBER	10	number	17	SENT_77	[p5l1075t1408r1148b1461],
17	2	CD	NUMBER	2	dep	13	SENT_77	[p5l1261t1408r1296b1460],
18	0.33	CD	NUMBER	0.33	num	19	SENT_77	[p5l1409t1408r1546b1461],
19	0.18	CD	NUMBER	0.18	dep	17	SENT_77	[p5l1676t1408r1815b1461],
20	0.042	CD	NUMBER	0.042	num	21	SENT_77	[p5l1948t1408r2127b1461],
21	Atorva	NN	ORGANIZATION	atorva	dep	28	SENT_77	[p5l6t1495r210b1547],
22	7	CD	NUMBER	7	number	23	SENT_77	[p5l455t1495r487b1547],
23	2	CD	NUMBER	2	num	25	SENT_77	[p5l594t1495r628b1546],
24	1	CD	NUMBER	1	number	25	SENT_77	[p5l765t1495r785b1546],
25	24	CD	NUMBER	24	dep	21	SENT_77	[p5l908t1495r985b1546],
26	7	CD	NUMBER	7	number	27	SENT_77	[p5l1116t1495r1149b1547],
27	3	CD	NUMBER	3	amod	25	SENT_77	[p5l1264t1495r1295b1547],
28	0.20	CD	NUMBER	0.20	dep	30	SENT_77	[p5l1409t1495r1548b1547],
29	0.19	CD	NUMBER	0.19	num	30	SENT_77	[p5l1676t1495r1814b1547],
30	0.48	CD	NUMBER	0.48	_	0	SENT_77	[p5l1948t1495r2087b1547],

1	significant	JJ	O	significant	amod	2	SENT_78	[p5l10t1788r381b1864],
2	differences	NNS	O	difference	_	0	SENT_78	[p5l412t1788r792b1846],
3	between	IN	O	between	_	0	SENT_78	[p5l821t1788r1119b1846],
4	cases	NNS	O	case	prep_between	2	SENT_78	[p5l1150t1805r1321b1846],
5	and	CC	O	and	_	0	SENT_78	[p5l1353t1788r1484b1846],
6	controls	NNS	O	control	conj_and	4	SENT_78	[p5l1514t1788r1801b1846],
7	in	IN	O	in	_	0	SENT_78	[p5l1832t1791r1902b1845],
8	age	NN	O	age	prep_in	2	SENT_78	[p5l1933t1805r2047b1864],
9	or	CC	O	or	_	0	SENT_78	[p5l2078t1805r2149b1846],
10	gender	NN	O	gender	prep_in	2	SENT_78	[p5l9t1883r261b1958],
11	.	.	O	.	_	0	SENT_78	[p5l9t1883r261b1958],

1	Most	JJS	O	most	amod	2	SENT_79	[p5l300t1885r476b1940],
2	patients	NNS	O	patient	nsubj	3	SENT_79	[p5l510t1886r793b1958],
3	received	VBD	O	receive	_	0	SENT_79	[p5l829t1883r1119b1940],
4	simvastatin	NN	O	simvastatin	dobj	3	SENT_79	[p5l1157t1886r1561b1940],
5	or	CC	O	or	_	0	SENT_79	[p5l1598t1899r1669b1940],
6	atorvastatin	NN	O	atorvastatin	conj_or	4	SENT_79	[p5l1704t1886r2144b1953],
7	,	,	O	,	_	0	SENT_79	[p5l1704t1886r2144b1953],
8	and	CC	O	and	_	0	SENT_79	[p5l9t1978r141b2036],
9	the	DT	O	the	det	10	SENT_79	[p5l163t1978r275b2036],
10	distribution	NN	O	distribution	nsubj	21	SENT_79	[p5l299t1978r718b2036],
11	of	IN	O	of	_	0	SENT_79	[p5l741t1978r812b2036],
12	patients	NNS	O	patient	prep_of	10	SENT_79	[p5l830t1981r1112b2054],
13	on	IN	O	on	_	0	SENT_79	[p5l1136t1995r1227b2036],
14	each	DT	O	each	det	15	SENT_79	[p5l1250t1978r1411b2036],
15	statin	NN	O	statin	prep_on	12	SENT_79	[p5l1435t1981r1631b2036],
16	and	CC	O	and	_	0	SENT_79	[p5l1654t1978r1785b2036],
17	total	JJ	O	total	amod	18	SENT_79	[p5l1807t1978r1969b2036],
18	dose	NN	O	dose	prep_on	12	SENT_79	[p5l1992t1978r2147b2036],
19	did	VBD	O	do	aux	21	SENT_79	[p5l9t2073r122b2130],
20	not	RB	O	not	neg	21	SENT_79	[p5l166t2080r286b2130],
21	differ	VB	O	differ	conj_and	3	SENT_79	[p5l332t2072r519b2130],
22	between	IN	O	between	_	0	SENT_79	[p5l560t2073r858b2130],
23	groups	NNS	O	group	prep_between	21	SENT_79	[p5l903t2089r1157b2148],
24	.	.	O	.	_	0	SENT_79	[p5l903t2089r1157b2148],

1	More	RBR	O	more	advmod	5	SENT_80	[p5l1205t2075r1388b2130],
2	cases	NNS	O	case	pobj	1	SENT_80	[p5l1434t2089r1606b2130],
3	than	IN	O	than	amod	4	SENT_80	[p5l1651t2073r1816b2130],
4	controls	NNS	O	control	nsubj	5	SENT_80	[p5l1861t2073r2148b2130],
5	received	VBD	O	receive	_	0	SENT_80	[p5l9t2167r299b2225],
6	a	DT	O	a	det	9	SENT_80	[p5l328t2183r363b2224],
7	concomitant	JJ	O	concomitant	amod	9	SENT_80	[p5l392t2170r847b2225],
8	fibrate	JJ	O	fibrate	amod	9	SENT_80	[p5l875t2166r1100b2225],
9	medication	NN	O	medication	dobj	5	SENT_80	[p5l1130t2167r1549b2237],
10	,	,	O	,	_	0	SENT_80	[p5l1130t2167r1549b2237],
11	whereas	IN	O	whereas	mark	22	SENT_80	[p5l1581t2167r1865b2225],
12	the	DT	O	the	det	13	SENT_80	[p5l1894t2167r2007b2225],
13	use	NN	O	use	nsubj	22	SENT_80	[p5l2035t2183r2148b2225],
14	of	IN	O	of	_	0	SENT_80	[p5l9t2263r81b2321],
15	calcium	NN	O	calcium	nn	17	SENT_80	[p5l140t2263r417b2321],
16	channel	NN	O	channel	nn	17	SENT_80	[p5l481t2263r766b2321],
17	antagonists	NNS	O	antagonist	prep_of	13	SENT_80	[p5l830t2266r1234b2339],
18	and	CC	O	and	_	0	SENT_80	[p5l1298t2263r1430b2321],
19	niacin	NN	O	niacin	prep_of	13	SENT_80	[p5l1493t2266r1714b2321],
20	was	VBD	O	be	cop	22	SENT_80	[p5l1775t2280r1903b2321],
21	more	RBR	O	more	advmod	22	SENT_80	[p5l1966t2280r2147b2321],
22	common	JJ	O	common	advcl	5	SENT_80	[p5l9t2373r329b2414],
23	in	IN	O	in	_	0	SENT_80	[p5l396t2360r467b2413],
24	controls	NNS	O	control	prep_in	22	SENT_80	[p5l536t2357r841b2414],
25	.	.	O	.	_	0	SENT_80	[p5l536t2357r841b2414],

1	These	DT	O	these	det	2	SENT_81	[p5l911t2357r1107b2414],
2	differences	NNS	O	difference	nsubj	5	SENT_81	[p5l1175t2357r1538b2414],
3	did	VBD	O	do	aux	5	SENT_81	[p5l1606t2357r1715b2414],
4	not	RB	O	not	neg	5	SENT_81	[p5l1781t2364r1899b2414],
5	reach	VB	O	reach	_	0	SENT_81	[p5l1965t2357r2149b2414],
6	statistical	JJ	O	statistical	amod	7	SENT_81	[p5l10t2452r323b2510],
7	signiﬁcance	NN	O	signiﬁcance	dobj	5	SENT_81	[p5l355t2452r770b2528],
8	.	.	O	.	_	0	SENT_81	[p5l355t2452r770b2528],

1	No	DT	O	no	det	2	SENT_82	[p5l803t2454r904b2510],
2	cases	NNS	O	case	nsubj	5	SENT_82	[p5l935t2469r1100b2510],
3	or	CC	O	or	_	0	SENT_82	[p5l1131t2469r1201b2510],
4	controls	NNS	O	control	nsubj	5	SENT_82	[p5l1229t2452r1504b2510],
5	received	VBD	O	receive	_	0	SENT_82	[p5l1534t2452r1813b2510],
6	amiodar	JJ	O	amiodar	amod	7	SENT_82	[p5l1843t2452r2147b2510],
7	—	NN	O	—	iobj	5	SENT_82	[p5l1843t2452r2147b2510],
8	one	CD	NUMBER	one	dobj	5	SENT_82	[p5l9t2562r152b2603],
9	.	.	O	.	_	0	SENT_82	[p5l9t2562r152b2603],

1	Overall	RB	O	overall	advmod	12	SENT_83	[p5l193t2545r452b2616],
2	,	,	O	,	_	0	SENT_83	[p5l193t2545r452b2616],
3	32.0	CD	PERCENT	32.0	num	4	SENT_83	[p5l494t2547r705b2603],
4	%	NN	PERCENT	%	nsubj	12	SENT_83	[p5l494t2547r705b2603],
5	of	IN	O	of	_	0	SENT_83	[p5l742t2545r812b2603],
6	cases	NNS	O	case	prep_of	4	SENT_83	[p5l843t2562r1008b2603],
7	and	CC	O	and	_	0	SENT_83	[p5l1045t2545r1173b2603],
8	28.6	CD	PERCENT	28.6	num	9	SENT_83	[p5l1210t2547r1421b2603],
9	%	NN	PERCENT	%	prep_of	4	SENT_83	[p5l1210t2547r1421b2603],
10	of	IN	O	of	_	0	SENT_83	[p5l1458t2545r1527b2603],
11	controls	NNS	O	control	prep_of	9	SENT_83	[p5l1559t2546r1834b2603],
12	received	VBD	O	receive	_	0	SENT_83	[p5l1871t2545r2150b2603],
13	one	CD	NUMBER	one	nsubj	19	SENT_83	[p5l9t2657r134b2698],
14	of	IN	O	of	_	0	SENT_83	[p5l171t2640r241b2698],
15	these	DT	O	these	det	18	SENT_83	[p5l271t2640r446b2698],
16	four	CD	NUMBER	four	num	18	SENT_83	[p5l482t2640r622b2698],
17	additional	JJ	O	additional	amod	18	SENT_83	[p5l657t2640r1004b2698],
18	medications	NNS	O	medication	prep_of	13	SENT_83	[p5l1039t2640r1455b2698],
19	(	VBP	O	(	ccomp	12	SENT_83	[p5l1494t2632r1581b2713],
20	X2	NN	O	x2	nn	22	SENT_83	[p5l1494t2632r1581b2713],
21	P	NN	O	p	nn	22	SENT_83	[p5l1613t2643r1659b2697],
22	value	NN	O	value	dobj	19	SENT_83	[p5l1689t2640r1870b2698],
23	=	JJ	O	=	amod	22	SENT_83	[p5l1888t2668r1939b2687],
24	0.74	CD	NUMBER	0.74	num	25	SENT_83	[p5l1957t2640r2144b2712],
25	)	NN	O	)	dep	23	SENT_83	[p5l1957t2640r2144b2712],
26	.	.	O	.	_	0	SENT_83	[p5l1957t2640r2144b2712],

1	No	DT	O	no	det	2	SENT_84	[p5l7t2738r108b2794],
2	cases	NNS	O	case	nsubjpass	4	SENT_84	[p5l172t2753r337b2794],
3	were	VBD	O	be	auxpass	4	SENT_84	[p5l399t2753r557b2794],
4	reported	VBN	O	report	_	0	SENT_84	[p5l622t2736r908b2812],
5	to	TO	O	to	aux	7	SENT_84	[p5l970t2743r1038b2794],
6	have	VB	O	have	aux	7	SENT_84	[p5l1102t2736r1261b2794],
7	received	VBN	O	receive	xcomp	4	SENT_84	[p5l1325t2736r1604b2794],
8	other	JJ	O	other	amod	10	SENT_84	[p5l1667t2736r1850b2794],
9	known	JJ	O	known	amod	10	SENT_84	[p5l1911t2736r2149b2794],
10	inhibitors	NNS	O	inhibitor	dobj	7	SENT_84	[p5l9t2831r341b2888],
11	of	IN	O	of	_	0	SENT_84	[p5l367t2830r437b2888],
12	CYP3A4	NN	O	cyp3a4	prep_of	10	SENT_84	[p5l459t2832r734b2888],
13	or	CC	O	or	_	0	SENT_84	[p5l761t2847r831b2888],
14	SLCOIB1	NN	O	slcoib1	nn	17	SENT_84	[p5l856t2832r1171b2888],
15	(	NN	O	(	nn	17	SENT_84	[p5l1205t2831r1507b2906],
16	protease	NN	O	protease	nn	17	SENT_84	[p5l1205t2831r1507b2906],
17	inhibitors	NNS	O	inhibitor	dobj	7	SENT_84	[p5l1534t2831r1882b2901],
18	,	,	O	,	_	0	SENT_84	[p5l1534t2831r1882b2901],
19	macrolide	NN	O	macrolide	nn	20	SENT_84	[p5l1912t2847r2148b2888, p5l9t2926r131b2984],
20	antibiotics	NNS	O	antibiotic	conj_or	17	SENT_84	[p5l168t2926r540b2996],
21	,	,	O	,	_	0	SENT_84	[p5l168t2926r540b2996],
22	azole	NN	O	azole	nn	23	SENT_84	[p5l580t2926r751b2984],
23	antifungals	NNS	O	antifungal	conj_or	17	SENT_84	[p5l788t2926r1182b3002],
24	,	,	O	,	_	0	SENT_84	[p5l788t2926r1182b3002],
25	thiazolidinediones	NNS	O	thiazolidinedione	conj_or	17	SENT_84	[p5l1222t2926r1871b2996],
26	,	,	O	,	_	0	SENT_84	[p5l1222t2926r1871b2996],
27	tacrolimus	NN	O	tacrolimus	conj_or	17	SENT_84	[p5l1911t2926r2148b2984, p5l9t3039r168b3092],
28	,	,	O	,	_	0	SENT_84	[p5l1911t2926r2148b2984, p5l9t3039r168b3092],
29	cylcosporin	NN	O	cylcosporin	conj_or	17	SENT_84	[p5l201t3022r593b3098],
30	or	CC	O	or	_	0	SENT_84	[p5l621t3039r691b3080],
31	rifampicin	NN	O	rifampicin	nn	32	SENT_84	[p5l717t3022r1114b3098],
32	)	NN	O	)	conj_or	17	SENT_84	[p5l717t3022r1114b3098],
33	.	.	O	.	_	0	SENT_84	[p5l717t3022r1114b3098],

1	Amongst	IN	O	amongst	_	0	SENT_85	[p5l84t3118r404b3192],
2	the	DT	O	the	det	5	SENT_85	[p5l465t3117r578b3174],
3	entire	JJ	O	entire	amod	5	SENT_85	[p5l641t3120r845b3174],
4	study	NN	O	study	nn	5	SENT_85	[p5l910t3117r1102b3192],
5	group	NN	O	group	prep_amongst	8	SENT_85	[p5l1162t3133r1385b3192],
6	,	,	O	,	_	0	SENT_85	[p5l1162t3133r1385b3192],
7	there	EX	O	there	expl	8	SENT_85	[p5l1451t3117r1632b3174],
8	was	VBD	O	be	_	0	SENT_85	[p5l1693t3133r1821b3174],
9	a	DT	O	a	det	11	SENT_85	[p5l1884t3133r1919b3174],
10	nonsignificant	JJ	O	nonsignificant	amod	11	SENT_85	[p5l1981t3133r2148b3174, p5l10t3212r381b3288],
11	trend	NN	O	trend	nsubj	8	SENT_85	[p5l418t3212r607b3270],
12	towards	IN	O	towards	_	0	SENT_85	[p5l643t3212r920b3270],
13	increased	VBN	O	increase	amod	14	SENT_85	[p5l958t3212r1288b3270],
14	risk	NN	O	risk	prep_towards	11	SENT_85	[p5l1325t3212r1450b3270],
15	of	IN	O	of	_	0	SENT_85	[p5l1485t3212r1557b3270],
16	myopathy	NN	O	myopathy	prep_of	14	SENT_85	[p5l1589t3212r1955b3288],
17	with	IN	O	with	_	0	SENT_85	[p5l1987t3212r2149b3270],
18	SLCO1B1	NN	O	slco1b1	nn	20	SENT_85	[p5l7t3308r324b3365],
19	risk	NN	O	risk	nn	20	SENT_85	[p5l365t3307r490b3365],
20	genotype	NN	O	genotype	prep_with	16	SENT_85	[p5l521t3314r847b3383],
21	(	CD	NUMBER	(	num	22	SENT_85	[p5l886t3307r1008b3379],
22	TC	NN	O	tc	dep	16	SENT_85	[p5l886t3307r1008b3379],
23	or	CC	O	or	_	0	SENT_85	[p5l1043t3324r1115b3365],
24	CC	NN	O	cc	dep	16	SENT_85	[p5l1149t3308r1257b3365],
25	vs	CC	O	vs	_	0	SENT_85	[p5l1289t3324r1360b3365],
26	TT	NN	O	tt	nn	28	SENT_85	[p5l1392t3309r1486b3364],
27	genotype	NN	O	genotype	nn	28	SENT_85	[p5l1518t3314r1844b3383],
28	OR	NN	O	or	conj_vs	22	SENT_85	[p5l1881t3308r1988b3365],
29	1.5	CD	NUMBER	1.5	dep	28	SENT_85	[p5l2026t3309r2144b3377],
30	,	,	O	,	_	0	SENT_85	[p5l2026t3309r2144b3377],
31	95	CD	PERCENT	95	number	32	SENT_85	[p5l10t3401r162b3458],
32	%	NN	PERCENT	%	num	37	SENT_85	[p5l10t3401r162b3458],
33	confidence	NN	O	confidence	nn	37	SENT_85	[p5l191t3400r579b3458],
34	interval	NN	O	interval	nn	37	SENT_85	[p5l609t3400r881b3458],
35	(	CD	NUMBER	(	num	37	SENT_85	[p5l914t3400r1040b3472],
36	CI	NN	O	ci	nn	37	SENT_85	[p5l914t3400r1040b3472],
37	)	NN	O	)	appos	16	SENT_85	[p5l914t3400r1040b3472],
38	0.58-3	CD	NUMBER	0.58-3	number	39	SENT_85	[p5l1073t3401r1432b3470],
39	.69	CD	NUMBER	.69	num	37	SENT_85	[p5l1073t3401r1432b3470],
40	,	,	O	,	_	0	SENT_85	[p5l1073t3401r1432b3470],
41	X2	NN	O	x2	nn	42	SENT_85	[p5l1466t3393r1534b3472],
42	P	NN	O	p	appos	37	SENT_85	[p5l1558t3401r1857b3470],
43	=	JJ	O	=	amod	42	SENT_85	[p5l1558t3401r1857b3470],
44	0.21	CD	NUMBER	0.21	tmod	43	SENT_85	[p5l1558t3401r1857b3470],
45	,	,	O	,	_	0	SENT_85	[p5l1558t3401r1857b3470],
46	Fisher	NNP	PERSON	Fisher	poss	52	SENT_85	[p5l1892t3400r2148b3458],
47	's	POS	O	's	_	0	SENT_85	[p5l1892t3400r2148b3458],
48	exact	JJ	O	exact	amod	52	SENT_85	[p5l9t3503r193b3553],
49	P	NN	O	p	nn	52	SENT_85	[p5l236t3496r563b3567],
50	=	JJ	O	=	amod	52	SENT_85	[p5l236t3496r563b3567],
51	0.14	CD	NUMBER	0.14	num	52	SENT_85	[p5l236t3496r563b3567],
52	)	NN	O	)	appos	37	SENT_85	[p5l236t3496r563b3567],
53	.	.	O	.	_	0	SENT_85	[p5l236t3496r563b3567],

1	The	DT	O	the	det	2	SENT_86	[p5l613t3495r746b3553],
2	frequency	NN	O	frequency	nsubj	20	SENT_86	[p5l794t3495r1149b3571],
3	of	IN	O	of	_	0	SENT_86	[p5l1195t3495r1267b3553],
4	the	DT	O	the	det	10	SENT_86	[p5l1309t3495r1422b3553],
5	rs4149056	NN	O	rs4149056	nn	10	SENT_86	[p5l1471t3497r1833b3553],
6	risk	NN	O	risk	nn	10	SENT_86	[p5l1882t3495r2007b3553],
7	‘	NN	O	‘	nn	10	SENT_86	[p5l2055t3495r2146b3553],
8	C	NN	O	c	nn	10	SENT_86	[p5l2055t3495r2146b3553],
9	’	CD	NUMBER	’	num	10	SENT_86	[p5l2055t3495r2146b3553],
10	allele	NN	O	allele	prep_of	2	SENT_86	[p5l9t3590r191b3648],
11	was	VBD	O	be	cop	12	SENT_86	[p5l251t3607r379b3648],
12	similar	JJ	O	similar	_	0	SENT_86	[p5l443t3590r682b3648],
13	in	IN	O	in	_	0	SENT_86	[p5l743t3593r813b3647],
14	cases	NNS	O	case	prep_in	12	SENT_86	[p5l874t3607r1046b3648],
15	(	VBP	O	(	dep	14	SENT_86	[p5l1112t3590r1312b3662],
16	23	CD	PERCENT	23	num	17	SENT_86	[p5l1112t3590r1312b3662],
17	%	NN	PERCENT	%	dobj	15	SENT_86	[p5l1112t3590r1312b3662],
18	)	CD	NUMBER	)	tmod	12	SENT_86	[p5l1112t3590r1312b3662],
19	and	CC	O	and	_	0	SENT_86	[p5l1378t3590r1509b3648],
20	controls	VBZ	O	control	conj_and	12	SENT_86	[p5l1570t3590r1857b3648],
21	(	CD	PERCENT	(	number	22	SENT_86	[p5l1922t3590r2144b3662],
22	19	CD	PERCENT	19	num	23	SENT_86	[p5l1922t3590r2144b3662],
23	%	NN	PERCENT	%	dobj	20	SENT_86	[p5l1922t3590r2144b3662],
24	)	CD	NUMBER	)	dobj	12	SENT_86	[p5l1922t3590r2144b3662],
25	.	.	O	.	_	0	SENT_86	[p5l1922t3590r2144b3662],

1	Therefore	RB	O	therefore	advmod	20	SENT_87	[p6l7t19r365b89],
2	,	,	O	,	_	0	SENT_87	[p6l7t19r365b89],
3	in	IN	O	in	_	0	SENT_87	[p6l401t22r471b76],
4	this	DT	O	this	det	5	SENT_87	[p6l502t19r631b77],
5	cohort	NN	O	cohort	prep_in	20	SENT_87	[p6l664t19r896b77],
6	of	IN	O	of	_	0	SENT_87	[p6l927t19r999b77],
7	patients	NNS	O	patient	prep_of	5	SENT_87	[p6l1025t22r1307b95],
8	on	IN	O	on	_	0	SENT_87	[p6l1339t36r1431b77],
9	a	DT	O	a	det	10	SENT_87	[p6l1462t36r1497b77],
10	variety	NN	O	variety	prep_on	7	SENT_87	[p6l1525t22r1770b95],
11	of	IN	O	of	_	0	SENT_87	[p6l1799t19r1871b77],
12	statins	NNS	O	statin	prep_of	10	SENT_87	[p6l1899t22r2144b89],
13	,	,	O	,	_	0	SENT_87	[p6l1899t22r2144b89],
14	the	DT	O	the	det	16	SENT_87	[p6l8t114r121b171],
15	rs4149056	NN	O	rs4149056	nn	16	SENT_87	[p6l152t115r514b171],
16	variant	NN	O	variant	nsubjpass	20	SENT_87	[p6l544t117r795b171],
17	was	VBD	O	be	auxpass	20	SENT_87	[p6l824t130r951b171],
18	not	RB	O	not	neg	20	SENT_87	[p6l982t121r1103b171],
19	significantly	RB	O	significantly	advmod	20	SENT_87	[p6l1135t113r1574b189],
20	associated	VBN	O	associate	_	0	SENT_87	[p6l1603t114r1959b171],
21	with	IN	O	with	_	0	SENT_87	[p6l1987t114r2148b171],
22	myopathy	NN	O	myopathy	prep_with	20	SENT_87	[p6l9t209r384b285],
23	.	.	O	.	_	0	SENT_87	[p6l9t209r384b285],

1	We	PRP	O	we	nsubj	3	SENT_88	[p6l84t307r193b362],
2	next	RB	O	next	advmod	3	SENT_88	[p6l248t311r405b362],
3	examined	VBD	O	examine	_	0	SENT_88	[p6l460t304r808b362],
4	only	RB	O	only	advmod	6	SENT_88	[p6l862t304r1021b380],
5	those	DT	O	those	det	6	SENT_88	[p6l1073t304r1262b362],
6	patients	NNS	O	patient	dobj	3	SENT_88	[p6l1316t307r1598b380],
7	who	WP	O	who	nsubj	8	SENT_88	[p6l1651t304r1804b362],
8	received	VBD	O	receive	rcmod	6	SENT_88	[p6l1858t304r2149b362],
9	simvastatin	NN	O	simvastatin	dobj	8	SENT_88	[p6l10t402r433b469],
10	,	,	O	,	_	0	SENT_88	[p6l10t402r433b469],
11	consisting	VBG	O	consist	partmod	8	SENT_88	[p6l471t402r831b474],
12	of	IN	O	of	_	0	SENT_88	[p6l864t398r936b456],
13	12	CD	NUMBER	12	num	14	SENT_88	[p6l970t400r1048b456],
14	cases	NNS	O	case	prep_of	11	SENT_88	[p6l1082t415r1253b456],
15	and	CC	O	and	_	0	SENT_88	[p6l1288t399r1419b456],
16	39	CD	NUMBER	39	num	17	SENT_88	[p6l1453t400r1533b456],
17	controls	NNS	O	control	prep_of	11	SENT_88	[p6l1569t399r1874b456],
18	.	.	O	.	_	0	SENT_88	[p6l1569t399r1874b456],

1	In	IN	O	in	_	0	SENT_89	[p6l1913t401r1985b456],
2	this	DT	O	this	det	3	SENT_89	[p6l2018t399r2148b456],
3	subset	NN	O	subset	prep_in	5	SENT_89	[p6l10t494r226b552],
4	there	EX	O	there	expl	5	SENT_89	[p6l261t494r442b552],
5	were	VBD	O	be	_	0	SENT_89	[p6l476t511r639b552],
6	no	DT	O	no	det	8	SENT_89	[p6l676t511r767b552],
7	significant	JJ	O	significant	amod	8	SENT_89	[p6l805t494r1176b570],
8	differences	NNS	O	difference	nsubj	5	SENT_89	[p6l1212t494r1593b552],
9	in	IN	O	in	_	0	SENT_89	[p6l1629t497r1700b551],
10	age	NN	O	age	prep_in	8	SENT_89	[p6l1737t511r1868b570],
11	,	,	O	,	_	0	SENT_89	[p6l1737t511r1868b570],
12	gender	NN	O	gender	prep_in	8	SENT_89	[p6l1908t494r2150b570],
13	or	CC	O	or	_	0	SENT_89	[p6l9t605r81b646],
14	simvastatin	NN	O	simvastatin	nn	15	SENT_89	[p6l133t591r538b646],
15	dose	NN	O	dose	conj_or	10	SENT_89	[p6l591t588r766b646],
16	.	.	O	.	_	0	SENT_89	[p6l591t588r766b646],

1	In	IN	O	in	_	0	SENT_90	[p6l823t591r896b645],
2	this	DT	O	this	det	3	SENT_90	[p6l948t588r1077b646],
3	group	NN	O	group	prep_in	8	SENT_90	[p6l1130t605r1353b664],
4	,	,	O	,	_	0	SENT_90	[p6l1130t605r1353b664],
5	SLCO1B1	NN	O	slco1b1	nn	7	SENT_90	[p6l1409t590r1725b646],
6	rs4149056	NN	O	rs4149056	nn	7	SENT_90	[p6l1785t590r2148b646],
7	genotype	NN	O	genotype	nsubj	8	SENT_90	[p6l9t691r335b760],
8	conferred	VBD	O	confer	_	0	SENT_90	[p6l364t684r701b742],
9	a	DT	O	a	det	10	SENT_90	[p6l729t701r764b742],
10	significant	JJ	O	significant	dobj	8	SENT_90	[p6l793t684r1164b760],
11	threefold	RB	O	threefold	advmod	12	SENT_90	[p6l1192t684r1515b742],
12	increased	VBN	O	increase	partmod	10	SENT_90	[p6l1542t684r1873b742],
13	risk	NN	O	risk	iobj	12	SENT_90	[p6l1901t684r2026b742],
14	for	IN	O	for	_	0	SENT_90	[p6l2051t684r2150b742],
15	myopathy	NN	O	myopathy	nn	17	SENT_90	[p6l9t776r374b852],
16	(	CD	NUMBER	(	num	17	SENT_90	[p6l400t776r533b849],
17	OR	NN	O	or	prep_for	13	SENT_90	[p6l400t776r533b849],
18	3.2	CD	NUMBER	3.2	num	17	SENT_90	[p6l558t778r680b847],
19	,	,	O	,	_	0	SENT_90	[p6l558t778r680b847],
20	95	CD	PERCENT	95	number	21	SENT_90	[p6l711t778r863b834],
21	%	NN	PERCENT	%	amod	13	SENT_90	[p6l711t778r863b834],
22	CI	NN	O	ci	dobj	12	SENT_90	[p6l890t778r968b834],
23	0.83	CD	NUMBER	0.83	num	22	SENT_90	[p6l995t778r1398b847],
24	—	CD	NUMBER	—	number	25	SENT_90	[p6l995t778r1398b847],
25	11.96	CD	NUMBER	11.96	dep	22	SENT_90	[p6l995t778r1398b847],
26	,	,	O	,	_	0	SENT_90	[p6l995t778r1398b847],
27	X2	NN	O	x2	nn	28	SENT_90	[p6l1428t769r1496b849],
28	P	NN	O	p	appos	22	SENT_90	[p6l1517t779r1631b833],
29	:	:	O	:	_	0	SENT_90	[p6l1517t779r1631b833],
30	0.042	CD	NUMBER	0.042	dep	22	SENT_90	[p6l1650t778r1860b847],
31	,	,	O	,	_	0	SENT_90	[p6l1650t778r1860b847],
32	Fisher	NNP	PERSON	Fisher	poss	38	SENT_90	[p6l1892t776r2148b834],
33	's	POS	O	's	_	0	SENT_90	[p6l1892t776r2148b834],
34	exact	JJ	O	exact	amod	38	SENT_90	[p6l9t880r192b931],
35	P	NN	O	p	nn	38	SENT_90	[p6l218t873r588b945],
36	=	JJ	O	=	amod	38	SENT_90	[p6l218t873r588b945],
37	0.064	CD	NUMBER	0.064	num	38	SENT_90	[p6l218t873r588b945],
38	)	NN	O	)	appos	30	SENT_90	[p6l218t873r588b945],
39	.	.	O	.	_	0	SENT_90	[p6l218t873r588b945],

1	The	DT	O	the	det	2	SENT_91	[p6l620t873r752b931],
2	frequency	NN	O	frequency	nsubj	11	SENT_91	[p6l782t873r1136b949],
3	of	IN	O	of	_	0	SENT_91	[p6l1164t873r1236b931],
4	the	DT	O	the	det	8	SENT_91	[p6l1260t873r1372b931],
5	‘	NN	O	‘	nn	8	SENT_91	[p6l1405t873r1496b931],
6	C	NN	O	c	nn	8	SENT_91	[p6l1405t873r1496b931],
7	’	CD	NUMBER	’	num	8	SENT_91	[p6l1405t873r1496b931],
8	allele	NN	O	allele	prep_of	2	SENT_91	[p6l1528t873r1710b931],
9	was	VBD	O	be	cop	11	SENT_91	[p6l1738t890r1866b931],
10	33	CD	PERCENT	33	num	11	SENT_91	[p6l1897t875r2049b931],
11	%	NN	PERCENT	%	_	0	SENT_91	[p6l1897t875r2049b931],
12	in	IN	O	in	_	0	SENT_91	[p6l2078t876r2149b930],
13	cases	NNS	O	case	prep_in	11	SENT_91	[p6l9t984r181b1024],
14	and	CC	O	and	_	0	SENT_91	[p6l208t967r339b1024],
15	18	CD	PERCENT	18	num	16	SENT_91	[p6l369t969r516b1024],
16	%	NN	PERCENT	%	conj_and	11	SENT_91	[p6l369t969r516b1024],
17	in	IN	O	in	_	0	SENT_91	[p6l541t970r612b1023],
18	controls	NNS	O	control	prep_in	16	SENT_91	[p6l637t967r942b1024],
19	.	.	O	.	_	0	SENT_91	[p6l637t967r942b1024],

1	The	DT	O	the	det	2	SENT_92	[p6l969t967r1102b1024],
2	association	NN	O	association	nsubj	10	SENT_92	[p6l1129t970r1520b1024],
3	of	IN	O	of	_	0	SENT_92	[p6l1545t967r1616b1024],
4	rs4149056	NN	O	rs4149056	nn	6	SENT_92	[p6l1637t969r2000b1024],
5	risk	NN	O	risk	nn	6	SENT_92	[p6l2026t967r2151b1024],
6	genotype	NN	O	genotype	prep_of	2	SENT_92	[p6l9t1069r335b1137],
7	with	IN	O	with	_	0	SENT_92	[p6l362t1062r523b1119],
8	myopathy	NN	O	myopathy	prep_with	6	SENT_92	[p6l551t1062r916b1137],
9	remained	VBD	O	remain	cop	10	SENT_92	[p6l942t1062r1276b1119],
10	significant	JJ	O	significant	_	0	SENT_92	[p6l1305t1061r1676b1137],
11	after	IN	O	after	_	0	SENT_92	[p6l1705t1061r1863b1119],
12	excluding	VBG	O	exclude	prepc_after	10	SENT_92	[p6l1891t1062r2147b1119, p6l9t1160r122b1233],
13	those	DT	O	those	det	14	SENT_92	[p6l142t1157r331b1215],
14	patients	NNS	O	patient	dobj	12	SENT_92	[p6l354t1160r636b1233],
15	who	WP	O	who	nsubj	16	SENT_92	[p6l657t1157r810b1215],
16	received	VBD	O	receive	rcmod	14	SENT_92	[p6l834t1157r1124b1215],
17	a	DT	O	a	det	18	SENT_92	[p6l1147t1174r1182b1215],
18	fibrate	NN	O	fibrate	dobj	16	SENT_92	[p6l1204t1157r1447b1227],
19	,	,	O	,	_	0	SENT_92	[p6l1204t1157r1447b1227],
20	calcium	NN	O	calcium	nn	21	SENT_92	[p6l1475t1157r1752b1215],
21	antagonist	NN	O	antagonist	dobj	16	SENT_92	[p6l1775t1160r2148b1233],
22	or	CC	O	or	_	0	SENT_92	[p6l9t1267r81b1308],
23	niacin	NN	O	niacin	dobj	16	SENT_92	[p6l110t1253r331b1308],
24	(	CD	NUMBER	(	num	23	SENT_92	[p6l364t1250r496b1322],
25	OR	NN	O	or	dep	18	SENT_92	[p6l364t1250r496b1322],
26	4.5	CD	NUMBER	4.5	num	25	SENT_92	[p6l525t1253r648b1321],
27	,	,	O	,	_	0	SENT_92	[p6l525t1253r648b1321],
28	95	CD	PERCENT	95	num	29	SENT_92	[p6l684t1252r837b1308],
29	%	NN	PERCENT	%	appos	18	SENT_92	[p6l684t1252r837b1308],
30	CI	NN	O	ci	dep	29	SENT_92	[p6l868t1252r945b1308],
31	0.73	CD	NUMBER	0.73	num	30	SENT_92	[p6l976t1252r1379b1320],
32	—	CD	NUMBER	—	number	33	SENT_92	[p6l976t1252r1379b1320],
33	27.59	CD	NUMBER	27.59	dep	30	SENT_92	[p6l976t1252r1379b1320],
34	,	,	O	,	_	0	SENT_92	[p6l976t1252r1379b1320],
35	xz	NN	O	xz	nn	36	SENT_92	[p6l1416t1243r1487b1323],
36	P	NN	O	p	appos	18	SENT_92	[p6l1513t1252r1856b1320],
37	=	JJ	O	=	amod	36	SENT_92	[p6l1513t1252r1856b1320],
38	0.044	CD	NUMBER	0.044	tmod	37	SENT_92	[p6l1513t1252r1856b1320],
39	,	,	O	,	_	0	SENT_92	[p6l1513t1252r1856b1320],
40	Fisher	NNP	PERSON	Fisher	poss	43	SENT_92	[p6l1892t1250r2148b1308],
41	's	POS	O	's	_	0	SENT_92	[p6l1892t1250r2148b1308],
42	exact	JJ	O	exact	amod	43	SENT_92	[p6l9t1352r193b1403],
43	P	NN	O	p	appos	18	SENT_92	[p6l218t1347r331b1402],
44	:	:	O	:	_	0	SENT_92	[p6l218t1347r331b1402],
45	0.085	CD	NUMBER	0.085	number	46	SENT_92	[p6l350t1345r567b1417],
46	)	CD	NUMBER	)	dep	43	SENT_92	[p6l350t1345r567b1417],
47	(	CD	NUMBER	(	num	48	SENT_92	[p6l604t1345r811b1417],
48	Table	NNP	O	Table	tmod	16	SENT_92	[p6l604t1345r811b1417],
49	2	CD	NUMBER	2	num	48	SENT_92	[p6l842t1345r926b1417],
50	)	CD	NUMBER	)	dep	48	SENT_92	[p6l842t1345r926b1417],
51	.	.	O	.	_	0	SENT_92	[p6l842t1345r926b1417],

1	In	IN	O	in	_	0	SENT_93	[p6l86t1443r159b1497],
2	contrast	NN	O	contrast	prep_in	23	SENT_93	[p6l196t1447r482b1498],
3	to	TO	O	to	_	0	SENT_93	[p6l518t1447r588b1498],
4	the	DT	O	the	det	5	SENT_93	[p6l625t1440r738b1498],
5	results	NNS	O	result	prep_to	2	SENT_93	[p6l776t1440r1000b1498],
6	for	IN	O	for	_	0	SENT_93	[p6l1038t1440r1136b1498],
7	simvastatin	NN	O	simvastatin	prep_for	5	SENT_93	[p6l1174t1443r1596b1511],
8	,	,	O	,	_	0	SENT_93	[p6l1174t1443r1596b1511],
9	in	IN	O	in	_	0	SENT_93	[p6l1638t1443r1708b1497],
10	the	DT	O	the	det	12	SENT_93	[p6l1745t1440r1857b1498],
11	limited	JJ	O	limited	amod	12	SENT_93	[p6l1895t1440r2149b1498],
12	number	NN	O	number	prep_in	5	SENT_93	[p6l9t1536r288b1593],
13	of	IN	O	of	_	0	SENT_93	[p6l321t1535r393b1593],
14	patients	NNS	O	patient	prep_of	12	SENT_93	[p6l421t1538r703b1611],
15	receiving	VBG	O	receive	partmod	14	SENT_93	[p6l737t1538r1060b1611],
16	atorvastatin	NN	O	atorvastatin	dobj	15	SENT_93	[p6l1093t1538r1515b1593],
17	(	CD	NUMBER	(	number	18	SENT_93	[p6l1552t1535r1659b1608],
18	10	CD	NUMBER	10	num	19	SENT_93	[p6l1552t1535r1659b1608],
19	cases	NNS	O	case	nsubj	23	SENT_93	[p6l1694t1552r1865b1593],
20	and	CC	O	and	_	0	SENT_93	[p6l1901t1535r2032b1593],
21	35	CD	NUMBER	35	num	22	SENT_93	[p6l2066t1537r2145b1593],
22	controls	NNS	O	control	conj_and	19	SENT_93	[p6l9t1631r320b1703],
23	)	VBP	O	)	_	0	SENT_93	[p6l9t1631r320b1703],
24	the	DT	O	the	det	26	SENT_93	[p6l376t1631r488b1689],
25	SLC01B1	NN	O	slc01b1	nn	26	SENT_93	[p6l541t1632r844b1689],
26	genotype	NN	O	genotype	nsubj	27	SENT_93	[p6l904t1638r1230b1707],
27	conferred	VBD	O	confer	ccomp	23	SENT_93	[p6l1285t1631r1621b1689],
28	no	DT	O	no	det	30	SENT_93	[p6l1674t1648r1765b1689],
29	increased	VBN	O	increase	amod	30	SENT_93	[p6l1819t1631r2149b1689],
30	risk	NN	O	risk	dobj	27	SENT_93	[p6l9t1724r133b1781],
31	of	IN	O	of	_	0	SENT_93	[p6l167t1723r238b1781],
32	myopathy	NN	O	myopathy	nn	34	SENT_93	[p6l268t1724r633b1799],
33	(	CD	NUMBER	(	num	34	SENT_93	[p6l669t1724r801b1795],
34	OR	NN	O	or	prep_of	30	SENT_93	[p6l669t1724r801b1795],
35	1.06	CD	NUMBER	1.06	num	34	SENT_93	[p6l840t1725r1001b1794],
36	,	,	O	,	_	0	SENT_93	[p6l840t1725r1001b1794],
37	95	CD	PERCENT	95	number	38	SENT_93	[p6l1042t1725r1194b1781],
38	%	NN	PERCENT	%	amod	39	SENT_93	[p6l1042t1725r1194b1781],
39	CI	NN	O	ci	appos	30	SENT_93	[p6l1230t1725r1308b1781],
40	0.22-4	CD	NUMBER	0.22-4	number	41	SENT_93	[p6l1343t1725r1702b1794],
41	.80	CD	NUMBER	.80	num	39	SENT_93	[p6l1343t1725r1702b1794],
42	,	,	O	,	_	0	SENT_93	[p6l1343t1725r1702b1794],
43	X2	NN	O	x2	nn	44	SENT_93	[p6l1743t1716r1814b1796],
44	P	NN	O	p	appos	39	SENT_93	[p6l1844t1725r2144b1794],
45	=	JJ	O	=	amod	44	SENT_93	[p6l1844t1725r2144b1794],
46	0.48	CD	NUMBER	0.48	tmod	45	SENT_93	[p6l1844t1725r2144b1794],
47	,	,	O	,	_	0	SENT_93	[p6l1844t1725r2144b1794],
48	Fisher	NNP	PERSON	Fisher	poss	54	SENT_93	[p6l9t1820r266b1878],
49	's	POS	O	's	_	0	SENT_93	[p6l9t1820r266b1878],
50	exact	JJ	O	exact	amod	54	SENT_93	[p6l302t1827r485b1878],
51	P	NN	O	p	nn	54	SENT_93	[p6l516t1820r843b1892],
52	=	JJ	O	=	amod	54	SENT_93	[p6l516t1820r843b1892],
53	0.30	CD	NUMBER	0.30	num	54	SENT_93	[p6l516t1820r843b1892],
54	)	NN	O	)	appos	39	SENT_93	[p6l516t1820r843b1892],
55	.	.	O	.	_	0	SENT_93	[p6l516t1820r843b1892],

1	The	DT	O	the	det	2	SENT_94	[p6l881t1820r1013b1878],
2	frequency	NN	O	frequency	nsubj	11	SENT_94	[p6l1049t1820r1403b1896],
3	of	IN	O	of	_	0	SENT_94	[p6l1437t1820r1508b1878],
4	the	DT	O	the	det	8	SENT_94	[p6l1538t1820r1651b1878],
5	‘	NN	O	‘	nn	8	SENT_94	[p6l1689t1820r1780b1878],
6	C	NN	O	c	nn	8	SENT_94	[p6l1689t1820r1780b1878],
7	’	CD	NUMBER	’	num	8	SENT_94	[p6l1689t1820r1780b1878],
8	allele	NN	O	allele	prep_of	2	SENT_94	[p6l1818t1820r2000b1878],
9	did	VBD	O	do	aux	11	SENT_94	[p6l2037t1820r2149b1878],
10	not	RB	O	not	neg	11	SENT_94	[p6l9t1921r129b1972],
11	differ	VB	O	differ	_	0	SENT_94	[p6l196t1914r383b1972],
12	between	IN	O	between	_	0	SENT_94	[p6l445t1914r743b1972],
13	cases	NNS	O	case	prep_between	11	SENT_94	[p6l809t1931r981b1972],
14	and	CC	O	and	_	0	SENT_94	[p6l1048t1914r1179b1972],
15	controls	NNS	O	control	prep_between	11	SENT_94	[p6l1245t1914r1532b1972],
16	(	RB	O	(	dep	20	SENT_94	[p6l1602t1914r1709b1986],
17	20	CD	NUMBER	20	num	20	SENT_94	[p6l1602t1914r1709b1986],
18	and	CC	O	and	_	0	SENT_94	[p6l1776t1914r1907b1972],
19	19	CD	PERCENT	19	conj_and	17	SENT_94	[p6l1979t1916r2143b1984],
20	%	NN	PERCENT	%	dep	13	SENT_94	[p6l1979t1916r2143b1984],
21	,	,	O	,	_	0	SENT_94	[p6l1979t1916r2143b1984],
22	respectively	RB	O	respectively	advmod	13	SENT_94	[p6l9t2010r470b2085],
23	)	CD	NUMBER	)	dep	13	SENT_94	[p6l9t2010r470b2085],
24	.	.	O	.	_	0	SENT_94	[p6l9t2010r470b2085],

1	These	DT	O	these	det	2	SENT_95	[p6l509t2010r711b2067],
2	data	NNS	O	datum	nsubj	3	SENT_95	[p6l749t2010r898b2067],
3	suggest	VBP	O	suggest	_	0	SENT_95	[p6l935t2017r1189b2085],
4	that	IN	O	that	complm	17	SENT_95	[p6l1226t2010r1369b2067],
5	the	DT	O	the	det	7	SENT_95	[p6l1405t2010r1517b2067],
6	increased	VBN	O	increase	amod	7	SENT_95	[p6l1555t2010r1885b2067],
7	risk	NN	O	risk	nsubj	17	SENT_95	[p6l1921t2010r2047b2067],
8	of	IN	O	of	_	0	SENT_95	[p6l2081t2009r2153b2067],
9	myopathy	NN	O	myopathy	prep_of	7	SENT_95	[p6l9t2105r374b2181],
10	associated	VBN	O	associate	partmod	9	SENT_95	[p6l405t2105r761b2163],
11	with	IN	O	with	_	0	SENT_95	[p6l791t2105r952b2163],
12	the	DT	O	the	det	14	SENT_95	[p6l985t2105r1098b2163],
13	rs4149056	NN	O	rs4149056	nn	14	SENT_95	[p6l1131t2107r1493b2163],
14	genotype	NN	O	genotype	prep_with	10	SENT_95	[p6l1528t2112r1853b2181],
15	may	MD	O	may	aux	17	SENT_95	[p6l1887t2122r2040b2181],
16	be	VB	O	be	cop	17	SENT_95	[p6l2068t2105r2148b2163],
17	stronger	JJR	O	stronger	ccomp	3	SENT_95	[p6l10t2207r300b2276],
18	for	IN	O	for	_	0	SENT_95	[p6l325t2200r423b2258],
19	simvastatin	NN	O	simvastatin	prep_for	17	SENT_95	[p6l450t2203r855b2258],
20	than	IN	O	than	dep	17	SENT_95	[p6l881t2200r1045b2258],
21	for	IN	O	for	_	0	SENT_95	[p6l1071t2200r1169b2258],
22	other	JJ	O	other	amod	23	SENT_95	[p6l1195t2200r1384b2258],
23	statins	NNS	O	statin	prep_for	17	SENT_95	[p6l1411t2203r1637b2258],
24	in	IN	O	in	_	0	SENT_95	[p6l1663t2203r1734b2257],
25	this	DT	O	this	det	30	SENT_95	[p6l1759t2200r1889b2258],
26	cohort	NN	O	cohort	nn	30	SENT_95	[p6l1916t2200r2149b2258],
27	(	NN	O	(	nn	30	SENT_95	[p6l12t2295r251b2371],
28	Figure	NN	O	figure	nn	30	SENT_95	[p6l12t2295r251b2371],
29	1	CD	NUMBER	1	num	30	SENT_95	[p6l287t2295r366b2367],
30	)	NN	O	)	prep_in	23	SENT_95	[p6l287t2295r366b2367],
31	.	.	O	.	_	0	SENT_95	[p6l287t2295r366b2367],

1	SLCO1B1	NN	O	slco1b1	_	0	SENT_96	[p6l8t2538r204b2581],
2	and	CC	O	and	_	0	SENT_96	[p6l225t2536r313b2581],
3	statin	NN	O	statin	conj_and	1	SENT_96	[p6l333t2536r469b2581],
4	myopathy	NN	O	myopathy	dep	1	SENT_96	[p6l491t2536r732b2596],
5	@	IN	O	@	_	0	SENT_96	[p6l2023t2524r2150b2648],
6	LR	NNP	O	LR	nn	7	SENT_96	[p6l10t2610r54b2649],
7	Brunham	NNP	O	Brunham	prep_@	4	SENT_96	[p6l74t2608r257b2649],
8	et	FW	O	et	nn	9	SENT_96	[p6l279t2613r316b2649],
9	al	FW	O	al	dep	7	SENT_96	[p6l332t2608r368b2649],
10	'	''	O	'	_	0	SENT_96	[p6l2115t2603r2141b2620],

1	,	,	O	,	_	0	SENT_97	[p7l229t227r301b276],
2	n.	IN	O	n.	nsubj	4	SENT_97	[p7l229t227r301b276],
3	|	CD	NUMBER	|	pobj	2	SENT_97	[p7l229t227r301b276],
4	|	NN	O	|	_	0	SENT_97	[p7l229t227r301b276],
5	.	.	O	.	_	0	SENT_97	[p7l229t227r301b276],

1	éF	NN	O	éf	_	0	SENT_98	[p7l836t211r1009b265],
2	'	''	O	'	_	0	SENT_98	[p7l836t211r1009b265],
3	=	JJ	O	=	amod	4	SENT_98	[p7l836t211r1009b265],
4	ﬂ	NN	O	ﬂ	dep	1	SENT_98	[p7l836t211r1009b265],
5	.	.	O	.	_	0	SENT_98	[p7l836t211r1009b265],

1	i	LS	O	i	_	0	SENT_99	[p7l836t211r1009b265],
2	'	''	O	'	_	0	SENT_99	[p7l836t211r1009b265],

1	ﬁigr-via	NN	O	ﬁigr-vium	_	0	SENT_100	[p7l98t550r283b600],
2	o	NN	O	o	nsubj	5	SENT_100	[p7l959t538r1136b591],
3	,	,	O	,	_	0	SENT_100	[p7l959t538r1136b591],
4	-	:	O	-	_	0	SENT_100	[p7l959t538r1136b591],
5	+	CC	O	+	rcmod	1	SENT_100	[p7l959t538r1136b591],

1	Simira	FW	O	simira	_	0	SENT_101	[p7l111t878r283b931],
2	"	``	O	"	punct	3	SENT_101	[p7l299t899r306b910, p7l1845t878r1924b927],
3	E	NN	O	e	dep	1	SENT_101	[p7l299t899r306b910, p7l1845t878r1924b927],

1	G	NN	O	g	_	0	SENT_102	[p7l1927t874r1961b931],
2	“	CD	NUMBER	“	num	4	SENT_102	[p7l1927t874r1961b931],
3	G	NN	O	g	nn	4	SENT_102	[p7l1981t878r2018b927],
4	IFJ1	NN	O	ifj1	dep	1	SENT_102	[p7l2022t878r2055b927],

1	U123-45E	NN	O	u123-45e	_	0	SENT_103	[p7l324t1127r1842b1176],
2	?	.	O	?	_	0	SENT_103	[p7l324t1127r1842b1176],

1	EQ	NN	O	eq	_	0	SENT_104	[p7l324t1127r1842b1176],
2	'	''	O	'	_	0	SENT_104	[p7l324t1127r1842b1176],
3	1D1	NN	O	1d1	nn	5	SENT_104	[p7l324t1127r1842b1176],
4	"	''	O	"	punct	5	SENT_104	[p7l324t1127r1842b1176],
5	I12	NN	O	i12	dep	1	SENT_104	[p7l324t1127r1842b1176],

1	Ddds	NNS	O	ddd	_	0	SENT_105	[p7l922t1213r1083b1266],
2	ratin	NN	O	ratin	dep	1	SENT_105	[p7l1103t1213r1231b1266],

1	Figure	NNP	O	Figure	nsubj	6	SENT_106	[p7l12t1334r204b1402],
2	1	CD	NUMBER	1	num	1	SENT_106	[p7l249t1335r270b1385],
3	SLCO7B1	NN	O	slco7b1	nn	5	SENT_106	[p7l351t1335r607b1385],
4	rs4l49056	NN	O	rs4l49056	nn	5	SENT_106	[p7l657t1335r972b1385],
5	genotype	NN	O	genotype	dep	1	SENT_106	[p7l1013t1340r1294b1402],
6	influences	VBZ	O	influence	_	0	SENT_106	[p7l1336t1334r1629b1385],
7	susceptibility	NN	O	susceptibility	dobj	6	SENT_106	[p7l1669t1334r2051b1402],
8	to	TO	O	to	_	0	SENT_106	[p7l2089t1340r2148b1385],
9	myopathy	NN	O	myopathy	prep_to	6	SENT_106	[p7l11t1419r311b1487],
10	in	IN	O	in	_	0	SENT_106	[p7l333t1420r380b1470],
11	response	NN	O	response	prep_in	9	SENT_106	[p7l408t1434r665b1487],
12	to	TO	O	to	_	0	SENT_106	[p7l685t1425r744b1471],
13	simvastatin	NN	O	simvastatin	prep_to	6	SENT_106	[p7l766t1420r1093b1471],
14	but	CC	O	but	_	0	SENT_106	[p7l1120t1419r1218b1471],
15	not	RB	O	not	_	0	SENT_106	[p7l1241t1425r1338b1471],
16	atorvastatin	NN	O	atorvastatin	prep_to	6	SENT_106	[p7l1358t1420r1719b1471],
17	.	.	O	.	_	0	SENT_106	[p7l1358t1420r1719b1471],

1	ORs	NNS	O	or	nsubjpass	14	SENT_107	[p7l1745t1421r1858b1471],
2	and	CC	O	and	_	0	SENT_107	[p7l1880t1419r1988b1471],
3	95	CD	PERCENT	95	number	4	SENT_107	[p7l2013t1421r2148b1471],
4	%	NN	PERCENT	%	amod	5	SENT_107	[p7l2013t1421r2148b1471],
5	Cls	NNS	O	cl	conj_and	1	SENT_107	[p7l9t1505r95b1555],
6	for	IN	O	for	_	0	SENT_107	[p7l127t1504r210b1555],
7	myopathy	NN	O	myopathy	prep_for	5	SENT_107	[p7l243t1504r543b1571],
8	with	IN	O	with	_	0	SENT_107	[p7l574t1504r702b1555],
9	SLCOIBI	NN	O	slcoibus	nn	12	SENT_107	[p7l740t1505r997b1555],
10	rs4l49056	NN	O	rs4l49056	nn	12	SENT_107	[p7l1040t1505r1355b1555],
11	risk	NN	O	risk	nn	12	SENT_107	[p7l1392t1504r1485b1555],
12	genotype	NN	O	genotype	prep_with	7	SENT_107	[p7l1518t1510r1799b1571],
13	are	VBP	O	be	auxpass	14	SENT_107	[p7l1834t1519r1921b1555],
14	shown	VBN	O	show	_	0	SENT_107	[p7l1955t1504r2146b1555],
15	per	IN	O	per	_	0	SENT_107	[p7l11t1604r106b1657],
16	statin	NN	O	statin	nn	17	SENT_107	[p7l126t1590r282b1640],
17	type	NN	O	type	prep_per	14	SENT_107	[p7l307t1595r453b1657],
18	.	.	O	.	_	0	SENT_107	[p7l307t1595r453b1657],

1	In	IN	O	in	_	0	SENT_108	[p7l483t1591r530b1640],
2	the	DT	O	the	det	4	SENT_108	[p7l555t1589r649b1640],
3	entire	JJ	O	entire	amod	4	SENT_108	[p7l673t1590r840b1640],
4	cohort	NN	O	cohort	prep_in	15	SENT_108	[p7l864t1589r1059b1640],
5	of	IN	O	of	_	0	SENT_108	[p7l1080t1589r1138b1640],
6	patients	NNS	O	patient	prep_of	4	SENT_108	[p7l1160t1590r1392b1657],
7	a	DT	O	a	det	9	SENT_108	[p7l1415t1604r1444b1640],
8	nonsignificant	JJ	O	nonsignificant	amod	9	SENT_108	[p7l1471t1589r1889b1657],
9	trend	NN	O	trend	nsubjpass	15	SENT_108	[p7l1909t1589r2065b1640],
10	to	TO	O	to	_	0	SENT_108	[p7l2089t1595r2148b1640],
11	increased	VBN	O	increase	amod	13	SENT_108	[p7l10t1674r284b1726],
12	myopathy	NN	O	myopathy	nn	13	SENT_108	[p7l321t1674r621b1742],
13	risk	NN	O	risk	prep_to	9	SENT_108	[p7l655t1674r748b1726],
14	was	VBD	O	be	auxpass	15	SENT_108	[p7l777t1689r889b1726],
15	observed	VBN	O	observe	_	0	SENT_108	[p7l922t1674r1187b1726],
16	in	IN	O	in	_	0	SENT_108	[p7l1223t1675r1271b1725],
17	individuals	NNS	O	individual	prep_in	15	SENT_108	[p7l1308t1674r1620b1726],
18	with	IN	O	with	_	0	SENT_108	[p7l1651t1674r1779b1726],
19	the	DT	O	the	det	24	SENT_108	[p7l1813t1674r1907b1726],
20	risk	NN	O	risk	nn	24	SENT_108	[p7l1943t1674r2036b1726],
21	‘	NN	O	‘	nn	24	SENT_108	[p7l2069t1674r2147b1726],
22	C	NN	O	c	nn	24	SENT_108	[p7l2069t1674r2147b1726],
23	’	CD	NUMBER	’	num	24	SENT_108	[p7l2069t1674r2147b1726],
24	allele	NN	O	allele	prep_with	17	SENT_108	[p7l9t1759r173b1811],
25	.	.	O	.	_	0	SENT_108	[p7l9t1759r173b1811],

1	In	IN	O	in	_	0	SENT_109	[p7l217t1761r264b1810],
2	the	DT	O	the	det	3	SENT_109	[p7l303t1759r398b1811],
3	subset	NN	O	subset	prep_in	11	SENT_109	[p7l435t1759r623b1811],
4	of	IN	O	of	_	0	SENT_109	[p7l659t1759r716b1811],
5	patients	NNS	O	patient	prep_of	3	SENT_109	[p7l753t1760r985b1827],
6	administered	VBN	O	administer	partmod	5	SENT_109	[p7l1022t1759r1405b1811],
7	simvastatin	NN	O	simvastatin	dobj	6	SENT_109	[p7l1444t1760r1790b1822],
8	,	,	O	,	_	0	SENT_109	[p7l1444t1760r1790b1822],
9	rs4l49056	NN	O	rs4l49056	nn	10	SENT_109	[p7l1833t1761r2148b1811],
10	genotype	NN	O	genotype	nsubj	11	SENT_109	[p7l9t1850r290b1912],
11	conferred	VBD	O	confer	_	0	SENT_109	[p7l314t1844r595b1895],
12	a	DT	O	a	det	15	SENT_109	[p7l622t1859r650b1895],
13	threefold	RB	O	threefold	advmod	15	SENT_109	[p7l674t1844r940b1895],
14	increased	VBN	O	increase	amod	15	SENT_109	[p7l968t1844r1242b1895],
15	risk	NN	O	risk	nsubj	22	SENT_109	[p7l1270t1844r1364b1895],
16	for	IN	O	for	_	0	SENT_109	[p7l1384t1844r1467b1895],
17	myopathy	NN	O	myopathy	nn	21	SENT_109	[p7l1491t1844r1791b1912],
18	(	CD	NUMBER	(	num	21	SENT_109	[p7l1814t1844r2146b1908],
19	One-tailed	NN	O	one-tailed	nn	21	SENT_109	[p7l1814t1844r2146b1908],
20	X2	NN	O	x2	nn	21	SENT_109	[p7l9t1922r70b1993],
21	P	NN	O	p	prep_for	15	SENT_109	[p7l113t1930r146b1979],
22	value	NN	O	value	ccomp	11	SENT_109	[p7l179t1928r333b1979],
23	0.042	CD	NUMBER	0.042	num	24	SENT_109	[p7l373t1928r584b1992],
24	)	NN	O	)	dobj	22	SENT_109	[p7l373t1928r584b1992],
25	.	.	O	.	_	0	SENT_109	[p7l373t1928r584b1992],

1	In	IN	O	in	_	0	SENT_110	[p7l630t1930r677b1979],
2	contrast	NN	O	contrast	prep_in	9	SENT_110	[p7l719t1934r973b1990],
3	,	,	O	,	_	0	SENT_110	[p7l719t1934r973b1990],
4	in	IN	O	in	_	0	SENT_110	[p7l1017t1929r1064b1979],
5	patients	NNS	O	patient	prep_in	2	SENT_110	[p7l1109t1929r1340b1996],
6	administered	VBN	O	administer	partmod	5	SENT_110	[p7l1379t1928r1762b1980],
7	atorvastatin	NN	O	atorvastatin	nn	8	SENT_110	[p7l1803t1929r2146b1980],
8	rs4149056	NN	O	rs4149056	nsubj	9	SENT_110	[p7l11t2015r326b2065],
9	conferred	VBD	O	confer	_	0	SENT_110	[p7l358t2013r639b2065],
10	no	DT	O	no	det	12	SENT_110	[p7l676t2028r747b2065],
11	increased	VBN	O	increase	amod	12	SENT_110	[p7l782t2013r1055b2065],
12	risk	NN	O	risk	dobj	9	SENT_110	[p7l1092t2013r1185b2065],
13	for	IN	O	for	_	0	SENT_110	[p7l1213t2013r1296b2065],
14	myopathy	NN	O	myopathy	prep_for	12	SENT_110	[p7l1329t2013r1642b2081],
15	,	,	O	,	_	0	SENT_110	[p7l1329t2013r1642b2081],
16	suggesting	VBG	O	suggest	partmod	9	SENT_110	[p7l1678t2014r1998b2081],
17	that	IN	O	that	complm	25	SENT_110	[p7l2031t2013r2151b2065],
18	the	DT	O	the	det	19	SENT_110	[p7l8t2098r102b2149],
19	influence	NN	O	influence	nsubj	25	SENT_110	[p7l130t2098r397b2149],
20	of	IN	O	of	_	0	SENT_110	[p7l424t2098r481b2149],
21	SLCO1B7	NN	O	slco1b7	prep_of	19	SENT_110	[p7l507t2099r764b2149],
22	on	IN	O	on	_	0	SENT_110	[p7l798t2113r869b2149],
23	myopathy	NN	O	myopathy	prep_on	21	SENT_110	[p7l901t2098r1201b2166],
24	is	VBZ	O	be	cop	25	SENT_110	[p7l1227t2099r1264b2149],
25	statin	NN	O	statin	ccomp	16	SENT_110	[p7l1290t2099r1447b2149],
26	specific	JJ	O	specific	amod	25	SENT_110	[p7l1475t2098r1707b2166],
27	.	.	O	.	_	0	SENT_110	[p7l1475t2098r1707b2166],

1	Discussion	NN	O	discussion	_	0	SENT_111	[p7l11t2320r404b2378],

1	Statin-associated	JJ	O	statin-associated	amod	2	SENT_112	[p7l9t2509r600b2567],
2	myopathy	NN	O	myopathy	nsubj	11	SENT_112	[p7l623t2509r989b2585],
3	is	VBZ	O	be	cop	11	SENT_112	[p7l1010t2512r1060b2567],
4	a	DT	O	a	det	11	SENT_112	[p7l1086t2526r1121b2567],
5	rare	JJ	O	rare	amod	11	SENT_112	[p7l1145t2526r1276b2567],
6	but	CC	O	but	_	0	SENT_112	[p7l1299t2510r1418b2567],
7	clinically	RB	O	clinically	advmod	8	SENT_112	[p7l1442t2509r1766b2585],
8	important	JJ	O	important	amod	11	SENT_112	[p7l1788t2512r2149b2585],
9	adverse	JJ	O	adverse	amod	11	SENT_112	[p7l9t2605r268b2663],
10	drug	NN	O	drug	nn	11	SENT_112	[p7l323t2605r484b2681],
11	reaction	NN	O	reaction	_	0	SENT_112	[p7l536t2608r842b2663],
12	.	.	O	.	_	0	SENT_112	[p7l536t2608r842b2663],

1	Currently	RB	DATE	currently	advmod	3	SENT_113	[p7l902t2605r1245b2681],
2	we	PRP	O	we	nsubj	3	SENT_113	[p7l1294t2622r1390b2663],
3	lack	VBP	O	lack	_	0	SENT_113	[p7l1444t2605r1585b2663],
4	the	DT	O	the	det	5	SENT_113	[p7l1636t2605r1748b2663],
5	ability	NN	O	ability	nsubj	7	SENT_113	[p7l1803t2605r2028b2681],
6	to	TO	O	to	aux	7	SENT_113	[p7l2078t2612r2148b2663],
7	identify	VB	O	identify	xcomp	3	SENT_113	[p7l8t2699r287b2775],
8	patients	NNS	O	patient	dobj	7	SENT_113	[p7l320t2702r603b2775],
9	at	IN	O	at	_	0	SENT_113	[p7l641t2707r705b2757],
10	high	JJ	O	high	amod	11	SENT_113	[p7l741t2699r903b2775],
11	risk	NN	O	risk	prep_at	7	SENT_113	[p7l940t2699r1065b2757],
12	of	IN	O	of	_	0	SENT_113	[p7l1100t2699r1172b2757],
13	developing	VBG	O	develop	prepc_of	11	SENT_113	[p7l1205t2699r1598b2775],
14	this	DT	O	this	det	15	SENT_113	[p7l1633t2699r1763b2757],
15	complication	NN	O	complication	dobj	13	SENT_113	[p7l1801t2699r2147b2775, p7l8t2798r171b2852],
16	.	.	O	.	_	0	SENT_113	[p7l1801t2699r2147b2775, p7l8t2798r171b2852],

1	Recently	RB	DATE	recently	advmod	9	SENT_114	[p7l200t2795r516b2870],
2	,	,	O	,	_	0	SENT_114	[p7l200t2795r516b2870],
3	variants	NNS	O	variant	nsubjpass	9	SENT_114	[p7l543t2798r824b2852],
4	in	IN	O	in	_	0	SENT_114	[p7l850t2798r920b2852],
5	the	DT	O	the	det	7	SENT_114	[p7l945t2795r1057b2852],
6	SLCO1B1	NN	O	slco1b1	nn	7	SENT_114	[p7l1081t2796r1398b2852],
7	gene	NN	O	gene	prep_in	3	SENT_114	[p7l1430t2811r1593b2870],
8	were	VBD	O	be	auxpass	9	SENT_114	[p7l1617t2811r1780b2852],
9	identified	VBN	O	identify	_	0	SENT_114	[p7l1806t2794r2148b2852],
10	as	IN	O	as	_	0	SENT_114	[p7l9t2907r74b2948],
11	a	DT	O	a	det	14	SENT_114	[p7l114t2907r149b2948],
12	significant	JJ	O	significant	amod	14	SENT_114	[p7l188t2890r559b2966],
13	risk	NN	O	risk	nn	14	SENT_114	[p7l597t2890r722b2948],
14	factor	NN	O	factor	prep_as	9	SENT_114	[p7l759t2890r962b2948],
15	for	IN	O	for	_	0	SENT_114	[p7l999t2890r1098b2948],
16	simvastatin-associated	JJ	O	simvastatin-associated	amod	17	SENT_114	[p7l1137t2890r1928b2948],
17	myopathy	NN	O	myopathy	prep_for	14	SENT_114	[p7l1966t2907r2148b2966, p7l8t2975r294b3058],
18	.	.	O	.	_	0	SENT_114	[p7l1966t2907r2148b2966, p7l8t2975r294b3058],

1	”	NN	O	”	nsubj	3	SENT_115	[p7l1966t2907r2148b2966, p7l8t2975r294b3058],
2	We	PRP	O	we	nsubj	3	SENT_115	[p7l326t2985r435b3040],
3	identified	VBD	O	identify	_	0	SENT_115	[p7l469t2982r812b3040],
4	patients	NNS	O	patient	dobj	3	SENT_115	[p7l844t2986r1126b3058],
5	from	IN	O	from	_	0	SENT_115	[p7l1161t2982r1330b3040],
6	two	CD	NUMBER	two	num	9	SENT_115	[p7l1364t2990r1494b3040],
7	large	JJ	O	large	amod	9	SENT_115	[p7l1529t2983r1696b3058],
8	lipid	NN	O	lipid	nn	9	SENT_115	[p7l1731t2983r1891b3058],
9	clinics	NNS	O	clinic	prep_from	3	SENT_115	[p7l1925t2983r2147b3040],
10	with	IN	O	with	_	0	SENT_115	[p7l7t3079r168b3137],
11	an	DT	O	a	det	13	SENT_115	[p7l201t3096r285b3137],
12	extreme	JJ	O	extreme	amod	13	SENT_115	[p7l318t3086r602b3137],
13	phenotype	NN	O	phenotype	prep_with	3	SENT_115	[p7l634t3079r1015b3155],
14	consisting	VBG	O	consist	partmod	13	SENT_115	[p7l1049t3082r1409b3155],
15	of	IN	O	of	_	0	SENT_115	[p7l1441t3079r1512b3137],
16	CK	NN	O	ck	nn	17	SENT_115	[p7l1541t3081r1646b3137],
17	elevations	NNS	O	elevation	prep_of	14	SENT_115	[p7l1676t3079r2032b3137],
18	10	CD	NUMBER	10	num	19	SENT_115	[p7l2071t3081r2148b3137],
19	times	NNS	O	time	npadvmod	20	SENT_115	[p7l8t3177r198b3232],
20	greater	JJR	O	greater	amod	17	SENT_115	[p7l236t3181r478b3250],
21	than	IN	O	than	_	0	SENT_115	[p7l513t3174r678b3232],
22	the	DT	O	the	det	24	SENT_115	[p7l715t3174r827b3232],
23	upper	JJ	O	upper	amod	24	SENT_115	[p7l863t3191r1069b3250],
24	limit	NN	O	limit	prep_than	14	SENT_115	[p7l1105t3174r1274b3232],
25	of	IN	O	of	_	0	SENT_115	[p7l1312t3174r1383b3232],
26	normal	JJ	O	normal	prep_of	24	SENT_115	[p7l1416t3174r1691b3232],
27	.	.	O	.	_	0	SENT_115	[p7l1416t3174r1691b3232],

1	We	PRP	O	we	nsubj	2	SENT_116	[p7l1731t3177r1840b3232],
2	chose	VBD	O	choose	_	0	SENT_116	[p7l1878t3174r2075b3232],
3	a	DT	O	a	det	4	SENT_116	[p7l2114t3191r2149b3232],
4	biochemical	JJ	O	biochemical	dobj	2	SENT_116	[p7l6t3269r441b3327],
5	rather	RB	O	rather	_	0	SENT_116	[p7l480t3269r693b3327],
6	than	IN	O	than	_	0	SENT_116	[p7l730t3269r895b3327],
7	a	DT	O	a	det	9	SENT_116	[p7l935t3286r969b3327],
8	clinical	JJ	O	clinical	amod	9	SENT_116	[p7l1009t3269r1264b3327],
9	phenotype	NN	O	phenotype	conj_negcc	4	SENT_116	[p7l1302t3269r1684b3345],
10	because	IN	O	because	mark	23	SENT_116	[p7l1722t3269r1995b3327],
11	the	DT	O	the	det	12	SENT_116	[p7l2035t3269r2147b3327],
12	association	NN	O	association	nsubj	23	SENT_116	[p7l9t3366r400b3421],
13	between	IN	O	between	_	0	SENT_116	[p7l434t3363r732b3421],
14	muscle	NN	O	muscle	nn	15	SENT_116	[p7l769t3363r1014b3421],
15	symptoms	NNS	O	symptom	prep_between	12	SENT_116	[p7l1054t3371r1417b3439],
16	and	CC	O	and	_	0	SENT_116	[p7l1456t3363r1588b3421],
17	objective	JJ	O	objective	amod	18	SENT_116	[p7l1625t3363r1942b3439],
18	findings	NNS	O	finding	conj_and	12	SENT_116	[p7l1981t3363r2148b3421, p7l8t3461r150b3534],
19	of	IN	O	of	_	0	SENT_116	[p7l193t3458r265b3516],
20	muscle	NN	O	muscle	nn	21	SENT_116	[p7l302t3458r547b3516],
21	damage	NN	O	damage	prep_of	18	SENT_116	[p7l591t3458r862b3534],
22	is	VBZ	O	be	cop	23	SENT_116	[p7l905t3461r955b3516],
23	weak	JJ	O	weak	advcl	2	SENT_116	[p7l996t3459r1192b3516],
24	.	.	O	.	_	0	SENT_116	[p7l996t3459r1192b3516],

1	Our	PRP$	O	we	poss	2	SENT_117	[p7l1239t3460r1374b3516],
2	results	NNS	O	result	nsubj	3	SENT_117	[p7l1415t3458r1640b3516],
3	confirm	VBP	O	confirm	_	0	SENT_117	[p7l1683t3458r1964b3516],
4	that	IN	O	that	complm	11	SENT_117	[p7l2005t3459r2149b3516],
5	the	DT	O	the	det	7	SENT_117	[p7l8t3553r121b3610],
6	rs4149056	NN	O	rs4149056	nn	7	SENT_117	[p7l159t3555r522b3610],
7	variant	NN	O	variant	nsubj	11	SENT_117	[p7l558t3556r810b3610],
8	in	IN	O	in	_	0	SENT_117	[p7l847t3556r918b3609],
9	SLCO1B1	NN	O	slco1b1	nn	10	SENT_117	[p7l954t3555r1270b3610],
10	inﬂuences	NNS	O	inﬂuences	prep_in	7	SENT_117	[p7l1316t3553r1678b3610],
11	simvastatinassociated	VBD	O	simvastatinassociate	ccomp	3	SENT_117	[p7l1717t3556r2147b3610, p8l9t26r365b83],

1	myopathy	NN	O	myopathy	nsubj	4	SENT_118	[p8l387t26r762b101],
2	,	,	O	,	_	0	SENT_118	[p8l387t26r762b101],
3	and	CC	O	and	advmod	4	SENT_118	[p8l791t26r922b83],
4	suggest	VBP	O	suggest	_	0	SENT_118	[p8l946t33r1200b101],
5	that	IN	O	that	complm	10	SENT_118	[p8l1222t26r1365b83],
6	this	DT	O	this	det	7	SENT_118	[p8l1387t26r1517b83],
7	association	NN	O	association	nsubj	10	SENT_118	[p8l1541t29r1932b83],
8	is	VBZ	O	be	cop	10	SENT_118	[p8l1954t29r2005b83],
9	less	RBR	O	less	advmod	10	SENT_118	[p8l2028t26r2147b83],
10	significant	JJ	O	significant	ccomp	4	SENT_118	[p8l10t120r381b196],
11	for	IN	O	for	_	0	SENT_118	[p8l410t120r508b178],
12	atorvastatin	NN	O	atorvastatin	prep_for	10	SENT_118	[p8l538t124r978b178],
13	.	.	O	.	_	0	SENT_118	[p8l538t124r978b178],

1	Based	VBN	O	base	_	0	SENT_119	[p8l86t216r283b274],
2	on	IN	O	on	prepc_based_on	8	SENT_119	[p8l307t233r398b274],
3	our	PRP$	O	we	poss	5	SENT_119	[p8l421t233r540b274],
4	power	NN	O	power	nn	5	SENT_119	[p8l561t233r779b292],
5	calculations	NNS	O	calculation	pobj	8	SENT_119	[p8l801t216r1241b287],
6	,	,	O	,	_	0	SENT_119	[p8l801t216r1241b287],
7	we	PRP	O	we	nsubj	8	SENT_119	[p8l1268t233r1364b274],
8	had	VBD	O	have	_	0	SENT_119	[p8l1388t216r1521b274],
9	greater	JJR	O	greater	mwe	10	SENT_119	[p8l1544t223r1785b292],
10	than	IN	O	than	quantmod	11	SENT_119	[p8l1807t216r1972b274],
11	80	CD	PERCENT	80	dep	12	SENT_119	[p8l1997t218r2148b274],
12	%	NN	PERCENT	%	dep	13	SENT_119	[p8l1997t218r2148b274],
13	power	NN	O	power	dobj	8	SENT_119	[p8l8t327r226b386],
14	to	TO	O	to	aux	15	SENT_119	[p8l265t318r335b368],
15	identify	VB	O	identify	xcomp	8	SENT_119	[p8l377t310r655b386],
16	an	DT	O	a	det	17	SENT_119	[p8l694t327r779b368],
17	association	NN	O	association	dobj	15	SENT_119	[p8l821t314r1211b368],
18	of	IN	O	of	_	0	SENT_119	[p8l1253t310r1325b368],
19	rs4149056	NN	O	rs4149056	prep_of	17	SENT_119	[p8l1362t312r1724b368],
20	with	IN	O	with	_	0	SENT_119	[p8l1764t311r1925b368],
21	myopathy	NN	O	myopathy	prep_with	15	SENT_119	[p8l1967t327r2148b386, p8l8t406r213b482],
22	in	IN	O	in	_	0	SENT_119	[p8l257t409r327b463],
23	the	DT	O	the	det	25	SENT_119	[p8l374t406r486b464],
24	entire	JJ	O	entire	amod	25	SENT_119	[p8l534t409r737b464],
25	cohort	NN	O	cohort	prep_in	21	SENT_119	[p8l786t406r1018b464],
26	with	IN	O	with	_	0	SENT_119	[p8l1062t406r1223b464],
27	an	DT	O	a	det	29	SENT_119	[p8l1270t423r1355b464],
28	effect	NN	O	effect	nn	29	SENT_119	[p8l1402t406r1593b464],
29	size	NN	O	size	prep_with	15	SENT_119	[p8l1641t409r1764b464],
30	of	IN	O	of	_	0	SENT_119	[p8l1812t406r1883b464],
31	3.0	CD	NUMBER	3.0	prep_of	29	SENT_119	[p8l1926t407r2031b464],
32	or	CC	O	or	_	0	SENT_119	[p8l2078t423r2149b464],
33	greater	JJR	O	greater	prep_of	29	SENT_119	[p8l8t508r261b577],
34	.	.	O	.	_	0	SENT_119	[p8l8t508r261b577],

1	Therefore	RB	O	therefore	advmod	23	SENT_120	[p8l299t501r657b571],
2	,	,	O	,	_	0	SENT_120	[p8l299t501r657b571],
3	the	DT	O	the	det	4	SENT_120	[p8l697t501r809b559],
4	lack	NN	O	lack	nsubj	23	SENT_120	[p8l845t501r986b559],
5	of	IN	O	of	_	0	SENT_120	[p8l1019t501r1091b559],
6	association	NN	O	association	prep_of	4	SENT_120	[p8l1122t504r1513b559],
7	of	IN	O	of	_	0	SENT_120	[p8l1548t501r1620b559],
8	this	DT	O	this	det	9	SENT_120	[p8l1651t501r1780b559],
9	SNP	NN	O	snp	prep_of	6	SENT_120	[p8l1816t503r1954b559],
10	with	IN	O	with	_	0	SENT_120	[p8l1987t501r2148b559],
11	myopathy	NN	O	myopathy	prep_with	9	SENT_120	[p8l8t596r374b672],
12	in	IN	O	in	_	0	SENT_120	[p8l405t599r476b653],
13	a	DT	O	a	det	14	SENT_120	[p8l510t613r545b654],
14	cohort	NN	O	cohort	prep_in	11	SENT_120	[p8l579t596r812b654],
15	of	IN	O	of	_	0	SENT_120	[p8l846t596r917b654],
16	patients	NNS	O	patient	prep_of	14	SENT_120	[p8l947t599r1229b672],
17	on	IN	O	on	_	0	SENT_120	[p8l1264t613r1356b654],
18	a	DT	O	a	det	19	SENT_120	[p8l1390t613r1424b654],
19	variety	NN	O	variety	prep_on	16	SENT_120	[p8l1456t599r1701b672],
20	of	IN	O	of	_	0	SENT_120	[p8l1733t596r1805b654],
21	statins	NNS	O	statin	prep_of	19	SENT_120	[p8l1836t599r2063b654],
22	is	VBZ	O	be	cop	23	SENT_120	[p8l2097t599r2148b654],
23	unlikely	JJ	O	unlikely	_	0	SENT_120	[p8l7t690r299b766],
24	to	TO	O	to	aux	25	SENT_120	[p8l319t698r388b748],
25	represent	VB	O	represent	xcomp	23	SENT_120	[p8l412t698r738b766],
26	type	NN	O	type	nn	28	SENT_120	[p8l760t698r911b766],
27	II	CD	NUMBER	ii	num	28	SENT_120	[p8l936t693r984b747],
28	error	NN	O	error	dobj	25	SENT_120	[p8l1009t707r1189b748],
29	.	.	O	.	_	0	SENT_120	[p8l1009t707r1189b748],

1	This	DT	O	this	det	2	SENT_121	[p8l1214t690r1363b748],
2	finding	NN	O	finding	nsubj	3	SENT_121	[p8l1387t690r1647b766],
3	indicates	VBZ	O	indicate	_	0	SENT_121	[p8l1668t690r1982b748],
4	that	IN	O	that	complm	7	SENT_121	[p8l2005t690r2149b748],
5	rs4149056	NN	O	rs4149056	nsubj	7	SENT_121	[p8l8t787r371b843],
6	is	VBZ	O	be	cop	7	SENT_121	[p8l400t788r450b843],
7	unlikely	JJ	O	unlikely	ccomp	3	SENT_121	[p8l478t785r770b861],
8	to	TO	O	to	_	0	SENT_121	[p8l795t793r865b843],
9	inﬂuence	NN	O	inﬂuence	nn	10	SENT_121	[p8l894t785r1225b843],
10	myopathy	NN	O	myopathy	prep_to	7	SENT_121	[p8l1254t785r1619b861],
11	in	IN	O	in	_	0	SENT_121	[p8l1645t788r1716b842],
12	response	NN	O	response	prep_in	10	SENT_121	[p8l1743t802r2049b861],
13	to	TO	O	to	_	0	SENT_121	[p8l2078t793r2148b843],
14	statins	NNS	O	statin	prep_to	7	SENT_121	[p8l10t884r237b939],
15	in	IN	O	in	_	0	SENT_121	[p8l273t884r344b938],
16	general	JJ	O	general	prep_in	14	SENT_121	[p8l380t881r655b957],
17	.	.	O	.	_	0	SENT_121	[p8l380t881r655b957],

1	In	IN	O	in	_	0	SENT_122	[p8l696t883r769b938],
2	contrast	NN	O	contrast	prep_in	14	SENT_122	[p8l806t888r1109b951],
3	,	,	O	,	_	0	SENT_122	[p8l806t888r1109b951],
4	the	DT	O	the	det	5	SENT_122	[p8l1150t881r1262b939],
5	sample	NN	O	sample	nsubj	14	SENT_122	[p8l1301t881r1546b957],
6	of	IN	O	of	_	0	SENT_122	[p8l1584t881r1655b939],
7	10	CD	NUMBER	10	num	8	SENT_122	[p8l1693t883r1771b939],
8	cases	NNS	O	case	prep_of	5	SENT_122	[p8l1808t898r1980b939],
9	and	CC	O	and	_	0	SENT_122	[p8l2018t881r2148b939],
10	34	CD	NUMBER	34	num	11	SENT_122	[p8l10t977r91b1033],
11	controls	NNS	O	control	prep_of	5	SENT_122	[p8l122t976r408b1033],
12	using	VBG	O	use	partmod	11	SENT_122	[p8l437t979r629b1051],
13	atorvastatin	NN	O	atorvastatin	dobj	12	SENT_122	[p8l658t979r1079b1033],
14	provides	VBZ	O	provide	_	0	SENT_122	[p8l1108t976r1407b1051],
15	only	RB	O	only	advmod	17	SENT_122	[p8l1438t976r1598b1051],
16	44-52	CD	PERCENT	44-52	num	17	SENT_122	[p8l1624t977r1903b1033],
17	%	NN	PERCENT	%	iobj	14	SENT_122	[p8l1624t977r1903b1033],
18	power	NN	O	power	dobj	14	SENT_122	[p8l1932t992r2150b1051],
19	to	TO	O	to	aux	20	SENT_122	[p8l8t1078r78b1128],
20	detect	VB	O	detect	xcomp	14	SENT_122	[p8l102t1071r316b1128],
21	an	DT	O	a	det	22	SENT_122	[p8l338t1087r423b1128],
22	association	NN	O	association	dobj	20	SENT_122	[p8l447t1074r837b1128],
23	with	IN	O	with	_	0	SENT_122	[p8l858t1071r1020b1128],
24	myopathy	NN	O	myopathy	prep_with	22	SENT_122	[p8l1042t1071r1408b1146],
25	with	IN	O	with	_	0	SENT_122	[p8l1426t1071r1587b1128],
26	an	DT	O	a	det	28	SENT_122	[p8l1611t1087r1696b1128],
27	effect	NN	O	effect	nn	28	SENT_122	[p8l1719t1070r1910b1128],
28	size	NN	O	size	prep_with	20	SENT_122	[p8l1934t1074r2057b1128],
29	of	IN	O	of	_	0	SENT_122	[p8l2081t1070r2153b1128],
30	3-3	CD	NUMBER	3-3	num	31	SENT_122	[p8l10t1167r214b1236],
31	.5	CD	NUMBER	.5	prep_of	28	SENT_122	[p8l10t1167r214b1236],
32	,	,	O	,	_	0	SENT_122	[p8l10t1167r214b1236],
33	as	IN	O	as	mark	35	SENT_122	[p8l254t1182r319b1223],
34	we	PRP	O	we	nsubj	35	SENT_122	[p8l352t1182r448b1223],
35	observed	VBD	O	observe	advcl	20	SENT_122	[p8l484t1165r796b1223],
36	for	IN	O	for	_	0	SENT_122	[p8l831t1165r929b1223],
37	simvastatin	NN	O	simvastatin	prep_for	35	SENT_122	[p8l964t1168r1387b1223],
38	.	.	O	.	_	0	SENT_122	[p8l964t1168r1387b1223],

1	In	IN	O	in	_	0	SENT_123	[p8l1426t1168r1499b1222],
2	addition	NN	O	addition	prep_in	13	SENT_123	[p8l1534t1165r1851b1235],
3	,	,	O	,	_	0	SENT_123	[p8l1534t1165r1851b1235],
4	the	DT	O	the	det	5	SENT_123	[p8l1889t1165r2002b1223],
5	CIs	NNS	O	ci	nsubj	13	SENT_123	[p8l2039t1167r2148b1223],
6	for	IN	O	for	_	0	SENT_123	[p8l8t1260r107b1318],
7	patients	NNS	O	patient	prep_for	5	SENT_123	[p8l134t1264r416b1336],
8	administered	VBN	O	administer	partmod	7	SENT_123	[p8l446t1261r910b1318],
9	simvastatin	NN	O	simvastatin	dobj	8	SENT_123	[p8l940t1264r1345b1318],
10	and	CC	O	and	_	0	SENT_123	[p8l1374t1261r1505b1318],
11	atorvastatin	NN	O	atorvastatin	conj_and	9	SENT_123	[p8l1535t1264r1957b1318],
12	were	VBD	O	be	cop	13	SENT_123	[p8l1984t1277r2147b1318],
13	overlapping	VBG	O	overlap	_	0	SENT_123	[p8l9t1356r449b1432],
14	.	.	O	.	_	0	SENT_123	[p8l9t1356r449b1432],

1	Therefore	RB	O	therefore	advmod	25	SENT_124	[p8l478t1356r837b1426],
2	,	,	O	,	_	0	SENT_124	[p8l478t1356r837b1426],
3	although	IN	O	although	mark	8	SENT_124	[p8l870t1356r1191b1432],
4	our	PRP$	O	we	poss	5	SENT_124	[p8l1218t1373r1337b1414],
5	results	NNS	O	result	nsubj	8	SENT_124	[p8l1363t1356r1588b1414],
6	do	VBP	O	do	aux	8	SENT_124	[p8l1616t1356r1702b1414],
7	not	RB	O	not	neg	8	SENT_124	[p8l1731t1363r1851b1414],
8	support	VB	O	support	dep	25	SENT_124	[p8l1880t1363r2149b1432],
9	an	DT	O	a	det	10	SENT_124	[p8l9t1467r94b1507],
10	association	NN	O	association	dobj	8	SENT_124	[p8l179t1453r570b1507],
11	between	IN	O	between	_	0	SENT_124	[p8l653t1450r950b1507],
12	rs4149056	NN	O	rs4149056	nn	15	SENT_124	[p8l1035t1452r1398b1507],
13	and	CC	O	and	_	0	SENT_124	[p8l1484t1450r1616b1507],
14	atorvastatinassociated	JJ	O	atorvastatinassociated	nn	15	SENT_124	[p8l1701t1453r2147b1507, p8l9t1545r365b1603],
15	myopathy	NN	O	myopathy	prep_between	10	SENT_124	[p8l399t1545r774b1621],
16	,	,	O	,	_	0	SENT_124	[p8l399t1545r774b1621],
17	our	PRP$	O	we	poss	18	SENT_124	[p8l813t1562r932b1603],
18	ability	NN	O	ability	nsubjpass	25	SENT_124	[p8l966t1545r1190b1621],
19	to	TO	O	to	aux	20	SENT_124	[p8l1221t1552r1291b1603],
20	refute	VB	O	refute	infmod	18	SENT_124	[p8l1326t1545r1529b1603],
21	such	PDT	O	such	predet	23	SENT_124	[p8l1566t1545r1726b1603],
22	an	DT	O	a	det	23	SENT_124	[p8l1761t1562r1846b1603],
23	association	NN	O	association	dobj	20	SENT_124	[p8l1880t1548r2147b1603, p8l8t1642r153b1697],
24	is	VBZ	O	be	auxpass	25	SENT_124	[p8l176t1642r227b1697],
25	limited	VBN	O	limit	_	0	SENT_124	[p8l251t1639r505b1697],
26	due	JJ	O	due	acomp	25	SENT_124	[p8l529t1640r655b1697],
27	to	TO	O	to	_	0	SENT_124	[p8l680t1647r750b1697],
28	the	DT	O	the	det	31	SENT_124	[p8l774t1640r887b1697],
29	relatively	RB	O	relatively	advmod	30	SENT_124	[p8l912t1639r1240b1715],
30	small	JJ	O	small	amod	31	SENT_124	[p8l1263t1639r1448b1697],
31	number	NN	O	number	prep_to	26	SENT_124	[p8l1472t1639r1752b1697],
32	of	IN	O	of	_	0	SENT_124	[p8l1775t1639r1847b1697],
33	patients	NNS	O	patient	prep_of	31	SENT_124	[p8l1865t1642r2148b1715],
34	with	IN	O	with	_	0	SENT_124	[p8l7t1734r168b1792],
35	this	DT	O	this	det	37	SENT_124	[p8l208t1734r337b1792],
36	extreme	JJ	O	extreme	amod	37	SENT_124	[p8l379t1742r663b1792],
37	phenotype	NN	O	phenotype	prep_with	25	SENT_124	[p8l703t1735r1104b1810],
38	,	,	O	,	_	0	SENT_124	[p8l703t1735r1104b1810],
39	and	CC	O	and	_	0	SENT_124	[p8l1149t1734r1281b1792],
40	this	DT	O	this	det	41	SENT_124	[p8l1320t1734r1450b1792],
41	finding	NN	O	finding	nsubj	43	SENT_124	[p8l1490t1734r1750b1810],
42	should	MD	O	should	aux	43	SENT_124	[p8l1791t1734r2029b1792],
43	be	VB	O	be	conj_and	25	SENT_124	[p8l2067t1734r2147b1792],

1	The	DT	O	the	det	3	SENT_125	[p8l1260t2002r1362b2047],
2	Pharmacogenomics	NNP	MISC	Pharmacogenomics	nn	3	SENT_125	[p8l1389t2002r1930b2061],
3	journal	NN	O	journal	_	0	SENT_125	[p8l1953t2002r2146b2057],

1	®	NN	O	®	nsubj	11	SENT_126	[p8l6t2163r134b2287],
2	SLCO1B1	NN	O	slco1b1	nn	7	SENT_126	[p8l1427t2176r1622b2220],
3	and	CC	O	and	_	0	SENT_126	[p8l1644t2175r1732b2220],
4	statin	NN	O	statin	nn	7	SENT_126	[p8l1751t2175r1888b2220],
5	myopathy	NN	O	myopathy	nn	7	SENT_126	[p8l1909t2175r2151b2235],
6	'	''	O	'	_	0	SENT_126	[p8l99t2242r125b2259],
7	LR	NNP	ORGANIZATION	LR	dep	1	SENT_126	[p8l1795t2249r1840b2288],
8	Brunham	NNP	ORGANIZATION	Brunham	dep	1	SENT_126	[p8l1860t2247r2043b2288],
9	et	FW	O	et	nn	10	SENT_126	[p8l2065t2252r2101b2288],
10	al	FW	O	al	dep	8	SENT_126	[p8l2117t2247r2153b2288],
11	considered	VBN	O	consider	_	0	SENT_126	[p8l9t2535r392b2593],
12	hypothesis	NN	O	hypothesis	dobj	11	SENT_126	[p8l421t2535r803b2611],
13	generating	VBG	O	generate	partmod	12	SENT_126	[p8l834t2538r1229b2611],
14	.	.	O	.	_	0	SENT_126	[p8l834t2538r1229b2611],

1	In	IN	O	in	_	0	SENT_127	[p8l1263t2537r1335b2592],
2	patients	NNS	O	patient	prep_in	25	SENT_127	[p8l1365t2538r1647b2611],
3	who	WP	O	who	nsubj	4	SENT_127	[p8l1675t2535r1828b2593],
4	received	VBD	O	receive	rcmod	2	SENT_127	[p8l1858t2535r2149b2593],
5	simvastatin	NN	O	simvastatin	dobj	4	SENT_127	[p8l10t2632r433b2700],
6	,	,	O	,	_	0	SENT_127	[p8l10t2632r433b2700],
7	the	DT	O	the	det	8	SENT_127	[p8l477t2629r589b2687],
8	OR	NN	O	or	nsubj	25	SENT_127	[p8l631t2631r739b2687],
9	of	IN	O	of	_	0	SENT_127	[p8l777t2629r849b2687],
10	myopathy	NN	O	myopathy	prep_of	8	SENT_127	[p8l883t2629r1249b2705],
11	of	IN	O	of	_	0	SENT_127	[p8l1287t2629r1359b2687],
12	3.2	CD	NUMBER	3.2	prep_of	10	SENT_127	[p8l1395t2631r1499b2687],
13	per	IN	O	per	_	0	SENT_127	[p8l1538t2646r1650b2705],
14	genotype	NN	O	genotype	prep_per	8	SENT_127	[p8l1689t2637r2033b2705],
15	,	,	O	,	_	0	SENT_127	[p8l1689t2637r2033b2705],
16	or	CC	O	or	_	0	SENT_127	[p8l2078t2646r2149b2687],
17	2.3	CD	NUMBER	2.3	conj_or	8	SENT_127	[p8l10t2726r112b2783],
18	per	IN	O	per	_	0	SENT_127	[p8l140t2742r252b2801],
19	‘	NN	O	‘	nn	20	SENT_127	[p8l280t2725r371b2783],
20	C	NN	O	c	prep_per	17	SENT_127	[p8l280t2725r371b2783],
21	’	CD	NUMBER	’	num	22	SENT_127	[p8l280t2725r371b2783],
22	allele	NN	O	allele	dep	17	SENT_127	[p8l401t2725r601b2795],
23	,	,	O	,	_	0	SENT_127	[p8l401t2725r601b2795],
24	is	VBZ	O	be	cop	25	SENT_127	[p8l632t2728r683b2783],
25	lower	JJR	O	lower	_	0	SENT_127	[p8l710t2725r905b2783],
26	than	IN	O	than	_	0	SENT_127	[p8l930t2725r1094b2783],
27	that	DT	O	that	det	61	SENT_127	[p8l1121t2725r1264b2783],
28	reported	VBN	O	report	amod	61	SENT_127	[p8l1290t2725r1588b2801],
29	in	IN	O	in	_	0	SENT_127	[p8l1615t2728r1685b2782],
30	the	DT	O	the	det	58	SENT_127	[p8l1711t2725r1824b2783],
31	SEARCH	NN	O	search	nn	32	SENT_127	[p8l1852t2726r2147b2783],
32	study	NN	O	study	nn	58	SENT_127	[p8l10t2820r203b2896],
33	(	CD	NUMBER	(	number	34	SENT_127	[p8l227t2820r353b2892],
34	4.5	CD	NUMBER	4.5	dep	32	SENT_127	[p8l227t2820r353b2892],
35	per	IN	O	per	_	0	SENT_127	[p8l380t2837r492b2896],
36	‘	NN	O	‘	nn	37	SENT_127	[p8l517t2820r609b2878],
37	C	NN	O	c	prep_per	34	SENT_127	[p8l517t2820r609b2878],
38	’	CD	NUMBER	’	num	40	SENT_127	[p8l517t2820r609b2878],
39	allele	NN	O	allele	nn	40	SENT_127	[p8l635t2820r841b2892],
40	)	NN	O	)	dep	34	SENT_127	[p8l635t2820r841b2892],
41	but	CC	O	but	_	0	SENT_127	[p8l867t2820r986b2878],
42	similar	JJ	O	similar	conj_but	32	SENT_127	[p8l1011t2820r1250b2878],
43	to	TO	O	to	_	0	SENT_127	[p8l1274t2827r1343b2878],
44	that	DT	O	that	prep_to	42	SENT_127	[p8l1368t2820r1511b2878],
45	in	IN	O	in	_	0	SENT_127	[p8l1534t2823r1605b2877],
46	the	DT	O	the	det	52	SENT_127	[p8l1628t2820r1741b2878],
47	replication	NN	O	replication	nn	52	SENT_127	[p8l1766t2820r2148b2896],
48	Heart	NNP	O	Heart	nn	52	SENT_127	[p8l9t2915r202b2970],
49	Protection	NNP	O	Protection	nn	52	SENT_127	[p8l272t2915r639b2970],
50	Study	NNP	O	Study	nn	52	SENT_127	[p8l711t2913r911b2988],
51	Cohort	NNP	O	Cohort	nn	52	SENT_127	[p8l980t2913r1231b2970],
52	(	NN	O	(	prep_in	44	SENT_127	[p8l1304t2913r1433b2985],
53	2.6	CD	NUMBER	2.6	num	52	SENT_127	[p8l1304t2913r1433b2985],
54	per	IN	O	per	_	0	SENT_127	[p8l1503t2929r1615b2988],
55	‘	NN	O	‘	nn	56	SENT_127	[p8l1686t2913r1777b2970],
56	C	NN	O	c	prep_per	52	SENT_127	[p8l1686t2913r1777b2970],
57	’	CD	NUMBER	’	num	56	SENT_127	[p8l1686t2913r1777b2970],
58	allele	NN	O	allele	prep_in	28	SENT_127	[p8l1851t2906r2149b2985],
59	)	CD	NUMBER	)	number	60	SENT_127	[p8l1851t2906r2149b2985],
60	,1	CD	NUMBER	,1	num	61	SENT_127	[p8l1851t2906r2149b2985],
61	°	NN	O	°	prep_than	25	SENT_127	[p8l1851t2906r2149b2985],
62	suggesting	VBG	O	suggest	partmod	61	SENT_127	[p8l10t3012r381b3085],
63	that	IN	O	that	complm	73	SENT_127	[p8l405t3009r548b3067],
64	the	DT	O	the	det	66	SENT_127	[p8l573t3009r685b3067],
65	true	JJ	O	true	amod	66	SENT_127	[p8l711t3016r850b3067],
66	magnitude	NN	O	magnitude	nsubj	73	SENT_127	[p8l876t3009r1259b3085],
67	of	IN	O	of	_	0	SENT_127	[p8l1286t3009r1357b3067],
68	the	DT	O	the	det	69	SENT_127	[p8l1378t3009r1490b3067],
69	effect	NN	O	effect	prep_of	66	SENT_127	[p8l1517t3009r1708b3067],
70	of	IN	O	of	_	0	SENT_127	[p8l1734t3009r1805b3067],
71	SLCO1B1	NN	O	slco1b1	prep_of	69	SENT_127	[p8l1825t3011r2141b3067],
72	is	VBZ	O	be	cop	73	SENT_127	[p8l9t3107r59b3161],
73	likely	JJ	O	likely	ccomp	62	SENT_127	[p8l83t3104r277b3179],
74	within	IN	O	within	_	0	SENT_127	[p8l296t3104r531b3161],
75	this	DT	O	this	det	76	SENT_127	[p8l555t3104r685b3161],
76	range	NN	O	range	prep_within	73	SENT_127	[p8l709t3120r922b3179],
77	.	.	O	.	_	0	SENT_127	[p8l709t3120r922b3179],

1	The	DT	O	the	det	4	SENT_128	[p8l948t3104r1080b3161],
2	mean	NN	O	mean	nn	4	SENT_128	[p8l1105t3120r1302b3161],
3	simvastatin	NN	O	simvastatin	nn	4	SENT_128	[p8l1327t3107r1732b3161],
4	dose	NN	O	dose	nsubj	37	SENT_128	[p8l1756t3104r1912b3161],
5	in	IN	O	in	_	0	SENT_128	[p8l1937t3107r2007b3161],
6	our	PRP$	O	we	poss	9	SENT_128	[p8l2031t3120r2150b3161],
7	population	NN	O	population	nn	9	SENT_128	[p8l8t3199r401b3274],
8	(	CD	NUMBER	(	num	9	SENT_128	[p8l442t3199r625b3271],
9	~	NN	O	~	prep_in	4	SENT_128	[p8l442t3199r625b3271],
10	30	CD	NUMBER	30	num	12	SENT_128	[p8l442t3199r625b3271],
11	mg	NN	O	mg	nn	12	SENT_128	[p8l642t3199r776b3274],
12	)	NN	O	)	nsubj	14	SENT_128	[p8l642t3199r776b3274],
13	was	VBD	O	be	cop	14	SENT_128	[p8l815t3215r943b3256],
14	lower	JJR	O	lower	rcmod	9	SENT_128	[p8l981t3199r1176b3256],
15	than	IN	O	than	_	0	SENT_128	[p8l1212t3199r1376b3256],
16	that	DT	O	that	prep_than	14	SENT_128	[p8l1413t3199r1557b3256],
17	in	IN	O	in	_	0	SENT_128	[p8l1593t3202r1663b3256],
18	the	DT	O	the	det	20	SENT_128	[p8l1701t3199r1813b3256],
19	SEARCH	NN	O	search	nn	20	SENT_128	[p8l1852t3200r2147b3256],
20	study	NN	O	study	prep_in	16	SENT_128	[p8l10t3294r203b3370],
21	(	CD	NUMBER	(	number	22	SENT_128	[p8l239t3294r346b3366],
22	80	CD	NUMBER	80	num	24	SENT_128	[p8l239t3294r346b3366],
23	mg	NN	O	mg	nn	24	SENT_128	[p8l363t3295r496b3370],
24	)	NN	O	)	dep	9	SENT_128	[p8l363t3295r496b3370],
25	and	CC	O	and	_	0	SENT_128	[p8l537t3294r668b3352],
26	Heart	NNP	ORGANIZATION	Heart	nn	28	SENT_128	[p8l704t3297r897b3352],
27	Protection	NNP	ORGANIZATION	Protection	nn	28	SENT_128	[p8l933t3297r1300b3352],
28	study	NN	O	study	dep	9	SENT_128	[p8l1337t3294r1530b3370],
29	(	CD	NUMBER	(	number	30	SENT_128	[p8l1566t3294r1674b3366],
30	40	CD	NUMBER	40	num	32	SENT_128	[p8l1566t3294r1674b3366],
31	mg	NN	O	mg	nn	32	SENT_128	[p8l1690t3295r1823b3370],
32	)	NN	O	)	dep	9	SENT_128	[p8l1690t3295r1823b3370],
33	and	CC	O	and	_	0	SENT_128	[p8l1864t3294r1995b3352],
34	our	PRP$	O	we	poss	35	SENT_128	[p8l2031t3311r2150b3352],
35	findings	NNS	O	finding	prep_in	4	SENT_128	[p8l9t3389r297b3465],
36	therefore	RB	O	therefore	advmod	35	SENT_128	[p8l329t3389r648b3447],
37	extend	VBP	O	extend	_	0	SENT_128	[p8l681t3389r922b3447],
38	this	DT	O	this	det	39	SENT_128	[p8l953t3389r1082b3447],
39	association	NN	O	association	dobj	37	SENT_128	[p8l1115t3392r1505b3447],
40	to	TO	O	to	_	0	SENT_128	[p8l1536t3396r1606b3447],
41	lower	JJR	O	lower	amod	42	SENT_128	[p8l1637t3389r1832b3447],
42	doses	NNS	O	dose	prep_to	37	SENT_128	[p8l1862t3389r2049b3447],
43	of	IN	O	of	_	0	SENT_128	[p8l2081t3389r2153b3447],
44	this	DT	O	this	det	45	SENT_128	[p8l8t3483r138b3540],
45	medication	NN	O	medication	prep_of	42	SENT_128	[p8l168t3483r588b3540],
46	.	.	O	.	_	0	SENT_128	[p8l168t3483r588b3540],

1	SLCO1B1	NN	O	slco1b1	nsubj	2	SENT_129	[p9l84t27r400b83],
2	mediates	VBZ	O	mediate	_	0	SENT_129	[p9l447t25r761b83],
3	the	DT	O	the	det	4	SENT_129	[p9l801t25r913b83],
4	transport	NN	O	transport	dobj	2	SENT_129	[p9l954t33r1279b101],
5	of	IN	O	of	_	0	SENT_129	[p9l1319t25r1391b83],
6	statins	NNS	O	statin	prep_of	4	SENT_129	[p9l1428t28r1654b83],
7	into	IN	O	into	_	0	SENT_129	[p9l1695t28r1839b83],
8	hepatocytes	NNS	O	hepatocyte	prep_into	2	SENT_129	[p9l1879t26r2148b101, p9l9t126r200b195],
9	,	,	O	,	_	0	SENT_129	[p9l1879t26r2148b101, p9l9t126r200b195],
10	including	VBG	O	include	_	0	SENT_129	[p9l256t119r598b195],
11	simvastatin	NN	O	simvastatin	prep_including	8	SENT_129	[p9l649t122r1054b177],
12	and	CC	O	and	_	0	SENT_129	[p9l1106t119r1237b177],
13	atorvastatin	NN	O	atorvastatin	prep_including	8	SENT_129	[p9l1289t112r1796b177],
14	.	.	O	.	_	0	SENT_129	[p9l1289t112r1796b177],

1	”	NN	O	”	nsubj	25	SENT_130	[p9l1289t112r1796b177],
2	The	DT	O	the	det	3	SENT_130	[p9l1848t119r1981b177],
3	frequency	NN	O	frequency	npadvmod	1	SENT_130	[p9l2033t119r2148b177, p9l9t232r269b291],
4	of	IN	O	of	_	0	SENT_130	[p9l299t215r370b273],
5	the	DT	O	the	det	9	SENT_130	[p9l397t215r510b273],
6	rs4149056	NN	O	rs4149056	nn	9	SENT_130	[p9l543t217r905b273],
7	minor	JJ	O	minor	amod	9	SENT_130	[p9l938t218r1157b273],
8	allele	NN	O	allele	nn	9	SENT_130	[p9l1188t215r1370b273],
9	ranges	NNS	O	range	prep_of	3	SENT_130	[p9l1403t232r1628b291],
10	from	IN	O	from	_	0	SENT_130	[p9l1661t215r1830b273],
11	<	JJR	O	<	prep_from	1	SENT_130	[p9l1874t231r1923b273],
12	1	CD	PERCENT	1	number	13	SENT_130	[p9l1943t217r2046b272],
13	%	NN	PERCENT	%	amod	11	SENT_130	[p9l1943t217r2046b272],
14	in	IN	O	in	_	0	SENT_130	[p9l2078t218r2149b272],
15	Yoruba	NNP	MISC	Yoruba	nn	16	SENT_130	[p9l7t310r254b367],
16	Nigerians	NNPS	MISC	Nigerians	prep_in	1	SENT_130	[p9l292t312r626b385],
17	to	TO	O	to	_	0	SENT_130	[p9l666t317r736b367],
18	more	JJR	O	more	mwe	19	SENT_130	[p9l776t326r957b367],
19	than	IN	O	than	quantmod	20	SENT_130	[p9l998t310r1162b367],
20	20	CD	PERCENT	20	num	21	SENT_130	[p9l1203t311r1355b367],
21	%	NN	PERCENT	%	prep_to	1	SENT_130	[p9l1203t311r1355b367],
22	in	IN	O	in	_	0	SENT_130	[p9l1394t313r1464b367],
23	European	JJ	MISC	european	amod	24	SENT_130	[p9l1504t312r1839b385],
24	populations	NNS	O	population	prep_in	21	SENT_130	[p9l1878t310r2148b385, p9l8t408r183b463],
25	(	VBP	O	(	_	0	SENT_130	[p9l221t405r545b481],
26	Hapmap	NNP	O	Hapmap	nn	28	SENT_130	[p9l221t405r545b481],
27	data	NNS	O	datum	nn	28	SENT_130	[p9l580t405r774b477],
28	)	NN	O	)	dobj	25	SENT_130	[p9l580t405r774b477],
29	.	.	O	.	_	0	SENT_130	[p9l580t405r774b477],

1	The	DT	O	the	det	2	SENT_131	[p9l810t405r943b463],
2	Valine	NNP	O	Valine	nsubj	16	SENT_131	[p9l975t405r1190b463],
3	to	TO	O	to	_	0	SENT_131	[p9l1225t412r1295b463],
4	alanine	NN	O	alanine	nn	5	SENT_131	[p9l1330t405r1589b463],
5	substitution	NN	O	substitution	prep_to	2	SENT_131	[p9l1626t405r2051b463],
6	at	IN	O	at	_	0	SENT_131	[p9l2085t412r2149b463],
7	amino	NN	O	amino	nn	8	SENT_131	[p9l9t503r235b557],
8	acid	NN	O	acid	prep_at	5	SENT_131	[p9l263t500r406b557],
9	174	CD	NUMBER	174	num	8	SENT_131	[p9l438t501r558b557],
10	that	WDT	O	that	nsubjpass	12	SENT_131	[p9l586t500r730b557],
11	is	VBZ	O	be	auxpass	12	SENT_131	[p9l755t503r806b557],
12	introduced	VBN	O	introduce	rcmod	5	SENT_131	[p9l833t500r1223b557],
13	by	IN	O	by	_	0	SENT_131	[p9l1247t500r1334b575],
14	this	DT	O	this	det	15	SENT_131	[p9l1358t500r1488b557],
15	SNP	NN	O	snp	agent	12	SENT_131	[p9l1516t501r1655b557],
16	appears	VBZ	O	appear	ccomp	60	SENT_131	[p9l1681t516r1945b575],
17	to	TO	O	to	aux	21	SENT_131	[p9l1973t507r2042b557],
18	be	VB	O	be	cop	21	SENT_131	[p9l2068t500r2148b557],
19	a	DT	O	a	det	21	SENT_131	[p9l9t611r44b652],
20	functionally	RB	O	functionally	advmod	21	SENT_131	[p9l85t594r522b670],
21	important	JJ	O	important	xcomp	16	SENT_131	[p9l561t598r922b670],
22	Variant	JJ	O	variant	amod	21	SENT_131	[p9l961t598r1229b665],
23	,	,	O	,	_	0	SENT_131	[p9l961t598r1229b665],
24	as	IN	O	as	mark	33	SENT_131	[p9l1276t611r1341b652],
25	individuals	NNS	O	individual	nsubj	33	SENT_131	[p9l1383t595r1776b652],
26	heterozygous	JJ	O	heterozygous	amod	25	SENT_131	[p9l1819t595r2148b670, p9l9t707r169b766],
27	or	CC	O	or	_	0	SENT_131	[p9l197t707r269b748],
28	homozygous	JJ	O	homozygous	conj_or	26	SENT_131	[p9l294t690r746b766],
29	for	IN	O	for	_	0	SENT_131	[p9l774t690r872b748],
30	this	DT	O	this	det	31	SENT_131	[p9l898t690r1027b748],
31	SNP	NN	O	snp	prep_for	25	SENT_131	[p9l1056t692r1194b748],
32	have	VBP	O	have	aux	33	SENT_131	[p9l1221t690r1386b748],
33	increased	VBN	O	increase	dep	21	SENT_131	[p9l1414t690r1744b748],
34	concentrations	NNS	O	concentration	dobj	33	SENT_131	[p9l1771t697r2147b748, p9l8t788r183b843],
35	of	IN	O	of	_	0	SENT_131	[p9l210t785r282b843],
36	drug	NN	O	drug	prep_of	34	SENT_131	[p9l303t785r464b861],
37	in	IN	O	in	_	0	SENT_131	[p9l489t788r559b842],
38	plasma	NN	O	plasma	prep_in	36	SENT_131	[p9l584t785r832b861],
39	after	IN	O	after	_	0	SENT_131	[p9l859t785r1017b843],
40	oral	JJ	O	oral	amod	41	SENT_131	[p9l1041t785r1174b843],
41	administration	NN	O	administration	prep_after	33	SENT_131	[p9l1202t785r1729b843],
42	of	IN	O	of	_	0	SENT_131	[p9l1755t785r1827b843],
43	a	DT	O	a	det	44	SENT_131	[p9l1849t802r1883b843],
44	variety	NN	O	variety	prep_of	41	SENT_131	[p9l1906t788r2151b861],
45	of	IN	O	of	_	0	SENT_131	[p9l9t878r81b936],
46	statins	NNS	O	statin	prep_of	44	SENT_131	[p9l122t871r519b936],
47	.16	CD	NUMBER	.16	number	48	SENT_131	[p9l122t871r519b936],
48	'17	CD	NUMBER	'17	npadvmod	33	SENT_131	[p9l122t871r519b936],
49	In	IN	O	in	_	0	SENT_131	[p9l564t880r637b935],
50	addition	NN	O	addition	prep_in	33	SENT_131	[p9l682t878r998b948],
51	,	,	O	,	_	0	SENT_131	[p9l682t878r998b948],
52	in	IN	O	in	_	0	SENT_131	[p9l1047t881r1118b935],
53	transfected	VBN	O	transfect	prepc_in	33	SENT_131	[p9l1161t878r1552b936],
54	HeLa	NN	O	helum	nn	55	SENT_131	[p9l1596t880r1775b936],
55	cells	NNS	O	cell	dobj	53	SENT_131	[p9l1819t878r1986b948],
56	,	,	O	,	_	0	SENT_131	[p9l1819t878r1986b948],
57	the	DT	O	the	det	59	SENT_131	[p9l2035t878r2148b936],
58	rs4149056	NN	O	rs4149056	nn	59	SENT_131	[p9l9t975r371b1031],
59	polymorphism	NN	O	polymorphism	nsubj	60	SENT_131	[p9l398t973r924b1049],
60	results	VBZ	O	result	_	0	SENT_131	[p9l951t973r1176b1031],
61	in	IN	O	in	_	0	SENT_131	[p9l1204t976r1274b1030],
62	reduced	VBN	O	reduce	amod	64	SENT_131	[p9l1301t973r1581b1031],
63	substrate	NN	O	substrate	nn	64	SENT_131	[p9l1609t973r1920b1031],
64	transport	NN	O	transport	prep_in	60	SENT_131	[p9l1948t981r2147b1031, p9l8t1059r242b1143],
65	,18	CD	NUMBER	,18	npadvmod	66	SENT_131	[p9l1948t981r2147b1031, p9l8t1059r242b1143],
66	further	JJ	O	further	amod	64	SENT_131	[p9l287t1067r533b1125],
67	supporting	VBG	O	support	partmod	64	SENT_131	[p9l578t1070r963b1143],
68	the	DT	O	the	det	69	SENT_131	[p9l1006t1067r1118b1125],
69	concept	NN	O	concept	dobj	67	SENT_131	[p9l1164t1074r1444b1143],
70	that	IN	O	that	complm	76	SENT_131	[p9l1487t1067r1630b1125],
71	this	DT	O	this	nsubj	76	SENT_131	[p9l1674t1067r1804b1125],
72	is	VBZ	O	be	cop	76	SENT_131	[p9l1848t1070r1899b1125],
73	a	DT	O	a	det	76	SENT_131	[p9l1944t1084r1979b1125],
74	low	JJ	O	low	amod	76	SENT_131	[p9l2023t1067r2151b1125],
75	activity	NN	O	activity	nn	76	SENT_131	[p9l9t1166r274b1239],
76	allele	NN	O	allele	ccomp	67	SENT_131	[p9l328t1163r509b1221],
77	resulting	VBG	O	result	partmod	76	SENT_131	[p9l566t1163r878b1239],
78	in	IN	O	in	_	0	SENT_131	[p9l933t1166r1003b1220],
79	diminished	VBN	O	diminish	prepc_in	77	SENT_131	[p9l1060t1163r1462b1221],
80	statin	NN	O	statin	nn	81	SENT_131	[p9l1519t1166r1716b1221],
81	uptake	NN	O	uptake	dobj	79	SENT_131	[p9l1771t1163r2009b1239],
82	by	IN	O	by	_	0	SENT_131	[p9l2063t1163r2151b1239],
83	hepatocytes	NNS	O	hepatocyte	prep_by	79	SENT_131	[p9l9t1258r449b1333],
84	.	.	O	.	_	0	SENT_131	[p9l9t1258r449b1333],

1	Therefore	RB	O	therefore	advmod	5	SENT_132	[p9l477t1257r835b1328],
2	,	,	O	,	_	0	SENT_132	[p9l477t1257r835b1328],
3	it	PRP	O	it	nsubj	5	SENT_132	[p9l867t1261r916b1315],
4	seems	VBZ	O	seem	cop	5	SENT_132	[p9l943t1274r1148b1315],
5	likely	JJ	O	likely	_	0	SENT_132	[p9l1175t1258r1368b1333],
6	that	IN	O	that	complm	10	SENT_132	[p9l1392t1258r1535b1315],
7	this	DT	O	this	det	8	SENT_132	[p9l1561t1258r1690b1315],
8	SNP	NN	O	snp	nsubj	10	SENT_132	[p9l1718t1259r1857b1315],
9	directly	RB	O	directly	advmod	10	SENT_132	[p9l1883t1258r2151b1333],
10	impacts	VBZ	O	impact	ccomp	5	SENT_132	[p9l9t1357r283b1430],
11	simvastatin-associated	JJ	O	simvastatin-associated	amod	12	SENT_132	[p9l309t1354r1100b1412],
12	myopathy	NN	O	myopathy	dobj	10	SENT_132	[p9l1124t1354r1499b1430],
13	,	,	O	,	_	0	SENT_132	[p9l1124t1354r1499b1430],
14	potentially	RB	O	potentially	amod	12	SENT_132	[p9l1527t1354r1917b1430],
15	via	IN	O	via	_	0	SENT_132	[p9l1936t1357r2039b1412],
16	an	DT	O	a	det	17	SENT_132	[p9l2064t1371r2149b1412],
17	effect	NN	O	effect	prep_via	14	SENT_132	[p9l9t1449r200b1507],
18	on	IN	O	on	_	0	SENT_132	[p9l235t1466r327b1507],
19	plasma	NN	O	plasma	nn	21	SENT_132	[p9l361t1449r610b1525],
20	drug	NN	O	drug	nn	21	SENT_132	[p9l645t1449r807b1525],
21	concentrations	NNS	O	concentration	prep_on	17	SENT_132	[p9l841t1452r1389b1520],
22	,	,	O	,	_	0	SENT_132	[p9l841t1452r1389b1520],
23	and	CC	O	and	_	0	SENT_132	[p9l1430t1449r1561b1507],
24	is	VBZ	O	be	cop	28	SENT_132	[p9l1596t1452r1647b1507],
25	not	RB	O	not	neg	28	SENT_132	[p9l1682t1456r1803b1507],
26	merely	RB	O	merely	advmod	28	SENT_132	[p9l1837t1449r2081b1525],
27	a	DT	O	a	det	28	SENT_132	[p9l2114t1466r2149b1507],
28	marker	NN	O	marker	ccomp	5	SENT_132	[p9l9t1544r257b1601],
29	for	IN	O	for	_	0	SENT_132	[p9l317t1543r415b1601],
30	a	DT	O	a	det	32	SENT_132	[p9l476t1560r511b1601],
31	nearby	JJ	O	nearby	amod	32	SENT_132	[p9l571t1544r814b1619],
32	variant	NN	O	variant	prep_for	28	SENT_132	[p9l870t1547r1121b1601],
33	in	IN	O	in	_	0	SENT_132	[p9l1182t1547r1252b1601],
34	linkage	NN	O	linkage	nn	35	SENT_132	[p9l1314t1544r1568b1619],
35	disequilibrium	NN	O	disequilibrium	prep_in	32	SENT_132	[p9l1631t1544r2148b1619],
36	with	IN	O	with	_	0	SENT_132	[p9l7t1638r168b1695],
37	rs4149056	NN	O	rs4149056	prep_with	35	SENT_132	[p9l197t1640r579b1695],
38	.	.	O	.	_	0	SENT_132	[p9l197t1640r579b1695],

1	The	DT	O	the	det	2	SENT_133	[p9l83t1733r216b1791],
2	impact	NN	O	impact	nsubj	10	SENT_133	[p9l240t1736r485b1809],
3	of	IN	O	of	_	0	SENT_133	[p9l509t1733r580b1791],
4	the	DT	O	the	det	6	SENT_133	[p9l599t1733r711b1791],
5	rs4149056	NN	O	rs4149056	nn	6	SENT_133	[p9l736t1734r1098b1791],
6	variant	NN	O	variant	prep_of	2	SENT_133	[p9l1121t1736r1372b1791],
7	on	IN	O	on	_	0	SENT_133	[p9l1396t1750r1488b1791],
8	statin	NN	O	statin	nn	9	SENT_133	[p9l1513t1736r1709b1791],
9	metabolism	NN	O	metabolism	prep_on	6	SENT_133	[p9l1732t1733r2148b1791],
10	appears	VBZ	O	appear	_	0	SENT_133	[p9l9t1845r274b1904],
11	to	TO	O	to	aux	12	SENT_133	[p9l317t1835r386b1886],
12	differ	VB	O	differ	xcomp	10	SENT_133	[p9l430t1828r618b1886],
13	between	IN	O	between	_	0	SENT_133	[p9l657t1828r955b1886],
14	different	JJ	O	different	amod	15	SENT_133	[p9l998t1828r1302b1886],
15	statins	NNS	O	statin	prep_between	12	SENT_133	[p9l1346t1831r1591b1886],
16	.	.	O	.	_	0	SENT_133	[p9l1346t1831r1591b1886],

1	Pasanen	NNP	PERSON	Pasanen	nsubj	52	SENT_134	[p9l1639t1830r1926b1886],
2	et	FW	O	et	nn	3	SENT_134	[p9l1970t1834r2030b1886],
3	al.	FW	O	al.	dep	1	SENT_134	[p9l2067t1828r2144b1886],
4	administered	VBN	O	administer	dep	1	SENT_134	[p9l9t1921r473b1979],
5	oral	JJ	O	oral	amod	7	SENT_134	[p9l513t1921r646b1979],
6	simvastatin	NN	O	simvastatin	nn	7	SENT_134	[p9l689t1924r1093b1979],
7	acid	NN	O	acid	dobj	4	SENT_134	[p9l1135t1921r1294b1992],
8	,	,	O	,	_	0	SENT_134	[p9l1135t1921r1294b1992],
9	atorvastatin	NN	O	atorvastatin	conj_and	7	SENT_134	[p9l1340t1924r1762b1979],
10	and	CC	O	and	_	0	SENT_134	[p9l1803t1921r1934b1979],
11	rosuvastatin	NN	O	rosuvastatin	conj_and	7	SENT_134	[p9l1974t1938r2148b1979, p9l6t2021r288b2076],
12	to	TO	O	to	_	0	SENT_134	[p9l313t2025r382b2076],
13	healthy	JJ	O	healthy	amod	14	SENT_134	[p9l410t2018r681b2094],
14	volunteers	NNS	O	volunteer	prep_to	4	SENT_134	[p9l702t2018r1074b2076],
15	and	CC	O	and	_	0	SENT_134	[p9l1101t2018r1233b2076],
16	compared	VBN	O	compare	dep	1	SENT_134	[p9l1258t2018r1609b2094],
17	the	DT	O	the	det	18	SENT_134	[p9l1634t2018r1747b2076],
18	area	NN	O	area	dobj	16	SENT_134	[p9l1774t2035r1915b2076],
19	under	IN	O	under	_	0	SENT_134	[p9l1940t2018r2150b2076],
20	the	DT	O	the	det	27	SENT_134	[p9l8t2113r121b2171],
21	plasma	NN	O	plasma	nn	27	SENT_134	[p9l190t2113r439b2189],
22	concentration	NN	O	concentration	nn	27	SENT_134	[p9l508t2116r1008b2171],
23	time	NN	O	time	nn	27	SENT_134	[p9l1077t2116r1235b2171],
24	curve	NN	O	curve	nn	27	SENT_134	[p9l1306t2130r1495b2171],
25	(	CD	NUMBER	(	num	27	SENT_134	[p9l1569t2113r1781b2185],
26	AUC	NN	O	auc	nn	27	SENT_134	[p9l1569t2113r1781b2185],
27	)	NN	O	)	prep_under	16	SENT_134	[p9l1569t2113r1781b2185],
28	between	IN	O	between	_	0	SENT_134	[p9l1851t2113r2149b2171],
29	individuals	NNS	O	individual	prep_between	27	SENT_134	[p9l9t2206r402b2263],
30	based	VBN	O	base	partmod	29	SENT_134	[p9l449t2206r647b2263],
31	on	IN	O	on	_	0	SENT_134	[p9l695t2223r786b2263],
32	their	PRP$	O	they	poss	34	SENT_134	[p9l834t2206r1002b2263],
33	rs4149056	NN	O	rs4149056	nn	34	SENT_134	[p9l1049t2207r1411b2263],
34	genotypes	NNS	O	genotype	prep_on	30	SENT_134	[p9l1461t2199r1988b2281],
35	.16	CD	NUMBER	.16	number	36	SENT_134	[p9l1461t2199r1988b2281],
36	'17	CD	NUMBER	'17	dobj	30	SENT_134	[p9l1461t2199r1988b2281],
37	For	IN	O	for	_	0	SENT_134	[p9l2038t2208r2150b2263],
38	simvastatin	NN	O	simvastatin	nn	39	SENT_134	[p9l10t2305r415b2360],
39	acid	NN	O	acid	prep_for	44	SENT_134	[p9l476t2302r635b2372],
40	,	,	O	,	_	0	SENT_134	[p9l476t2302r635b2372],
41	the	DT	O	the	det	42	SENT_134	[p9l701t2302r813b2360],
42	AUC	NN	ORGANIZATION	auc	nsubjpass	44	SENT_134	[p9l874t2304r1040b2360],
43	was	VBD	O	be	auxpass	44	SENT_134	[p9l1098t2319r1226b2360],
44	increased	VBN	O	increase	rcmod	36	SENT_134	[p9l1287t2302r1618b2360],
45	by	IN	O	by	_	0	SENT_134	[p9l1675t2302r1763b2378],
46	221	CD	PERCENT	221	num	47	SENT_134	[p9l1822t2304r2018b2359],
47	%	NN	PERCENT	%	agent	44	SENT_134	[p9l1822t2304r2018b2359],
48	in	IN	O	in	_	0	SENT_134	[p9l2078t2305r2149b2359],
49	genotype	NN	O	genotype	nn	51	SENT_134	[p9l9t2404r335b2473],
50	CC	NN	O	cc	nn	51	SENT_134	[p9l378t2399r485b2455],
51	individuals	NNS	O	individual	prep_in	47	SENT_134	[p9l526t2397r919b2455],
52	(	VBP	O	(	dep	60	SENT_134	[p9l965t2397r1180b2469],
53	1124	CD	DATE	1124	number	54	SENT_134	[p9l965t2397r1180b2469],
54	)	CD	NUMBER	)	dobj	52	SENT_134	[p9l965t2397r1180b2469],
55	compared	VBN	O	compare	_	0	SENT_134	[p9l1225t2397r1576b2473],
56	with	IN	O	with	prepc_compared_with	54	SENT_134	[p9l1615t2397r1776b2455],
57	wild-type	JJ	O	wild-type	amod	59	SENT_134	[p9l1815t2397r2148b2473],
58	TT	NN	O	tt	nn	59	SENT_134	[p9l7t2493r100b2548],
59	individuals	NNS	O	individual	pobj	54	SENT_134	[p9l125t2491r518b2549],
60	(	VBP	O	(	_	0	SENT_134	[p9l549t2491r613b2563],
61	11	CD	NUMBER	11	num	64	SENT_134	[p9l549t2491r613b2563],
62	=	JJ	O	=	amod	64	SENT_134	[p9l632t2519r683b2537],
63	16	CD	NUMBER	16	tmod	62	SENT_134	[p9l707t2491r830b2563],
64	)	NN	O	)	nsubj	60	SENT_134	[p9l707t2491r830b2563],
65	.	.	O	.	_	0	SENT_134	[p9l707t2491r830b2563],

1	For	IN	O	for	_	0	SENT_135	[p9l863t2493r974b2549],
2	atorvastatin	NN	O	atorvastatin	prep_for	6	SENT_135	[p9l1001t2494r1440b2561],
3	,	,	O	,	_	0	SENT_135	[p9l1001t2494r1440b2561],
4	AUC	NN	ORGANIZATION	auc	nsubjpass	6	SENT_135	[p9l1471t2492r1637b2549],
5	was	VBD	O	be	auxpass	6	SENT_135	[p9l1663t2508r1790b2549],
6	increased	VBN	O	increase	_	0	SENT_135	[p9l1819t2491r2149b2549],
7	145	CD	PERCENT	145	num	8	SENT_135	[p9l14t2589r205b2645],
8	%	NN	PERCENT	%	dobj	6	SENT_135	[p9l14t2589r205b2645],
9	and	CC	O	and	_	0	SENT_135	[p9l269t2587r401b2645],
10	for	IN	O	for	conj_and	6	SENT_135	[p9l464t2587r562b2645],
11	rosuvastatin	NN	O	rosuvastatin	pobj	10	SENT_135	[p9l624t2590r1056b2645],
12	62	CD	PERCENT	62	num	13	SENT_135	[p9l1122t2589r1273b2645],
13	%	NN	PERCENT	%	tmod	10	SENT_135	[p9l1122t2589r1273b2645],
14	(	CD	NUMBER	(	num	16	SENT_135	[p9l1340t2588r1680b2663],
15	One-way	JJ	O	one-way	amod	16	SENT_135	[p9l1340t2588r1680b2663],
16	analysis	NN	O	analysis	npadvmod	20	SENT_135	[p9l1741t2587r2017b2663],
17	of	IN	O	of	_	0	SENT_135	[p9l2081t2587r2153b2645],
18	variance	NN	O	variance	nn	19	SENT_135	[p9l6t2684r303b2738],
19	P	NN	O	p	prep_of	16	SENT_135	[p9l360t2683r467b2738],
20	<	JJR	O	<	amod	13	SENT_135	[p9l360t2683r467b2738],
21	0.05	CD	NUMBER	0.05	dep	20	SENT_135	[p9l483t2682r628b2738],
22	for	IN	O	for	dep	21	SENT_135	[p9l692t2681r790b2738],
23	difference	NN	O	difference	pobj	22	SENT_135	[p9l849t2681r1198b2738],
24	in	IN	O	in	_	0	SENT_135	[p9l1258t2684r1329b2737],
25	AUC	NN	O	auc	prep_in	10	SENT_135	[p9l1387t2682r1553b2738],
26	between	IN	O	between	_	0	SENT_135	[p9l1611t2681r1908b2738],
27	three	CD	NUMBER	three	num	28	SENT_135	[p9l1967t2681r2148b2738],
28	statins	NNS	O	statin	prep_between	25	SENT_135	[p9l10t2775r283b2847],
29	)	CD	NUMBER	)	dep	28	SENT_135	[p9l10t2775r283b2847],
30	.	.	O	.	_	0	SENT_135	[p9l10t2775r283b2847],

1	These	DT	O	these	det	2	SENT_136	[p9l318t2775r520b2833],
2	data	NNS	O	datum	nsubj	21	SENT_136	[p9l554t2775r703b2833],
3	indicate	VBP	O	indicate	_	0	SENT_136	[p9l736t2775r1019b2833],
4	that	IN	O	that	complm	10	SENT_136	[p9l1053t2775r1196b2833],
5	the	DT	O	the	det	6	SENT_136	[p9l1229t2775r1342b2833],
6	effect	NN	O	effect	nsubj	10	SENT_136	[p9l1376t2775r1567b2833],
7	of	IN	O	of	_	0	SENT_136	[p9l1601t2775r1672b2833],
8	rs4149056	NN	O	rs4149056	prep_of	6	SENT_136	[p9l1701t2776r2063b2833],
9	is	VBZ	O	be	cop	10	SENT_136	[p9l2097t2778r2148b2833],
10	greatest	JJS	O	greatest	ccomp	3	SENT_136	[p9l9t2878r280b2946],
11	for	IN	O	for	_	0	SENT_136	[p9l346t2870r444b2928],
12	simvastatin	NN	O	simvastatin	prep_for	10	SENT_136	[p9l510t2873r915b2928],
13	and	CC	O	and	_	0	SENT_136	[p9l982t2870r1113b2928],
14	less	JJR	O	less	conj_and	10	SENT_136	[p9l1179t2870r1299b2928],
15	for	IN	O	for	_	0	SENT_136	[p9l1365t2870r1464b2928],
16	atorvastatin	NN	O	atorvastatin	prep_for	10	SENT_136	[p9l1529t2873r1951b2928],
17	and	CC	O	and	_	0	SENT_136	[p9l2018t2870r2149b2928],
18	rosuvastatin	NN	O	rosuvastatin	prep_for	10	SENT_136	[p9l9t2969r458b3036],
19	,	,	O	,	_	0	SENT_136	[p9l9t2969r458b3036],
20	and	CC	O	and	_	0	SENT_136	[p9l532t2966r663b3024],
21	provide	VBP	O	provide	conj_and	3	SENT_136	[p9l730t2966r997b3042],
22	an	DT	O	a	dobj	3	SENT_136	[p9l1068t2983r1152b3024],
23	in	IN	O	in	dep	26	SENT_136	[p9l1222t2967r1282b3024],
24	viva	FW	O	viva	pobj	23	SENT_136	[p9l1350t2967r1480b3024],
25	pharmacokinetic	JJ	O	pharmacokinetic	amod	26	SENT_136	[p9l1547t2966r2148b3042],
26	correlate	NN	O	correlate	dep	22	SENT_136	[p9l9t3061r314b3119],
27	for	IN	O	for	_	0	SENT_136	[p9l381t3061r480b3119],
28	the	DT	O	the	det	31	SENT_136	[p9l545t3061r658b3119],
29	differential	JJ	O	differential	amod	31	SENT_136	[p9l726t3061r1116b3119],
30	pharmacogenetic	JJ	O	pharmacogenetic	amod	31	SENT_136	[p9l1182t3061r1797b3137],
31	risk	NN	O	risk	prep_for	22	SENT_136	[p9l1864t3061r1989b3119],
32	we	PRP	O	we	nsubj	33	SENT_136	[p9l2052t3078r2148b3119],
33	observed	VBD	O	observe	rcmod	22	SENT_136	[p9l9t3155r322b3212],
34	between	IN	O	between	_	0	SENT_136	[p9l354t3155r652b3212],
35	simvastatin	NN	O	simvastatin	prep_between	33	SENT_136	[p9l688t3158r1093b3212],
36	and	CC	O	and	_	0	SENT_136	[p9l1129t3155r1260b3212],
37	atorvastatin	NN	O	atorvastatin	prep_between	33	SENT_136	[p9l1295t3158r1735b3212],
38	.	.	O	.	_	0	SENT_136	[p9l1295t3158r1735b3212],

1	Rosuvastatin	NN	O	rosuvastatin	_	0	SENT_137	[p9l1775t3157r2147b3212, p10l8t29r108b84],

1	has	VBZ	O	have	aux	3	SENT_138	[p10l154t26r270b84],
2	been	VBN	O	be	auxpass	3	SENT_138	[p10l316t26r486b84],
3	associated	VBN	O	associate	_	0	SENT_138	[p10l533t26r889b84],
4	with	IN	O	with	_	0	SENT_138	[p10l934t26r1096b84],
5	a	DT	O	a	det	7	SENT_138	[p10l1143t43r1177b84],
6	higher	JJR	O	higher	amod	7	SENT_138	[p10l1224t26r1455b102],
7	risk	NN	O	risk	prep_with	3	SENT_138	[p10l1501t26r1626b84],
8	of	IN	O	of	_	0	SENT_138	[p10l1671t26r1743b84],
9	myopathy	NN	O	myopathy	prep_of	7	SENT_138	[p10l1786t26r2151b102],
10	compared	VBN	O	compare	_	0	SENT_138	[p10l9t119r360b195],
11	with	IN	O	with	prepc_compared_with	3	SENT_138	[p10l398t119r560b177],
12	other	JJ	O	other	amod	13	SENT_138	[p10l600t119r789b177],
13	statins	NNS	O	statin	pobj	3	SENT_138	[p10l830t122r1056b177],
14	in	IN	O	in	_	0	SENT_138	[p10l1098t122r1168b176],
15	some	DT	O	some	det	16	SENT_138	[p10l1210t136r1391b177],
16	studies	NNS	O	study	prep_in	13	SENT_138	[p10l1434t112r1762b177],
17	.	.	O	.	_	0	SENT_138	[p10l1434t112r1762b177],

1	”	NN	O	”	nsubj	8	SENT_139	[p10l1434t112r1762b177],
2	Only	RB	O	only	advmod	1	SENT_139	[p10l1805t119r1981b195],
3	one	CD	NUMBER	one	num	4	SENT_139	[p10l2019t136r2147b177],
4	patient	NN	O	patient	pobj	2	SENT_139	[p10l8t218r260b291],
5	in	IN	O	in	_	0	SENT_139	[p10l283t218r353b272],
6	our	PRP$	O	we	poss	7	SENT_139	[p10l376t232r495b273],
7	cohort	NN	O	cohort	prep_in	2	SENT_139	[p10l517t215r749b273],
8	received	VBD	O	receive	_	0	SENT_139	[p10l771t215r1062b273],
9	rosuvastatin	NN	O	rosuvastatin	dobj	8	SENT_139	[p10l1085t218r1534b285],
10	,	,	O	,	_	0	SENT_139	[p10l1085t218r1534b285],
11	but	CC	O	but	_	0	SENT_139	[p10l1561t215r1680b273],
12	the	DT	O	the	det	15	SENT_139	[p10l1702t215r1815b273],
13	available	JJ	O	available	amod	14	SENT_139	[p10l1839t215r2147b273],
14	pharmacokinetic	JJ	O	pharmacokinetic	amod	15	SENT_139	[p10l8t310r609b386],
15	data	NNS	O	datum	nsubj	16	SENT_139	[p10l666t310r815b368],
16	predict	VBP	O	predict	conj_but	8	SENT_139	[p10l870t310r1118b386],
17	that	IN	O	that	complm	26	SENT_139	[p10l1173t310r1317b368],
18	myopathy	NN	O	myopathy	nsubjpass	26	SENT_139	[p10l1373t310r1738b386],
19	associated	VBN	O	associate	partmod	18	SENT_139	[p10l1793t310r2149b368],
20	with	IN	O	with	_	0	SENT_139	[p10l7t404r168b462],
21	this	DT	O	this	det	22	SENT_139	[p10l224t404r353b462],
22	drug	NN	O	drug	prep_with	19	SENT_139	[p10l410t404r571b480],
23	would	MD	O	would	aux	26	SENT_139	[p10l624t404r846b462],
24	be	VB	O	be	auxpass	26	SENT_139	[p10l899t404r979b462],
25	less	RBR	O	less	advmod	26	SENT_139	[p10l1036t404r1156b462],
26	inﬂuenced	VBN	O	inﬂuenced	ccomp	16	SENT_139	[p10l1212t404r1591b462],
27	by	IN	O	by	_	0	SENT_139	[p10l1644t404r1732b480],
28	rs4149056	NN	O	rs4149056	nn	29	SENT_139	[p10l1785t406r2148b462],
29	genotype	NN	O	genotype	agent	26	SENT_139	[p10l9t507r354b576],
30	.	.	O	.	_	0	SENT_139	[p10l9t507r354b576],

1	A	DT	O	a	det	3	SENT_140	[p10l419t501r469b557],
2	stronger	JJR	O	stronger	amod	3	SENT_140	[p10l531t507r821b576],
3	effect	NN	O	effect	nsubjpass	17	SENT_140	[p10l882t500r1073b558],
4	of	IN	O	of	_	0	SENT_140	[p10l1135t500r1207b558],
5	rs4149056	NN	O	rs4149056	nn	6	SENT_140	[p10l1264t501r1627b558],
6	genotype	NN	O	genotype	prep_of	3	SENT_140	[p10l1690t507r2016b576],
7	in	IN	O	in	_	0	SENT_140	[p10l2078t503r2149b557],
8	patients	NNS	O	patient	prep_in	6	SENT_140	[p10l8t597r290b670],
9	with	IN	O	with	_	0	SENT_140	[p10l329t594r491b652],
10	simvastatin	NN	O	simvastatin	prep_with	8	SENT_140	[p10l533t597r938b652],
11	compared	VBN	O	compare	_	0	SENT_140	[p10l978t594r1329b670],
12	with	IN	O	with	prepc_compared_with	10	SENT_140	[p10l1367t594r1529b652],
13	atorvastatin	NN	O	atorvastatin	pobj	10	SENT_140	[p10l1570t597r1992b652],
14	has	VBZ	O	have	aux	17	SENT_140	[p10l2032t594r2148b652],
15	also	RB	O	also	advmod	17	SENT_140	[p10l9t690r143b748],
16	been	VBN	O	be	auxpass	17	SENT_140	[p10l200t690r369b748],
17	reported	VBN	O	report	_	0	SENT_140	[p10l426t690r725b766],
18	for	IN	O	for	_	0	SENT_140	[p10l782t690r881b748],
19	patients	NNS	O	patient	prep_for	17	SENT_140	[p10l936t693r1219b766],
20	with	IN	O	with	_	0	SENT_140	[p10l1275t690r1437b748],
21	milder	JJR	O	milder	amod	22	SENT_140	[p10l1495t690r1726b748],
22	symptoms	NNS	O	symptom	prep_with	19	SENT_140	[p10l1784t697r2148b766],
23	consisting	VBG	O	consist	xcomp	17	SENT_140	[p10l9t788r370b861],
24	of	IN	O	of	_	0	SENT_140	[p10l404t785r476b843],
25	subjective	JJ	O	subjective	amod	26	SENT_140	[p10l509t785r858b861],
26	reports	NNS	O	report	prep_of	23	SENT_140	[p10l893t792r1138b861],
27	of	IN	O	of	_	0	SENT_140	[p10l1175t785r1246b843],
28	myalgias	NNS	O	myalgia	prep_of	26	SENT_140	[p10l1277t785r1604b861],
29	,	,	O	,	_	0	SENT_140	[p10l1277t785r1604b861],
30	drug	NN	O	drug	nn	31	SENT_140	[p10l1645t785r1806b861],
31	discontinuation	NN	O	discontinuation	conj_or	28	SENT_140	[p10l1840t785r2147b843, p10l9t883r307b950],
32	,	,	O	,	_	0	SENT_140	[p10l1840t785r2147b843, p10l9t883r307b950],
33	or	CC	O	or	_	0	SENT_140	[p10l351t896r423b937],
34	CK	NN	O	ck	nn	35	SENT_140	[p10l462t881r566b937],
35	values	NNS	O	value	conj_or	28	SENT_140	[p10l601t880r820b937],
36	greater	JJR	O	greater	mwe	37	SENT_140	[p10l860t887r1102b955],
37	than	IN	O	than	quantmod	39	SENT_140	[p10l1140t880r1305b937],
38	three	CD	NUMBER	three	number	39	SENT_140	[p10l1343t880r1523b937],
39	times	NNS	O	time	num	42	SENT_140	[p10l1563t883r1753b937],
40	the	DT	O	the	det	42	SENT_140	[p10l1793t880r1905b937],
41	upper	JJ	O	upper	amod	42	SENT_140	[p10l1944t896r2150b955],
42	limit	NN	O	limit	dobj	23	SENT_140	[p10l9t974r178b1032],
43	of	IN	O	of	_	0	SENT_140	[p10l208t974r279b1032],
44	normal	JJ	O	normal	prep_of	42	SENT_140	[p10l304t967r646b1032],
45	.	.	O	.	_	0	SENT_140	[p10l304t967r646b1032],

1	“	NN	O	“	_	0	SENT_141	[p10l304t967r646b1032],

1	In	IN	O	in	_	0	SENT_142	[p10l86t1073r159b1127],
2	summary	NN	O	summary	prep_in	6	SENT_142	[p10l218t1087r562b1146],
3	,	,	O	,	_	0	SENT_142	[p10l218t1087r562b1146],
4	our	PRP$	O	we	poss	5	SENT_142	[p10l625t1087r744b1128],
5	results	NNS	O	result	nsubj	6	SENT_142	[p10l801t1070r1028b1128],
6	provide	VBP	O	provide	_	0	SENT_142	[p10l1086t1070r1356b1146],
7	further	JJ	O	further	amod	8	SENT_142	[p10l1415t1070r1663b1128],
8	support	NN	O	support	dobj	6	SENT_142	[p10l1722t1077r1993b1146],
9	for	IN	O	for	_	0	SENT_142	[p10l2050t1070r2150b1128],
10	the	DT	O	the	det	12	SENT_142	[p10l8t1165r121b1223],
11	important	JJ	O	important	amod	12	SENT_142	[p10l182t1168r546b1241],
12	role	NN	O	role	prep_for	8	SENT_142	[p10l606t1165r739b1223],
13	of	IN	O	of	_	0	SENT_142	[p10l801t1165r872b1223],
14	SLCO1B1	NN	O	slco1b1	prep_of	12	SENT_142	[p10l927t1166r1245b1223],
15	in	IN	O	in	_	0	SENT_142	[p10l1313t1168r1384b1222],
16	inﬂuencing	VBG	O	inﬂuencing	prepc_in	6	SENT_142	[p10l1443t1165r1857b1241],
17	simvaThe	NN	O	simvathe	dobj	16	SENT_142	[p10l1918t1168r2147b1223, p10l7t1433r109b1478],

1	Pharmacogenomics	NNP	O	Pharmacogenomics	nn	2	SENT_143	[p10l136t1433r677b1492],
2	Journal	NNP	O	Journal	_	0	SENT_143	[p10l699t1433r893b1488],
3	statin	JJ	O	statin	amod	6	SENT_143	[p10l11t1645r481b1703],
4	—	NN	O	—	nn	6	SENT_143	[p10l11t1645r481b1703],
5	related	JJ	O	related	amod	6	SENT_143	[p10l11t1645r481b1703],
6	myopathy	NN	O	myopathy	dep	2	SENT_143	[p10l542t1645r920b1721],
7	.	.	O	.	_	0	SENT_143	[p10l542t1645r920b1721],

1	Importantly	RB	O	importantly	advmod	5	SENT_144	[p10l986t1645r1431b1721],
2	,	,	O	,	_	0	SENT_144	[p10l986t1645r1431b1721],
3	our	PRP$	O	we	poss	4	SENT_144	[p10l1498t1662r1617b1703],
4	data	NNS	O	datum	nsubj	5	SENT_144	[p10l1679t1645r1828b1703],
5	suggest	VBP	O	suggest	_	0	SENT_144	[p10l1891t1652r2146b1721],
6	that	IN	O	that	complm	11	SENT_144	[p10l9t1739r153b1797],
7	this	DT	O	this	det	8	SENT_144	[p10l207t1739r337b1797],
8	association	NN	O	association	nsubj	11	SENT_144	[p10l393t1742r787b1797],
9	may	MD	O	may	aux	11	SENT_144	[p10l841t1756r994b1815],
10	not	RB	O	not	neg	11	SENT_144	[p10l1046t1747r1167b1797],
11	exist	VB	O	exist	ccomp	5	SENT_144	[p10l1221t1742r1384b1797],
12	or	CC	O	or	_	0	SENT_144	[p10l1438t1756r1510b1797],
13	may	MD	O	may	aux	15	SENT_144	[p10l1563t1756r1716b1815],
14	be	VB	O	be	cop	15	SENT_144	[p10l1765t1739r1845b1797],
15	weaker	JJR	O	weaker	ccomp	5	SENT_144	[p10l1899t1739r2147b1797],
16	for	IN	O	for	_	0	SENT_144	[p10l9t1835r108b1893],
17	other	JJ	O	other	amod	18	SENT_144	[p10l180t1835r370b1893],
18	statins	NNS	O	statin	prep_for	15	SENT_144	[p10l442t1838r689b1905],
19	,	,	O	,	_	0	SENT_144	[p10l442t1838r689b1905],
20	and	CC	O	and	_	0	SENT_144	[p10l767t1835r899b1893],
21	therefore	RB	O	therefore	advmod	15	SENT_144	[p10l970t1835r1292b1893],
22	raise	VB	O	raise	conj_or	11	SENT_144	[p10l1365t1838r1523b1893],
23	the	DT	O	the	det	24	SENT_144	[p10l1596t1835r1709b1893],
24	possibility	NN	O	possibility	dobj	22	SENT_144	[p10l1781t1835r2149b1911],
25	that	IN	O	that	complm	43	SENT_144	[p10l9t1930r153b1988],
26	patients	NNS	O	patient	nsubj	43	SENT_144	[p10l203t1933r488b2006],
27	found	VBN	O	find	partmod	26	SENT_144	[p10l540t1930r753b1988],
28	to	TO	O	to	aux	29	SENT_144	[p10l804t1937r874b1988],
29	be	VB	O	be	xcomp	27	SENT_144	[p10l924t1930r1004b1988],
30	at	IN	O	at	_	0	SENT_144	[p10l1057t1937r1121b1988],
31	high	JJ	O	high	amod	32	SENT_144	[p10l1172t1930r1335b2006],
32	risk	NN	O	risk	prep_at	29	SENT_144	[p10l1386t1930r1512b1988],
33	for	IN	O	for	_	0	SENT_144	[p10l1561t1930r1661b1988],
34	simvastatinassociated	JJ	O	simvastatinassociated	amod	35	SENT_144	[p10l1712t1933r2146b1988, p10l10t2024r369b2082],
35	myopathy	NN	O	myopathy	prep_for	32	SENT_144	[p10l402t2025r770b2100],
36	by	IN	O	by	_	0	SENT_144	[p10l798t2024r886b2100],
37	virtue	NN	O	virtue	prep_by	29	SENT_144	[p10l915t2027r1123b2082],
38	of	IN	O	of	_	0	SENT_144	[p10l1158t2024r1230b2082],
39	their	PRP$	O	they	poss	41	SENT_144	[p10l1258t2025r1428b2082],
40	SLCO1B1	NN	O	slco1b1	nn	41	SENT_144	[p10l1458t2026r1777b2082],
41	genotype	NN	O	genotype	prep_of	37	SENT_144	[p10l1817t2032r2145b2100],
42	may	MD	O	may	aux	43	SENT_144	[p10l9t2137r162b2196],
43	be	VB	O	be	ccomp	22	SENT_144	[p10l210t2120r290b2178],
44	at	IN	O	at	_	0	SENT_144	[p10l344t2127r408b2178],
45	lower	JJR	O	lower	amod	46	SENT_144	[p10l460t2120r655b2178],
46	risk	NN	O	risk	prep_at	43	SENT_144	[p10l707t2120r833b2178],
47	for	IN	O	for	_	0	SENT_144	[p10l883t2120r982b2178],
48	myopathy	NN	O	myopathy	prep_for	46	SENT_144	[p10l1033t2120r1400b2196],
49	if	IN	O	if	mark	50	SENT_144	[p10l1451t2120r1501b2177],
50	treated	VBN	O	treat	advcl	43	SENT_144	[p10l1549t2120r1796b2178],
51	with	IN	O	with	_	0	SENT_144	[p10l1846t2120r2009b2178],
52	an	DT	O	a	det	54	SENT_144	[p10l2062t2137r2147b2178],
53	alternative	JJ	O	alternative	amod	54	SENT_144	[p10l10t2214r389b2271],
54	statin	NN	O	statin	prep_with	50	SENT_144	[p10l422t2217r638b2271],
55	.	.	O	.	_	0	SENT_144	[p10l422t2217r638b2271],

1	Conflict	NN	O	conflict	_	0	SENT_145	[p10l10t2425r313b2483],
2	of	IN	O	of	_	0	SENT_145	[p10l342t2425r423b2483],
3	interest	NN	O	interest	prep_of	1	SENT_145	[p10l451t2425r749b2483],

1	The	DT	O	the	det	2	SENT_146	[p10l8t2613r140b2670],
2	authors	NNS	O	author	nsubj	3	SENT_146	[p10l171t2614r436b2670],
3	declare	VBP	O	declare	_	0	SENT_146	[p10l467t2613r713b2670],
4	no	DT	O	no	det	5	SENT_146	[p10l744t2630r835b2670],
5	conﬂict	NN	O	conﬂict	dobj	3	SENT_146	[p10l866t2613r1135b2670],
6	of	IN	O	of	_	0	SENT_146	[p10l1164t2613r1236b2670],
7	interest	NN	O	interest	prep_of	5	SENT_146	[p10l1261t2616r1543b2670],
8	.	.	O	.	_	0	SENT_146	[p10l1261t2616r1543b2670],

1	Acknowledgments	NNS	O	acknowledgment	_	0	SENT_147	[p10l8t2818r728b2894],

1	This	DT	O	this	det	2	SENT_148	[p10l7t3003r140b3054],
2	work	NN	O	work	nsubjpass	4	SENT_148	[p10l174t3003r332b3054],
3	was	VBD	O	be	auxpass	4	SENT_148	[p10l363t3017r477b3054],
4	supported	VBN	O	support	_	0	SENT_148	[p10l513t3003r826b3070],
5	by	IN	O	by	_	0	SENT_148	[p10l859t3003r937b3070],
6	grants	NNS	O	grant	agent	4	SENT_148	[p10l970t3009r1161b3070],
7	from	IN	O	from	_	0	SENT_148	[p10l1196t3002r1347b3054],
8	the	DT	O	the	det	10	SENT_148	[p10l1381t3003r1481b3054],
9	Canadian	JJ	ORGANIZATION	canadian	amod	10	SENT_148	[p10l1518t3002r1819b3054],
10	Institutes	NNPS	ORGANIZATION	Institutes	prep_from	6	SENT_148	[p10l1854t3005r2147b3054],
11	of	IN	ORGANIZATION	of	_	0	SENT_148	[p10l10t3087r73b3137],
12	Health	NNP	ORGANIZATION	Health	nn	13	SENT_148	[p10l101t3087r312b3138],
13	Research	NNP	ORGANIZATION	Research	prep_of	6	SENT_148	[p10l343t3087r615b3138],
14	and	CC	O	and	_	0	SENT_148	[p10l647t3087r764b3137],
15	the	DT	O	the	det	17	SENT_148	[p10l795t3087r894b3138],
16	Canadian	JJ	ORGANIZATION	canadian	amod	17	SENT_148	[p10l928t3087r1228b3138],
17	Foundation	NNP	ORGANIZATION	Foundation	conj_and	6	SENT_148	[p10l1260t3087r1625b3138],
18	for	IN	ORGANIZATION	for	_	0	SENT_148	[p10l1656t3087r1744b3137],
19	Innovation	NNP	ORGANIZATION	Innovation	prep_for	17	SENT_148	[p10l1774t3089r2143b3138],
20	.	.	O	.	_	0	SENT_148	[p10l1774t3089r2143b3138],

1	LRB	NN	ORGANIZATION	lrb	nsubj	12	SENT_149	[p10l10t3174r128b3223],
2	is	VBZ	O	be	cop	6	SENT_149	[p10l207t3175r252b3223],
3	a	DT	O	a	det	6	SENT_149	[p10l331t3187r361b3223],
4	Canadian	JJ	MISC	canadian	amod	6	SENT_149	[p10l441t3172r742b3223],
5	Pharmacogenomic	JJ	MISC	pharmacogenomic	amod	6	SENT_149	[p10l819t3172r1406b3240],
6	Network	NNP	MISC	Network	_	0	SENT_149	[p10l1482t3172r1753b3224],
7	for	IN	MISC	for	_	0	SENT_149	[p10l1828t3172r1916b3223],
8	Drug	NNP	MISC	Drug	nn	10	SENT_149	[p10l1993t3174r2148b3239],
9	Safety	NNP	MISC	Safety	nn	10	SENT_149	[p10l10t3256r197b3324],
10	fellow	NN	O	fellow	prep_for	6	SENT_149	[p10l230t3256r422b3308],
11	and	CC	O	and	_	0	SENT_149	[p10l456t3256r572b3308],
12	received	VBD	O	receive	conj_and	6	SENT_149	[p10l607t3257r865b3308],
13	support	NN	O	support	dobj	12	SENT_149	[p10l901t3263r1139b3324],
14	from	IN	O	from	_	0	SENT_149	[p10l1174t3256r1325b3308],
15	the	DT	O	the	det	17	SENT_149	[p10l1360t3257r1460b3308],
16	UBC	NNP	ORGANIZATION	UBC	nn	17	SENT_149	[p10l1496t3258r1637b3308],
17	Department	NNP	ORGANIZATION	Department	prep_from	12	SENT_149	[p10l1673t3259r2052b3324],
18	of	IN	ORGANIZATION	of	_	0	SENT_149	[p10l2087t3256r2151b3308],
19	Medicine	NNP	ORGANIZATION	Medicine	prep_of	17	SENT_149	[p10l8t3342r315b3393],
20	.	.	O	.	_	0	SENT_149	[p10l8t3342r315b3393],

1	HV	NN	O	hv	nsubjpass	3	SENT_150	[p10l375t3344r476b3393],
2	is	VBZ	O	be	auxpass	3	SENT_150	[p10l529t3344r574b3393],
3	supported	VBN	O	support	_	0	SENT_150	[p10l631t3342r944b3409],
4	by	IN	O	by	_	0	SENT_150	[p10l997t3342r1075b3409],
5	fellowships	NNS	O	fellowship	agent	3	SENT_150	[p10l1128t3341r1480b3409],
6	from	IN	O	from	_	0	SENT_150	[p10l1535t3342r1685b3393],
7	the	DT	O	the	det	10	SENT_150	[p10l1741t3342r1841b3393],
8	Michael	NNP	ORGANIZATION	Michael	nn	10	SENT_150	[p10l1896t3342r2147b3393],
9	Smith	NNP	ORGANIZATION	Smith	nn	10	SENT_150	[p10l10t3427r195b3478],
10	Foundation	NNP	ORGANIZATION	Foundation	prep_from	5	SENT_150	[p10l245t3427r610b3478],
11	for	IN	ORGANIZATION	for	_	0	SENT_150	[p10l660t3427r747b3478],
12	Health	NNP	ORGANIZATION	Health	nn	13	SENT_150	[p10l796t3427r1007b3479],
13	Research	NNP	ORGANIZATION	Research	prep_for	3	SENT_150	[p10l1057t3427r1329b3479],
14	and	CC	ORGANIZATION	and	_	0	SENT_150	[p10l1379t3427r1496b3478],
15	Child	NNP	ORGANIZATION	Child	prep_for	3	SENT_150	[p10l1546t3427r1720b3478],
16	and	CC	ORGANIZATION	and	_	0	SENT_150	[p10l1770t3427r1886b3478],
17	Family	NNP	ORGANIZATION	Family	nn	19	SENT_150	[p10l1937t3427r2149b3495],
18	Research	NNP	ORGANIZATION	Research	nn	19	SENT_150	[p10l10t3511r282b3561],
19	Institute	NNP	ORGANIZATION	Institute	prep_for	3	SENT_150	[p10l309t3513r590b3561],
20	.	.	O	.	_	0	SENT_150	[p10l309t3513r590b3561],

1	References	NNS	O	reference	_	0	SENT_151	[p10l12t3715r425b3772],

1	Mitka	NNP	LOCATION	Mitka	nn	5	SENT_152	[p11l144t97r295b145],
2	M.	NNP	O	M.	nn	5	SENT_152	[p11l326t99r394b145],
3	Expanding	NNP	O	Expanding	nn	5	SENT_152	[p11l427t97r717b160],
4	statin	NN	O	statin	nn	5	SENT_152	[p11l747t98r893b145],
5	use	NN	O	use	nsubj	12	SENT_152	[p11l925t111r1012b145],
6	to	TO	O	to	aux	7	SENT_152	[p11l1038t103r1093b145],
7	help	VB	O	help	infmod	5	SENT_152	[p11l1123t97r1239b160],
8	more	JJR	O	more	amod	10	SENT_152	[p11l1269t111r1410b145],
9	at-risk	JJ	O	at-risk	amod	10	SENT_152	[p11l1437t97r1603b145],
10	patients	NNS	O	patient	dobj	7	SENT_152	[p11l1630t98r1846b160],
11	is	VBZ	O	be	aux	12	SENT_152	[p11l1875t98r1910b145],
12	causing	VBG	O	cause	_	0	SENT_152	[p11l1937t98r2144b160],
13	financial	JJ	O	financial	amod	14	SENT_152	[p11l139t172r368b220],
14	heartburn	NN	O	heartburn	dobj	12	SENT_152	[p11l399t172r686b220],
15	.	.	O	.	_	0	SENT_152	[p11l399t172r686b220],

1	/	:	O	/	punct	4	SENT_153	[p11l711t174r840b231],
2	Am	VBP	O	be	cop	4	SENT_153	[p11l711t174r840b231],
3	Med	NNP	O	Med	nn	4	SENT_153	[p11l866t172r985b220],
4	Assoc	NNP	O	Assoc	_	0	SENT_153	[p11l1003t174r1151b220],
5	2003	CD	DATE	2003	dep	4	SENT_153	[p11l1173t173r1329b230],
6	;	:	O	;	_	0	SENT_153	[p11l1173t173r1329b230],
7	290	CD	NUMBER	290	num	9	SENT_153	[p11l1358t173r1479b220],
8	:	:	O	:	_	0	SENT_153	[p11l1358t173r1479b220],
9	2243-2245	CD	DATE	2243-2245	dep	4	SENT_153	[p11l1508t173r1843b220],
10	.	.	O	.	_	0	SENT_153	[p11l1508t173r1843b220],

1	Silva	NNP	PERSON	Silva	nn	2	SENT_154	[p11l143t246r263b294],
2	MA	NNP	PERSON	MA	_	0	SENT_154	[p11l292t249r398b304],
3	,	,	O	,	_	0	SENT_154	[p11l292t249r398b304],
4	Swanson	NNP	ORGANIZATION	Swanson	nn	5	SENT_154	[p11l429t248r671b294],
5	AC	NN	ORGANIZATION	ac	appos	2	SENT_154	[p11l697t248r793b304],
6	,	,	O	,	_	0	SENT_154	[p11l697t248r793b304],
7	Gandhi	NNP	PERSON	Gandhi	nn	9	SENT_154	[p11l822t246r1022b294],
8	P	NN	O	p	nn	9	SENT_154	[p11l1052t249r1112b305],
9	]	NN	O	]	appos	2	SENT_154	[p11l1052t249r1112b305],
10	,	,	O	,	_	0	SENT_154	[p11l1052t249r1112b305],
11	Tataronis	NNP	O	Tataronis	nn	12	SENT_154	[p11l1139t248r1393b294],
12	GR	NN	O	gr	appos	2	SENT_154	[p11l1419t248r1512b294],
13	.	.	O	.	_	0	SENT_154	[p11l1419t248r1512b294],

1	Statin-related	JJ	O	statin-related	amod	3	SENT_155	[p11l1541t246r1910b294],
2	adverse	JJ	O	adverse	amod	3	SENT_155	[p11l1938t246r2146b294],
3	events	NNS	O	event	_	0	SENT_155	[p11l142t328r333b370],
4	:	:	O	:	_	0	SENT_155	[p11l142t328r333b370],
5	a	DT	O	a	det	6	SENT_155	[p11l362t336r388b370],
6	meta-analysis	NN	O	meta-analysis	dep	3	SENT_155	[p11l417t322r803b385],
7	.	.	O	.	_	0	SENT_155	[p11l417t322r803b385],

1	Clin	NNP	O	Clin	nn	2	SENT_156	[p11l836t322r933b370],
2	Ther	NNP	O	Ther	_	0	SENT_156	[p11l963t322r1080b370],
3	2006	CD	DATE	2006	num	2	SENT_156	[p11l1099t323r1256b380],
4	;	:	O	;	_	0	SENT_156	[p11l1099t323r1256b380],
5	28	CD	NUMBER	28	num	7	SENT_156	[p11l1285t323r1368b370],
6	:	:	O	:	_	0	SENT_156	[p11l1285t323r1368b370],
7	26-35	CD	NUMBER	26-35	dep	2	SENT_156	[p11l1397t323r1586b370],
8	.	.	O	.	_	0	SENT_156	[p11l1397t323r1586b370],

1	Staffa	NNP	O	Staffa	nn	2	SENT_157	[p11l143t397r292b444],
2	JA	NNP	O	JA	_	0	SENT_157	[p11l349t399r418b455],
3	,	,	O	,	_	0	SENT_157	[p11l349t399r418b455],
4	Chang	NNP	PERSON	Chang	nn	5	SENT_157	[p11l479t397r659b459],
5	J	NNP	PERSON	J	conj_and	2	SENT_157	[p11l717t399r746b455],
6	,	,	O	,	_	0	SENT_157	[p11l717t399r746b455],
7	Green	NNP	PERSON	Green	nn	9	SENT_157	[p11l807t398r971b444],
8	L.	NNP	PERSON	L.	nn	9	SENT_157	[p11l1033t399r1072b444],
9	Cerivastatin	NNP	PERSON	Cerivastatin	conj_and	2	SENT_157	[p11l1133t398r1454b444],
10	and	CC	O	and	_	0	SENT_157	[p11l1514t397r1615b444],
11	reports	NNS	O	report	conj_and	2	SENT_157	[p11l1676t402r1867b459],
12	of	IN	O	of	_	0	SENT_157	[p11l1923t397r1977b444],
13	fatal	JJ	O	fatal	amod	14	SENT_157	[p11l2028t397r2144b444],
14	rhabdomyolysis	NN	O	rhabdomyolysis	prep_of	11	SENT_157	[p11l144t472r593b535],
15	.	.	O	.	_	0	SENT_157	[p11l144t472r593b535],

1	N	NN	O	n	dep	2	SENT_158	[p11l624t474r668b519],
2	Engl	NNP	LOCATION	Engl	dep	4	SENT_158	[p11l693t472r805b534],
3	/	:	O	/	punct	4	SENT_158	[p11l821t474r842b531],
4	Med	VBD	O	med	_	0	SENT_158	[p11l866t472r985b520],
5	2002	CD	DATE	2002	num	7	SENT_158	[p11l1005t473r1162b530],
6	;	:	O	;	_	0	SENT_158	[p11l1005t473r1162b530],
7	346	CD	NUMBER	346	dobj	4	SENT_158	[p11l1192t473r1312b520],
8	:	:	O	:	_	0	SENT_158	[p11l1192t473r1312b520],
9	539-553a	NN	O	539-553a	dep	7	SENT_158	[p11l1340t473r1634b520],
10	.	.	O	.	_	0	SENT_158	[p11l1340t473r1634b520],

1	de	IN	O	de	dep	6	SENT_159	[p11l142t546r208b594],
2	Lemos	NNP	O	Lemos	nn	3	SENT_159	[p11l230t549r404b594],
3	JA	NNP	O	JA	pobj	1	SENT_159	[p11l423t549r491b605],
4	,	,	O	,	_	0	SENT_159	[p11l423t549r491b605],
5	Blazing	NNP	O	Blazing	nn	6	SENT_159	[p11l518t546r711b609],
6	MA	NNP	O	MA	_	0	SENT_159	[p11l736t549r842b604],
7	,	,	O	,	_	0	SENT_159	[p11l736t549r842b604],
8	Wiviott	NNP	PERSON	Wiviott	nn	9	SENT_159	[p11l863t548r1064b594],
9	SD	NN	O	sd	appos	6	SENT_159	[p11l1083t548r1173b604],
10	,	,	O	,	_	0	SENT_159	[p11l1083t548r1173b604],
11	Lewis	NNP	PERSON	Lewis	nn	12	SENT_159	[p11l1200t548r1346b594],
12	EF	NNP	O	EF	appos	6	SENT_159	[p11l1368t549r1439b604],
13	,	,	O	,	_	0	SENT_159	[p11l1368t549r1439b604],
14	Fox	NNP	ORGANIZATION	Fox	nn	15	SENT_159	[p11l1464t549r1558b594],
15	KAA	NNP	ORGANIZATION	KAA	appos	6	SENT_159	[p11l1580t548r1704b604],
16	,	,	O	,	_	0	SENT_159	[p11l1580t548r1704b604],
17	White	NNP	O	White	nn	18	SENT_159	[p11l1725t546r1890b594],
18	HD	NNP	O	HD	appos	6	SENT_159	[p11l1912t549r1997b594],
19	et	FW	O	et	nn	20	SENT_159	[p11l2019t552r2068b594],
20	al.	FW	O	al.	dep	18	SENT_159	[p11l2085t546r2143b594],
21	.	.	O	.	_	0	SENT_159	[p11l2085t546r2143b594],

1	Early	RB	O	early	advmod	2	SENT_160	[p11l144t622r271b685],
2	intensive	JJ	O	intensive	_	0	SENT_160	[p11l294t623r535b670],
3	vs	CC	O	vs	_	0	SENT_160	[p11l556t636r609b670],
4	a	DT	O	a	det	8	SENT_160	[p11l631t636r658b670],
5	delayed	VBN	O	delay	amod	8	SENT_160	[p11l681t622r894b685],
6	conservative	JJ	O	conservative	amod	8	SENT_160	[p11l919t623r1261b670],
7	simvastatin	NN	O	simvastatin	nn	8	SENT_160	[p11l1283t623r1590b670],
8	strategy	NN	O	strategy	conj_vs	2	SENT_160	[p11l1614t628r1836b685],
9	in	IN	O	in	_	0	SENT_160	[p11l1858t623r1903b669],
10	patients	NNS	O	patient	prep_in	8	SENT_160	[p11l1930t623r2146b685],
11	with	IN	O	with	_	0	SENT_160	[p11l139t697r259b744],
12	acute	JJ	O	acute	amod	14	SENT_160	[p11l289t702r438b744],
13	coronary	JJ	O	coronary	amod	14	SENT_160	[p11l465t711r711b759],
14	syndromes	NNS	O	syndrome	prep_with	10	SENT_160	[p11l736t697r1052b759],
15	:	:	O	:	_	0	SENT_160	[p11l736t697r1052b759],
16	phase	NN	O	phase	nn	17	SENT_160	[p11l1085t697r1242b759],
17	Z	NN	O	z	dep	8	SENT_160	[p11l1270t699r1305b744],
18	of	IN	O	of	_	0	SENT_160	[p11l1332t697r1386b744],
19	the	DT	O	the	det	20	SENT_160	[p11l1409t697r1497b744],
20	A	NN	O	a	prep_of	17	SENT_160	[p11l1522t699r1562b744],
21	to	TO	O	to	_	0	SENT_160	[p11l1586t702r1641b744],
22	Z	NN	O	z	nn	23	SENT_160	[p11l1668t699r1703b744],
23	trial	NN	O	trial	prep_to	20	SENT_160	[p11l1730t697r1848b744],
24	.	.	O	.	_	0	SENT_160	[p11l1730t697r1848b744],

1	/	:	O	/	punct	4	SENT_161	[p11l1875t699r2005b755],
2	Am	VBP	O	be	cop	4	SENT_161	[p11l1875t699r2005b755],
3	Med	NNP	O	Med	nn	4	SENT_161	[p11l2033t697r2152b744],
4	Assoc	NNP	O	Assoc	_	0	SENT_161	[p11l140t774r288b819],
5	2004	CD	DATE	2004	dep	4	SENT_161	[p11l310t773r467b829],
6	;	:	O	;	_	0	SENT_161	[p11l310t773r467b829],
7	292	CD	NUMBER	292	num	9	SENT_161	[p11l495t773r616b819],
8	:	:	O	:	_	0	SENT_161	[p11l495t773r616b819],
9	1307-1316	CD	DATE	1307-1316	dep	4	SENT_161	[p11l648t773r979b819],
10	.	.	O	.	_	0	SENT_161	[p11l648t773r979b819],

1	Dujovne	NNP	PERSON	Dujovne	nn	2	SENT_162	[p11l144t848r374b910],
2	CA	NNP	O	CA	_	0	SENT_162	[p11l399t848r492b905],
3	,	,	O	,	_	0	SENT_162	[p11l399t848r492b905],
4	Chremos	NNP	ORGANIZATION	Chremos	appos	2	SENT_162	[p11l521t847r770b895],
5	AN	DT	ORGANIZATION	a	dep	4	SENT_162	[p11l791t849r893b905],
6	,	,	O	,	_	0	SENT_162	[p11l791t849r893b905],
7	Pool	NNP	O	Pool	nn	8	SENT_162	[p11l924t847r1037b895],
8	JL	NNP	O	JL	appos	2	SENT_162	[p11l1063t849r1123b906],
9	,	,	O	,	_	0	SENT_162	[p11l1063t849r1123b906],
10	Schnaper	NNP	PERSON	Schnaper	nn	11	SENT_162	[p11l1152t847r1412b910],
11	H	NNP	O	H	appos	2	SENT_162	[p11l1436t849r1489b905],
12	,	,	O	,	_	0	SENT_162	[p11l1436t849r1489b905],
13	Bradford	NNP	ORGANIZATION	Bradford	nn	14	SENT_162	[p11l1520t847r1753b895],
14	RH	NNP	ORGANIZATION	RH	appos	2	SENT_162	[p11l1783t849r1872b905],
15	,	,	O	,	_	0	SENT_162	[p11l1783t849r1872b905],
16	Shear	NNP	ORGANIZATION	Shear	nn	17	SENT_162	[p11l1901t847r2055b895],
17	CL	NN	ORGANIZATION	cl	appos	2	SENT_162	[p11l2077t848r2148b895],
18	et	FW	O	et	nn	19	SENT_162	[p11l143t928r192b970],
19	al.	FW	O	al.	dep	17	SENT_162	[p11l210t922r267b970],
20	.	.	O	.	_	0	SENT_162	[p11l210t922r267b970],

1	Expanded	VBN	O	expand	dep	10	SENT_163	[p11l294t922r565b985],
2	clinical	JJ	O	clinical	amod	3	SENT_163	[p11l588t922r772b970],
3	evaluation	NN	O	evaluation	dobj	1	SENT_163	[p11l795t922r1079b970],
4	of	IN	O	of	_	0	SENT_163	[p11l1101t922r1155b970],
5	lovastatin	NN	O	lovastatin	prep_of	3	SENT_163	[p11l1174t922r1433b970],
6	(	CD	NUMBER	(	num	9	SENT_163	[p11l1457t922r1675b982],
7	EXCEL	NNP	MISC	EXCEL	nn	9	SENT_163	[p11l1457t922r1675b982],
8	)	CD	NUMBER	)	num	9	SENT_163	[p11l1457t922r1675b982],
9	study	NN	O	study	nsubj	10	SENT_163	[p11l1696t922r1846b985],
10	results	VBZ	O	result	_	0	SENT_163	[p11l1867t922r2054b970],
11	:	:	O	:	_	0	SENT_163	[p11l1867t922r2054b970],
12	IV	CD	NUMBER	iv	dobj	10	SENT_163	[p11l2080t924r2143b970],
13	.	.	O	.	_	0	SENT_163	[p11l2080t924r2143b970],

1	Additional	JJ	O	additional	amod	2	SENT_164	[p11l139t997r423b1045],
2	perspectives	NNS	O	perspective	_	0	SENT_164	[p11l450t998r787b1060],
3	on	IN	O	on	_	0	SENT_164	[p11l810t1011r877b1045],
4	the	DT	O	the	det	5	SENT_164	[p11l901t997r989b1045],
5	tolerability	NN	O	tolerability	prep_on	2	SENT_164	[p11l1011t997r1306b1060],
6	of	IN	O	of	_	0	SENT_164	[p11l1328t997r1381b1045],
7	lovastatin	NN	O	lovastatin	prep_of	2	SENT_164	[p11l1403t997r1679b1045],
8	.	.	O	.	_	0	SENT_164	[p11l1403t997r1679b1045],

1	Am	VBP	O	be	cop	12	SENT_165	[p11l1704t999r1792b1044],
2	/	:	O	/	punct	3	SENT_165	[p11l1808t999r1829b1056],
3	Med	VBN	O	med	parataxis	12	SENT_165	[p11l1850t997r1969b1045],
4	1991	CD	DATE	1991	dobj	3	SENT_165	[p11l1989t998r2143b1055],
5	;	:	O	;	_	0	SENT_165	[p11l1989t998r2143b1055],
6	91	CD	NUMBER	91	num	7	SENT_165	[p11l141t1073r202b1119],
7	(	NN	O	(	dep	4	SENT_165	[p11l216t1072r258b1131],
8	1	CD	NUMBER	1	num	10	SENT_165	[p11l216t1072r258b1131],
9	B	NN	O	b	nn	10	SENT_165	[p11l277t1072r344b1131],
10	)	NN	O	)	dep	7	SENT_165	[p11l277t1072r344b1131],
11	:	:	O	:	_	0	SENT_165	[p11l277t1072r344b1131],
12	25S-30S	NN	O	25s-30	_	0	SENT_165	[p11l373t1073r628b1119],
13	.	.	O	.	_	0	SENT_165	[p11l373t1073r628b1119],

1	Law	NN	O	law	nn	2	SENT_166	[p11l144t1149r251b1195],
2	M	NN	O	m	_	0	SENT_166	[p11l284t1149r352b1205],
3	,	,	O	,	_	0	SENT_166	[p11l284t1149r352b1205],
4	Rudnicka	FW	PERSON	rudnicka	appos	2	SENT_166	[p11l390t1147r637b1195],
5	AR	NN	O	ar	dep	4	SENT_166	[p11l667t1149r755b1195],
6	.	.	O	.	_	0	SENT_166	[p11l667t1149r755b1195],

1	Statin	NN	O	statin	nn	2	SENT_167	[p11l792t1148r946b1195],
2	safety	NN	O	safety	_	0	SENT_167	[p11l979t1147r1152b1210],
3	:	:	O	:	_	0	SENT_167	[p11l979t1147r1152b1210],
4	a	DT	O	a	det	6	SENT_167	[p11l1188t1161r1215b1195],
5	systematic	JJ	O	systematic	amod	6	SENT_167	[p11l1246t1148r1535b1210],
6	review	NN	O	review	dep	2	SENT_167	[p11l1569t1148r1761b1195],
7	.	.	O	.	_	0	SENT_167	[p11l1569t1148r1761b1195],

1	Am	VBP	O	be	_	0	SENT_168	[p11l1795t1149r1883b1194],
2	/	:	O	/	punct	3	SENT_168	[p11l1909t1149r1930b1206],
3	Cardiol	NNP	O	Cardiol	nsubj	12	SENT_168	[p11l1962t1147r2151b1195],
4	2006	CD	DATE	2006	num	3	SENT_168	[p11l142t1223r299b1279],
5	;	:	O	;	_	0	SENT_168	[p11l142t1223r299b1279],
6	97	CD	NUMBER	97	number	7	SENT_168	[p11l327t1222r577b1284],
7	(	CD	NUMBER	(	num	8	SENT_168	[p11l327t1222r577b1284],
8	Suppl	NN	O	suppl	dep	3	SENT_168	[p11l327t1222r577b1284],
9	1	CD	NUMBER	1	num	10	SENT_168	[p11l609t1222r676b1281],
10	)	NN	O	)	dep	8	SENT_168	[p11l609t1222r676b1281],
11	:	:	O	:	_	0	SENT_168	[p11l609t1222r676b1281],
12	S52-S60	NN	O	s52-s60	ccomp	1	SENT_168	[p11l706t1223r960b1269],
13	.	.	O	.	_	0	SENT_168	[p11l706t1223r960b1269],

1	Bruckert	NNP	O	Bruckert	nn	2	SENT_169	[p11l144t1296r372b1344],
2	E	NNP	O	E	_	0	SENT_169	[p11l429t1299r469b1354],
3	,	,	O	,	_	0	SENT_169	[p11l429t1299r469b1354],
4	Hayem	NNP	O	Hayem	nn	5	SENT_169	[p11l531t1299r720b1359],
5	G	NNP	O	G	appos	2	SENT_169	[p11l779t1298r837b1354],
6	,	,	O	,	_	0	SENT_169	[p11l779t1298r837b1354],
7	Dejager	NNP	PERSON	Dejager	nn	8	SENT_169	[p11l899t1298r1114b1359],
8	S	NNP	O	S	appos	2	SENT_169	[p11l1169t1298r1212b1354],
9	,	,	O	,	_	0	SENT_169	[p11l1169t1298r1212b1354],
10	Yau	NNP	PERSON	Yau	nn	11	SENT_169	[p11l1269t1298r1367b1344],
11	C	NNP	O	C	appos	2	SENT_169	[p11l1426t1298r1481b1354],
12	,	,	O	,	_	0	SENT_169	[p11l1426t1298r1481b1354],
13	Begaud	NNP	PERSON	Begaud	nn	15	SENT_169	[p11l1543t1296r1747b1359],
14	B.	NNP	PERSON	B.	nn	15	SENT_169	[p11l1808t1299r1853b1344],
15	Mild	NNP	PERSON	Mild	appos	2	SENT_169	[p11l1915t1296r2033b1344],
16	to	TO	O	to	_	0	SENT_169	[p11l2091t1302r2146b1344],
17	moderate	JJ	O	moderate	amod	19	SENT_169	[p11l144t1371r409b1419],
18	muscular	JJ	O	muscular	amod	19	SENT_169	[p11l458t1371r709b1419],
19	symptoms	NNS	O	symptom	prep_to	15	SENT_169	[p11l752t1377r1040b1434],
20	with	IN	O	with	_	0	SENT_169	[p11l1085t1371r1204b1419],
21	high	JJ	O	high	amod	25	SENT_169	[p11l1255t1371r1599b1434],
22	—	NN	O	—	nn	25	SENT_169	[p11l1255t1371r1599b1434],
23	dosage	NN	O	dosage	nn	25	SENT_169	[p11l1255t1371r1599b1434],
24	statin	NN	O	statin	nn	25	SENT_169	[p11l1645t1373r1792b1419],
25	therapy	NN	O	therapy	prep_with	19	SENT_169	[p11l1840t1371r2053b1434],
26	in	IN	O	in	_	0	SENT_169	[p11l2100t1373r2144b1419],
27	hyperlipidemic	JJ	O	hyperlipidemic	amod	28	SENT_169	[p11l144t1447r557b1510],
28	patients	NNS	O	patient	prep_in	25	SENT_169	[p11l582t1447r922b1510],
29	—	IN	O	—	_	0	SENT_169	[p11l582t1447r922b1510],
30	the	DT	O	the	det	32	SENT_169	[p11l582t1447r922b1510],
31	PRIMO	NNP	O	PRIMO	nn	32	SENT_169	[p11l949t1449r1137b1495],
32	study	NN	O	study	prep_—	28	SENT_169	[p11l1162t1447r1326b1510],
33	.	.	O	.	_	0	SENT_169	[p11l1162t1447r1326b1510],

1	Cardiovasc	NNP	O	Cardiovasc	nn	3	SENT_170	[p11l1357t1447r1648b1495],
2	Drugs	NNPS	O	Drugs	nn	3	SENT_170	[p11l1669t1449r1824b1510],
3	Ther	NNP	O	Ther	_	0	SENT_170	[p11l1852t1447r1969b1495],
4	2005	CD	DATE	2005	dep	3	SENT_170	[p11l1986t1448r2143b1505],
5	;	:	O	;	_	0	SENT_170	[p11l1986t1448r2143b1505],
6	19	CD	NUMBER	19	num	8	SENT_170	[p11l145t1525r226b1572],
7	:	:	O	:	_	0	SENT_170	[p11l145t1525r226b1572],
8	403-414	CD	NUMBER	403-414	dep	3	SENT_170	[p11l253t1525r517b1572],
9	.	.	O	.	_	0	SENT_170	[p11l253t1525r517b1572],

1	Nichols	NNP	ORGANIZATION	Nichols	nn	2	SENT_171	[p11l144t1597r346b1645],
2	GA	NNP	ORGANIZATION	GA	_	0	SENT_171	[p11l372t1599r468b1655],
3	,	,	O	,	_	0	SENT_171	[p11l372t1599r468b1655],
4	Koro	NNP	PERSON	Koro	nn	5	SENT_171	[p11l499t1599r624b1645],
5	CE	NNP	O	CE	appos	2	SENT_171	[p11l650t1599r737b1645],
6	.	.	O	.	_	0	SENT_171	[p11l650t1599r737b1645],

1	Does	VBZ	O	do	_	0	SENT_172	[p11l767t1600r901b1645],
2	statin	NN	O	statin	nn	4	SENT_172	[p11l925t1599r1071b1645],
3	therapy	NN	O	therapy	nn	4	SENT_172	[p11l1097t1597r1311b1660],
4	initiation	NN	O	initiation	nsubj	5	SENT_172	[p11l1335t1599r1575b1645],
5	increase	VBP	O	increase	ccomp	1	SENT_172	[p11l1603t1599r1824b1645],
6	the	DT	O	the	det	7	SENT_172	[p11l1848t1597r1936b1645],
7	risk	NN	O	risk	dobj	5	SENT_172	[p11l1963t1597r2050b1645],
8	for	IN	O	for	_	0	SENT_172	[p11l2071t1597r2149b1645],
9	myopathy	NN	O	myopathy	prep_for	7	SENT_172	[p11l144t1673r453b1736],
10	?	.	O	?	_	0	SENT_172	[p11l144t1673r453b1736],

1	An	DT	O	a	det	3	SENT_173	[p11l477t1675r549b1720],
2	observational	JJ	O	observational	amod	3	SENT_173	[p11l578t1673r946b1721],
3	study	NN	O	study	_	0	SENT_173	[p11l974t1673r1124b1736],
4	of	IN	O	of	_	0	SENT_173	[p11l1150t1673r1203b1721],
5	32	CD	NUMBER	32	number	6	SENT_173	[p11l1230t1674r1294b1721],
6	225	CD	NUMBER	225	num	10	SENT_173	[p11l1311t1674r1413b1721],
7	diabetic	JJ	O	diabetic	amod	10	SENT_173	[p11l1442t1673r1662b1721],
8	and	CC	O	and	_	0	SENT_173	[p11l1687t1673r1788b1721],
9	nondiabetic	JJ	O	nondiabetic	amod	10	SENT_173	[p11l1819t1673r2147b1721],
10	patients	NNS	O	patient	prep_of	3	SENT_173	[p11l144t1749r376b1810],
11	.	.	O	.	_	0	SENT_173	[p11l144t1749r376b1810],

1	Clin	NNP	O	Clin	nn	2	SENT_174	[p11l409t1748r506b1795],
2	Ther	NNP	O	Ther	_	0	SENT_174	[p11l536t1748r653b1795],
3	2007	CD	DATE	2007	num	2	SENT_174	[p11l672t1749r829b1805],
4	;	:	O	;	_	0	SENT_174	[p11l672t1749r829b1805],
5	29	CD	NUMBER	29	num	7	SENT_174	[p11l857t1749r941b1795],
6	:	:	O	:	_	0	SENT_174	[p11l857t1749r941b1795],
7	1761-1770	CD	DATE	1761-1770	dep	2	SENT_174	[p11l973t1749r1306b1795],
8	.	.	O	.	_	0	SENT_174	[p11l973t1749r1306b1795],

1	Kashani	NNP	PERSON	Kashani	nn	2	SENT_175	[p11l144t1823r352b1871],
2	A	NNP	O	A	_	0	SENT_175	[p11l374t1825r427b1881],
3	,	,	O	,	_	0	SENT_175	[p11l374t1825r427b1881],
4	Phillips	NNP	ORGANIZATION	Phillips	nn	5	SENT_175	[p11l456t1823r644b1886],
5	CO	NNP	ORGANIZATION	CO	appos	2	SENT_175	[p11l668t1825r773b1881],
6	,	,	O	,	_	0	SENT_175	[p11l668t1825r773b1881],
7	Foody	NNP	ORGANIZATION	Foody	nn	8	SENT_175	[p11l802t1823r970b1886],
8	JM	NN	ORGANIZATION	jm	appos	2	SENT_175	[p11l990t1825r1079b1882],
9	,	,	O	,	_	0	SENT_175	[p11l990t1825r1079b1882],
10	Wang	NNP	PERSON	Wang	nn	11	SENT_175	[p11l1104t1825r1266b1886],
11	Y	NN	PERSON	y	appos	2	SENT_175	[p11l1289t1825r1337b1881],
12	,	,	O	,	_	0	SENT_175	[p11l1289t1825r1337b1881],
13	Mangalmurti	NNP	PERSON	Mangalmurti	nn	14	SENT_175	[p11l1366t1823r1723b1886],
14	S	NNP	O	S	appos	2	SENT_175	[p11l1750t1825r1793b1881],
15	,	,	O	,	_	0	SENT_175	[p11l1750t1825r1793b1881],
16	Ko	NNP	O	Ko	nn	17	SENT_175	[p11l1822t1825r1889b1871],
17	DT	NNP	O	DT	appos	2	SENT_175	[p11l1915t1825r1993b1870],
18	et	FW	O	et	nn	19	SENT_175	[p11l2016t1829r2065b1871],
19	al.	FW	O	al.	dep	17	SENT_175	[p11l2085t1823r2143b1871],
20	.	.	O	.	_	0	SENT_175	[p11l2085t1823r2143b1871],

1	Risks	NNS	O	risk	nsubj	2	SENT_176	[p11l144t1897r268b1945],
2	associated	VBN	O	associate	_	0	SENT_176	[p11l328t1897r609b1945],
3	with	IN	O	with	_	0	SENT_176	[p11l670t1897r789b1945],
4	statin	NN	O	statin	nn	5	SENT_176	[p11l852t1899r999b1945],
5	therapy	NN	O	therapy	prep_with	2	SENT_176	[p11l1061t1897r1287b1960],
6	:	:	O	:	_	0	SENT_176	[p11l1061t1897r1287b1960],
7	a	DT	O	a	det	9	SENT_176	[p11l1352t1911r1378b1945],
8	systematic	JJ	O	systematic	amod	9	SENT_176	[p11l1439t1899r1728b1960],
9	overview	NN	O	overview	nsubj	11	SENT_176	[p11l1788t1899r2036b1945],
10	of	IN	O	of	prep	9	SENT_176	[p11l2095t1897r2149b1945],
11	randomized	VBN	O	randomize	parataxis	2	SENT_176	[p11l144t1973r472b2021],
12	clinical	JJ	O	clinical	amod	13	SENT_176	[p11l500t1973r684b2021],
13	trials	NNS	O	trial	dobj	11	SENT_176	[p11l712t1973r854b2021],
14	.	.	O	.	_	0	SENT_176	[p11l712t1973r854b2021],

1	Circulation	NN	O	circulation	_	0	SENT_177	[p11l887t1973r1171b2021],
2	2006	CD	DATE	2006	num	1	SENT_177	[p11l1195t1974r1352b2031],
3	;	:	O	;	_	0	SENT_177	[p11l1195t1974r1352b2031],
4	114	CD	NUMBER	114	num	6	SENT_177	[p11l1384t1974r1502b2021],
5	:	:	O	:	_	0	SENT_177	[p11l1384t1974r1502b2021],
6	2788-2797	CD	DATE	2788-2797	dep	1	SENT_177	[p11l1531t1974r1866b2021],
7	.	.	O	.	_	0	SENT_177	[p11l1531t1974r1866b2021],

1	The	DT	O	the	det	2	SENT_178	[p11l144t2048r247b2095],
2	SEARCH	NNP	O	SEARCH	_	0	SENT_178	[p11l300t2049r520b2095],
3	Collaborative	NNP	O	Collaborative	nn	4	SENT_178	[p11l576t2048r943b2095],
4	Group	NNP	O	Group	dep	2	SENT_178	[p11l996t2049r1187b2110],
5	.	.	O	.	_	0	SENT_178	[p11l996t2049r1187b2110],

1	SLCO1	NN	O	slco1	nn	3	SENT_179	[p11l1243t2049r1420b2095],
2	B1	NN	O	b1	nn	3	SENT_179	[p11l1440t2049r1493b2095],
3	variants	NNS	O	variant	nsubj	7	SENT_179	[p11l1556t2049r1769b2095],
4	and	CC	O	and	_	0	SENT_179	[p11l1822t2048r1922b2095],
5	statininduced	JJ	O	statininduced	amod	6	SENT_179	[p11l1976t2049r2146b2095, p11l148t2122r367b2170],
6	myopathy	NN	O	myopathy	conj_and	3	SENT_179	[p11l406t2122r780b2185],
7	—	VBD	O	—	_	0	SENT_179	[p11l406t2122r780b2185],
8	a	DT	O	a	det	10	SENT_179	[p11l406t2122r780b2185],
9	genomewide	JJ	O	genomewide	amod	10	SENT_179	[p11l815t2122r1180b2185],
10	study	NN	O	study	dobj	7	SENT_179	[p11l1213t2122r1377b2185],
11	.	.	O	.	_	0	SENT_179	[p11l1213t2122r1377b2185],

1	N	NN	O	n	dep	2	SENT_180	[p11l1416t2125r1460b2170],
2	Engl	NNP	LOCATION	Engl	dep	4	SENT_180	[p11l1493t2122r1605b2185],
3	/	:	O	/	punct	4	SENT_180	[p11l1629t2125r1650b2181],
4	Med	VBD	O	med	_	0	SENT_180	[p11l1682t2122r1800b2170],
5	2008	CD	DATE	2008	dobj	4	SENT_180	[p11l1829t2124r1985b2180],
6	;	:	O	;	_	0	SENT_180	[p11l1829t2124r1985b2180],
7	359	CD	NUMBER	359	num	9	SENT_180	[p11l2023t2124r2143b2170],
8	:	:	O	:	_	0	SENT_180	[p11l2023t2124r2143b2170],
9	789-799	CD	NUMBER	789-799	dep	5	SENT_180	[p11l149t2202r409b2249],
10	.	.	O	.	_	0	SENT_180	[p11l149t2202r409b2249],

1	Voora	NN	O	voora	nn	2	SENT_181	[p11l144t2275r305b2321],
2	D	NN	O	d	_	0	SENT_181	[p11l336t2276r391b2331],
3	,	,	O	,	_	0	SENT_181	[p11l336t2276r391b2331],
4	Shah	NNP	PERSON	Shah	nn	5	SENT_181	[p11l422t2274r554b2321],
5	SH	NNP	O	SH	appos	2	SENT_181	[p11l584t2275r671b2332],
6	,	,	O	,	_	0	SENT_181	[p11l584t2275r671b2332],
7	Spasojevic	NNP	PERSON	Spasojevic	nn	11	SENT_181	[p11l703t2275r987b2336],
8	I	PRP	O	I	dep	11	SENT_181	[p11l1016t2276r1040b2331],
9	,	,	O	,	_	0	SENT_181	[p11l1016t2276r1040b2331],
10	Ali	NNP	PERSON	Ali	dep	11	SENT_181	[p11l1067t2274r1133b2321],
11	S	NNP	O	S	appos	2	SENT_181	[p11l1163t2275r1206b2332],
12	,	,	O	,	_	0	SENT_181	[p11l1163t2275r1206b2332],
13	Reed	NNP	ORGANIZATION	Reed	nn	14	SENT_181	[p11l1238t2274r1367b2321],
14	CR	NN	ORGANIZATION	cr	appos	2	SENT_181	[p11l1396t2275r1485b2331],
15	,	,	O	,	_	0	SENT_181	[p11l1396t2275r1485b2331],
16	Salisbury	NNP	PERSON	Salisbury	nn	17	SENT_181	[p11l1516t2274r1761b2336],
17	BA	NN	O	ba	appos	2	SENT_181	[p11l1789t2276r1860b2321],
18	et	FW	O	et	nn	19	SENT_181	[p11l1886t2279r1934b2321],
19	al.	FW	O	al.	dep	17	SENT_181	[p11l1958t2274r2016b2321],
20	.	.	O	.	_	0	SENT_181	[p11l1958t2274r2016b2321],

1	The	DT	O	the	det	6	SENT_182	[p11l2043t2274r2146b2321],
2	SLCO1B1	NN	O	slco1b1	nn	6	SENT_182	[p11l148t2350r470b2397],
3	*	NN	O	*	nn	6	SENT_182	[p11l148t2350r470b2397],
4	5	CD	NUMBER	5	num	6	SENT_182	[p11l148t2350r470b2397],
5	genetic	JJ	O	genetic	amod	6	SENT_182	[p11l522t2350r726b2411],
6	variant	NN	O	variant	nsubjpass	8	SENT_182	[p11l772t2350r963b2397],
7	is	VBZ	O	be	auxpass	8	SENT_182	[p11l1011t2350r1046b2397],
8	associated	VBN	O	associate	_	0	SENT_182	[p11l1094t2349r1375b2397],
9	with	IN	O	with	_	0	SENT_182	[p11l1424t2349r1543b2397],
10	statin-induced	JJ	O	statin-induced	amod	12	SENT_182	[p11l1593t2349r1989b2397],
11	side	JJ	O	side	amod	12	SENT_182	[p11l2039t2349r2146b2397],
12	effects	NNS	O	effect	prep_with	8	SENT_182	[p11l146t2423r337b2471],
13	.	.	O	.	_	0	SENT_182	[p11l146t2423r337b2471],

1	/	:	O	/	punct	4	SENT_183	[p11l362t2426r490b2482],
2	Am	VBP	O	be	cop	4	SENT_183	[p11l362t2426r490b2482],
3	Coll	NNP	O	Coll	nn	4	SENT_183	[p11l518t2423r617b2471],
4	Cardiol	NNP	O	Cardiol	_	0	SENT_183	[p11l641t2423r830b2471],
5	2009	CD	DATE	2009	dep	4	SENT_183	[p11l851t2425r1008b2481],
6	;	:	O	;	_	0	SENT_183	[p11l851t2425r1008b2481],
7	54	CD	NUMBER	54	num	9	SENT_183	[p11l1036t2426r1121b2471],
8	:	:	O	:	_	0	SENT_183	[p11l1036t2426r1121b2471],
9	1609-1616	CD	DATE	1609-1616	dep	4	SENT_183	[p11l1153t2425r1484b2471],
10	.	.	O	.	_	0	SENT_183	[p11l1153t2425r1484b2471],

1	Mohaupt	NNP	O	Mohaupt	_	0	SENT_184	[p11l149t2499r405b2562],
2	MG	NN	O	mg	rcmod	1	SENT_184	[p11l438t2500r552b2557],
3	,	,	O	,	_	0	SENT_184	[p11l438t2500r552b2557],
4	Karas	NNP	PERSON	Karas	nn	5	SENT_184	[p11l591t2501r732b2547],
5	RH	NNP	O	RH	dep	2	SENT_184	[p11l766t2501r854b2557],
6	,	,	O	,	_	0	SENT_184	[p11l766t2501r854b2557],
7	Babiychuk	NNP	O	Babiychuk	dep	8	SENT_184	[p11l893t2499r1175b2562],
8	EB	NNP	O	EB	dep	5	SENT_184	[p11l1209t2501r1285b2557],
9	,	,	O	,	_	0	SENT_184	[p11l1209t2501r1285b2557],
10	Sanchez-Freire	NNP	O	Sanchez-Freire	nn	11	SENT_184	[p11l1322t2499r1723b2547],
11	V	NNP	O	V	dep	14	SENT_184	[p11l1753t2501r1804b2557],
12	,	,	O	,	_	0	SENT_184	[p11l1753t2501r1804b2557],
13	Monastyrskaya	NNP	LOCATION	Monastyrskaya	nn	14	SENT_184	[p11l1842t2501r2145b2562, p11l148t2574r267b2636],
14	K	NNP	LOCATION	K	dep	8	SENT_184	[p11l291t2576r337b2631],
15	,	,	O	,	_	0	SENT_184	[p11l291t2576r337b2631],
16	lyer	NN	O	lyer	nn	17	SENT_184	[p11l363t2576r462b2636],
17	L	NN	O	l	appos	14	SENT_184	[p11l482t2576r507b2621],
18	et	FW	O	et	dep	17	SENT_184	[p11l527t2579r576b2621],
19	o	NN	O	o	dep	17	SENT_184	[p11l593t2574r651b2621],
20	/	:	O	/	punct	5	SENT_184	[p11l593t2574r651b2621],
21	.	.	O	.	_	0	SENT_184	[p11l593t2574r651b2621],

1	Association	NNP	O	Association	_	0	SENT_185	[p11l672t2575r981b2621],
2	between	IN	O	between	_	0	SENT_185	[p11l1006t2574r1242b2621],
3	statin-associated	JJ	O	statin-associated	amod	4	SENT_185	[p11l1263t2574r1720b2621],
4	myopathy	NN	O	myopathy	prep_between	1	SENT_185	[p11l1744t2574r2025b2636],
5	and	CC	O	and	_	0	SENT_185	[p11l2043t2574r2144b2621],
6	skeletal	JJ	O	skeletal	amod	8	SENT_185	[p11l146t2648r344b2696],
7	muscle	NN	O	muscle	nn	8	SENT_185	[p11l374t2648r564b2696],
8	damage	NN	O	damage	prep_between	1	SENT_185	[p11l590t2648r830b2711],
9	.	.	O	.	_	0	SENT_185	[p11l590t2648r830b2711],

1	CMAI	NNP	O	CMAI	_	0	SENT_186	[p11l863t2650r1008b2707],
2	2009	CD	DATE	2009	num	1	SENT_186	[p11l1029t2650r1186b2706],
3	;	:	O	;	_	0	SENT_186	[p11l1029t2650r1186b2706],
4	181	CD	NUMBER	181	dep	1	SENT_186	[p11l1219t2650r1336b2696],
5	:	:	O	:	_	0	SENT_186	[p11l1219t2650r1336b2696],
6	E11-E18	NN	O	e11-e18	dep	4	SENT_186	[p11l1368t2650r1617b2696],
7	.	.	O	.	_	0	SENT_186	[p11l1368t2650r1617b2696],

1	Ross	NNP	PERSON	Ross	nn	2	SENT_187	[p11l149t2726r258b2772],
2	CJD	NNP	O	CJD	_	0	SENT_187	[p11l276t2726r389b2783],
3	,	,	O	,	_	0	SENT_187	[p11l276t2726r389b2783],
4	Katzov-Eckert	NNP	PERSON	Katzov-Eckert	nn	5	SENT_187	[p11l414t2724r766b2772],
5	H	NNP	PERSON	H	appos	2	SENT_187	[p11l785t2726r836b2782],
6	,	,	O	,	_	0	SENT_187	[p11l785t2726r836b2782],
7	Dube	NNP	PERSON	Dube	nn	8	SENT_187	[p11l861t2724r1002b2772],
8	MP	NNP	O	MP	appos	2	SENT_187	[p11l1023t2726r1122b2782],
9	,	,	O	,	_	0	SENT_187	[p11l1023t2726r1122b2782],
10	Brooks	NNP	ORGANIZATION	Brooks	nn	11	SENT_187	[p11l1146t2724r1317b2772],
11	B	NNP	ORGANIZATION	B	appos	2	SENT_187	[p11l1338t2726r1381b2782],
12	,	,	O	,	_	0	SENT_187	[p11l1338t2726r1381b2782],
13	Rassekh	NNP	O	Rassekh	nn	14	SENT_187	[p11l1406t2724r1601b2772],
14	SR	NN	O	sr	appos	2	SENT_187	[p11l1623t2726r1697b2782],
15	,	,	O	,	_	0	SENT_187	[p11l1623t2726r1697b2782],
16	Barhdadi	NNP	O	Barhdadi	nn	17	SENT_187	[p11l1722t2724r1951b2772],
17	A	NNP	O	A	appos	2	SENT_187	[p11l1968t2726r2008b2771],
18	et	FW	O	et	nn	19	SENT_187	[p11l2026t2730r2073b2772],
19	al.	FW	O	al.	dep	17	SENT_187	[p11l2089t2724r2143b2772],
20	.	.	O	.	_	0	SENT_187	[p11l2089t2724r2143b2772],

1	Genetic	JJ	O	genetic	amod	2	SENT_188	[p11l147t2800r349b2846],
2	variants	NNS	O	variant	nsubjpass	8	SENT_188	[p11l398t2800r599b2846],
3	in	IN	O	in	_	0	SENT_188	[p11l652t2800r694b2846],
4	TPMT	NN	O	tpmt	prep_in	2	SENT_188	[p11l746t2801r905b2846],
5	and	CC	O	and	_	0	SENT_188	[p11l953t2799r1050b2846],
6	COMT	NN	ORGANIZATION	comt	prep_in	2	SENT_188	[p11l1104t2800r1285b2846],
7	are	VBP	O	be	auxpass	8	SENT_188	[p11l1334t2813r1412b2846],
8	associated	VBN	O	associate	_	0	SENT_188	[p11l1464t2799r1728b2846],
9	with	IN	O	with	_	0	SENT_188	[p11l1780t2799r1893b2846],
10	hearing	NN	O	hearing	nn	11	SENT_188	[p11l1950t2799r2144b2861],
11	loss	NN	O	loss	prep_with	8	SENT_188	[p11l148t2874r238b2922],
12	in	IN	O	in	_	0	SENT_188	[p11l275t2875r318b2921],
13	children	NNS	O	child	prep_in	8	SENT_188	[p11l356t2874r564b2922],
14	receiving	VBG	O	receive	partmod	13	SENT_188	[p11l604t2875r836b2936],
15	cisplatin	NN	O	cisplatin	nn	16	SENT_188	[p11l874t2874r1083b2937],
16	chemotherapy	NN	O	chemotherapy	dobj	14	SENT_188	[p11l1121t2874r1520b2937],
17	.	.	O	.	_	0	SENT_188	[p11l1121t2874r1520b2937],

1	Nat	NNP	PERSON	Nat	nn	2	SENT_189	[p11l1560t2876r1657b2922],
2	Genet	NNP	PERSON	Genet	_	0	SENT_189	[p11l1693t2875r1842b2922],
3	2009	CD	DATE	2009	num	2	SENT_189	[p11l1874t2875r2023b2932],
4	;	:	O	;	_	0	SENT_189	[p11l1874t2875r2023b2932],
5	41	CD	NUMBER	41	num	7	SENT_189	[p11l2061t2875r2143b2922],
6	:	:	O	:	_	0	SENT_189	[p11l2061t2875r2143b2922],
7	1345-1349	CD	DATE	1345-1349	dep	2	SENT_189	[p11l149t2952r465b2998],
8	.	.	O	.	_	0	SENT_189	[p11l149t2952r465b2998],

1	Tobert	NNP	PERSON	Tobert	nn	4	SENT_190	[p11l144t3025r330b3073],
2	]	NNP	O	]	nn	4	SENT_190	[p11l357t3027r426b3084],
3	A.	NNP	O	A.	nn	4	SENT_190	[p11l357t3027r426b3084],
4	Efficacy	NNP	O	Efficacy	_	0	SENT_190	[p11l461t3025r665b3088],
5	and	CC	O	and	_	0	SENT_190	[p11l694t3025r794b3073],
6	long	JJ	O	long	amod	8	SENT_190	[p11l828t3025r1101b3088],
7	—	NN	O	—	nn	8	SENT_190	[p11l828t3025r1101b3088],
8	term	NN	O	term	conj_and	4	SENT_190	[p11l828t3025r1101b3088],
9	adverse	JJ	O	adverse	amod	11	SENT_190	[p11l1134t3025r1341b3073],
10	effect	NN	O	effect	nn	11	SENT_190	[p11l1372t3025r1524b3073],
11	pattern	NN	O	pattern	dep	4	SENT_190	[p11l1554t3031r1751b3088],
12	of	IN	O	of	_	0	SENT_190	[p11l1783t3025r1837b3073],
13	lovastatin	NN	O	lovastatin	prep_of	11	SENT_190	[p11l1866t3025r2143b3073],
14	.	.	O	.	_	0	SENT_190	[p11l1866t3025r2143b3073],

1	Am	VBP	O	be	_	0	SENT_191	[p11l145t3102r232b3147],
2	/	:	O	/	punct	3	SENT_191	[p11l253t3102r273b3158],
3	Cardiol	NNP	O	Cardiol	nsubj	9	SENT_191	[p11l299t3100r488b3147],
4	1988	CD	DATE	1988	num	3	SENT_191	[p11l511t3101r665b3157],
5	;	:	O	;	_	0	SENT_191	[p11l511t3101r665b3157],
6	62	CD	NUMBER	62	num	8	SENT_191	[p11l694t3101r779b3147],
7	:	:	O	:	_	0	SENT_191	[p11l694t3101r779b3147],
8	281-34	CD	NUMBER	281-34	dep	3	SENT_191	[p11l807t3101r1031b3159],
9	]	NN	O	]	ccomp	1	SENT_191	[p11l807t3101r1031b3159],
10	.	.	O	.	_	0	SENT_191	[p11l807t3101r1031b3159],

1	SLCOIBI	NNP	O	SLCOIBI	nn	6	SENT_192	[p11l1104t3241r1199b3262],
2	and	CC	O	and	_	0	SENT_192	[p11l1210t3240r1253b3262],
3	statin	NN	O	statin	nn	6	SENT_192	[p11l1262t3240r1329b3262],
4	myopathy	NN	O	myopathy	nn	6	SENT_192	[p11l1339t3240r1457b3269],
5	LR	NNP	O	LR	nn	6	SENT_192	[p11l1105t3276r1126b3295],
6	Brunham	NNP	O	Brunham	_	0	SENT_192	[p11l1136t3275r1226b3295],
7	et	FW	O	et	nn	8	SENT_192	[p11l1236t3277r1254b3295],
8	al	FW	O	al	dep	6	SENT_192	[p11l1262t3275r1280b3295],

1	Ghatak	NNP	MISC	Ghatak	nn	2	SENT_193	[p12l75t44r172b68],
2	A	NNP	MISC	A	_	0	SENT_193	[p12l186t45r212b73],
3	,	,	O	,	_	0	SENT_193	[p12l186t45r212b73],
4	Faheem	NNP	PERSON	Faheem	nn	5	SENT_193	[p12l231t44r335b68],
5	o	NN	O	o	appos	2	SENT_193	[p12l352t45r382b73],
6	,	,	O	,	_	0	SENT_193	[p12l352t45r382b73],
7	Thompson	NNP	PERSON	Thompson	nn	8	SENT_193	[p12l398t44r544b75],
8	PD	NN	O	pd	appos	5	SENT_193	[p12l562t45r607b68],
9	.	.	O	.	_	0	SENT_193	[p12l562t45r607b68],

1	The	DT	O	the	det	2	SENT_194	[p12l623t44r673b68],
2	genetics	NNS	O	genetics	_	0	SENT_194	[p12l689t44r801b75],
3	of	IN	O	of	_	0	SENT_194	[p12l817t44r843b68],
4	statin-induced	JJ	O	statin-induced	amod	5	SENT_194	[p12l858t44r1051b68],
5	myopathy	NN	O	myopathy	prep_of	2	SENT_194	[p12l76t81r220b112],
6	.	.	O	.	_	0	SENT_194	[p12l76t81r220b112],

1	Atheroscler	NNP	O	Atheroscler	_	0	SENT_195	[p12l234t81r379b105],
2	2009	CD	DATE	2009	num	1	SENT_195	[p12l389t81r465b110],
3	;	:	O	;	_	0	SENT_195	[p12l389t81r465b110],
4	210	CD	NUMBER	210	num	6	SENT_195	[p12l480t81r538b105],
5	:	:	O	:	_	0	SENT_195	[p12l480t81r538b105],
6	337-343	CD	NUMBER	337-343	dep	1	SENT_195	[p12l554t81r680b105],
7	.	.	O	.	_	0	SENT_195	[p12l554t81r680b105],

1	Pasanen	NNP	PERSON	Pasanen	nn	2	SENT_196	[p12l77t122r184b145],
2	MK	NNP	O	MK	_	0	SENT_196	[p12l216t122r267b149],
3	,	,	O	,	_	0	SENT_196	[p12l216t122r267b149],
4	Fredrikson	NNP	PERSON	Fredrikson	nn	5	SENT_196	[p12l300t121r437b145],
5	H	NNP	PERSON	H	appos	2	SENT_196	[p12l469t122r495b150],
6	,	,	O	,	_	0	SENT_196	[p12l469t122r495b150],
7	Neuvonen	NNP	PERSON	Neuvonen	nn	9	SENT_196	[p12l527t122r666b145],
8	P	NN	O	p	nn	9	SENT_196	[p12l698t122r727b150],
9	]	NN	O	]	appos	2	SENT_196	[p12l698t122r727b150],
10	,	,	O	,	_	0	SENT_196	[p12l698t122r727b150],
11	Niemi	NNP	PERSON	Niemi	nn	14	SENT_196	[p12l760t122r838b145],
12	M.	NNP	O	M.	nn	14	SENT_196	[p12l870t122r903b145],
13	Different	NNP	O	Different	nn	14	SENT_196	[p12l936t121r1053b145],
14	effects	NNS	O	effect	appos	2	SENT_196	[p12l75t161r161b184],
15	of	IN	O	of	_	0	SENT_196	[p12l198t161r224b184],
16	SLCO1B1	NN	O	slco1b1	nn	17	SENT_196	[p12l261t161r383b184],
17	polymorphism	NN	O	polymorphism	prep_of	14	SENT_196	[p12l428t161r623b192],
18	on	IN	O	on	_	0	SENT_196	[p12l662t168r695b184],
19	the	DT	O	the	det	20	SENT_196	[p12l733t161r776b184],
20	pharmacokinetics	NNS	O	pharmacokinetic	prep_on	17	SENT_196	[p12l814t161r1052b192],
21	of	IN	O	of	_	0	SENT_196	[p12l75t201r101b225],
22	atorvastatin	NN	O	atorvastatin	prep_of	20	SENT_196	[p12l126t201r283b225],
23	and	CC	O	and	_	0	SENT_196	[p12l311t201r360b225],
24	rosuvastatin	NN	O	rosuvastatin	prep_of	20	SENT_196	[p12l388t201r556b225],
25	.	.	O	.	_	0	SENT_196	[p12l388t201r556b225],

1	Clin	NNP	O	Clin	nn	3	SENT_197	[p12l586t201r633b225],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_197	[p12l660t201r799b225],
3	Ther	NNP	O	Ther	_	0	SENT_197	[p12l825t201r883b225],
4	2007	CD	DATE	2007	num	3	SENT_197	[p12l905t202r982b230],
5	;	:	O	;	_	0	SENT_197	[p12l905t202r982b230],
6	82	CD	NUMBER	82	num	8	SENT_197	[p12l1009t202r1051b225],
7	:	:	O	:	_	0	SENT_197	[p12l1009t202r1051b225],
8	726-733	CD	NUMBER	726-733	dep	3	SENT_197	[p12l77t238r203b262],
9	.	.	O	.	_	0	SENT_197	[p12l77t238r203b262],

1	Pasanen	NNP	PERSON	Pasanen	nn	2	SENT_198	[p12l77t277r184b300],
2	MK	NNP	O	MK	nsubj	17	SENT_198	[p12l214t276r265b305],
3	,	,	O	,	_	0	SENT_198	[p12l214t276r265b305],
4	Neuvonen	NNP	O	Neuvonen	nn	5	SENT_198	[p12l295t277r434b300],
5	M	NNP	O	M	appos	2	SENT_198	[p12l463t277r496b305],
6	,	,	O	,	_	0	SENT_198	[p12l463t277r496b305],
7	Neuvonen	NNP	PERSON	Neuvonen	nn	9	SENT_198	[p12l526t277r665b300],
8	P	NN	O	p	nn	9	SENT_198	[p12l695t277r724b305],
9	]	NN	O	]	npadvmod	16	SENT_198	[p12l695t277r724b305],
10	,	,	O	,	_	0	SENT_198	[p12l695t277r724b305],
11	Niemi	NNP	PERSON	Niemi	nn	13	SENT_198	[p12l754t276r833b300],
12	M.	NNP	O	M.	nn	13	SENT_198	[p12l862t277r895b299],
13	SLCO1	NNP	O	SLCO1	appos	9	SENT_198	[p12l924t276r1010b300],
14	B1	NN	O	b1	nn	15	SENT_198	[p12l1020t276r1046b299],
15	polymorphism	NN	O	polymorphism	dep	13	SENT_198	[p12l76t313r272b344],
16	markedly	RB	O	markedly	advmod	17	SENT_198	[p12l293t313r417b344],
17	affects	VBZ	O	affect	_	0	SENT_198	[p12l435t313r520b337],
18	the	DT	O	the	det	19	SENT_198	[p12l538t313r582b337],
19	pharmacokinetics	NNS	O	pharmacokinetic	dobj	17	SENT_198	[p12l601t313r839b344],
20	of	IN	O	of	_	0	SENT_198	[p12l858t313r884b337],
21	simvastatin	NN	O	simvastatin	nn	22	SENT_198	[p12l901t313r1051b337],
22	acid	NN	O	acid	prep_of	19	SENT_198	[p12l75t350r137b374],
23	.	.	O	.	_	0	SENT_198	[p12l75t350r137b374],

1	Pharmacogenet	NNP	O	Pharmacogenet	nn	2	SENT_199	[p12l152t350r357b382],
2	Genomics	NNP	O	Genomics	_	0	SENT_199	[p12l369t351r494b374],
3	2006	CD	DATE	2006	num	2	SENT_199	[p12l506t351r582b379],
4	;	:	O	;	_	0	SENT_199	[p12l506t351r582b379],
5	16	CD	NUMBER	16	num	7	SENT_199	[p12l598t351r638b374],
6	:	:	O	:	_	0	SENT_199	[p12l598t351r638b374],
7	873-879	CD	NUMBER	873-879	dep	2	SENT_199	[p12l652t351r780b374],
8	.	.	O	.	_	0	SENT_199	[p12l652t351r780b374],

1	Tirona	NNP	O	Tirona	nn	2	SENT_200	[p12l74t388r160b412],
2	RG	NNP	O	RG	_	0	SENT_200	[p12l177t389r222b417],
3	,	,	O	,	_	0	SENT_200	[p12l177t389r222b417],
4	Leake	NNP	PERSON	Leake	nn	5	SENT_200	[p12l241t388r315b412],
5	BF	NNP	O	BF	appos	2	SENT_200	[p12l332t389r369b417],
6	,	,	O	,	_	0	SENT_200	[p12l332t389r369b417],
7	Merino	NNP	O	Merino	nn	8	SENT_200	[p12l388t388r483b412],
8	C	NNP	O	C	appos	2	SENT_200	[p12l500t389r528b417],
9	,	,	O	,	_	0	SENT_200	[p12l500t389r528b417],
10	Kim	NNP	PERSON	Kim	nn	11	SENT_200	[p12l547t388r596b411],
11	RB	NN	O	rb	appos	2	SENT_200	[p12l615t389r654b412],
12	.	.	O	.	_	0	SENT_200	[p12l615t389r654b412],

1	Polymorphisms	NNS	O	polymorphism	_	0	SENT_201	[p12l673t388r880b419],
2	in	IN	O	in	_	0	SENT_201	[p12l897t388r918b411],
3	OATP-C	NN	O	oatp-c	prep_in	1	SENT_201	[p12l936t389r1051b412],
4	.	.	O	.	_	0	SENT_201	[p12l936t389r1051b412],
5	]	SYM	O	]	dep	1	SENT_201	[p12l73t427r83b455],

1	Biol	NNP	ORGANIZATION	Biol	nn	2	SENT_202	[p12l95t425r141b449],
2	Chem	NNP	ORGANIZATION	Chem	_	0	SENT_202	[p12l153t425r226b449],
3	2001	CD	DATE	2001	num	2	SENT_202	[p12l238t426r315b454],
4	;	:	O	;	_	0	SENT_202	[p12l238t426r315b454],
5	276	CD	NUMBER	276	num	7	SENT_202	[p12l329t426r388b449],
6	:	:	O	:	_	0	SENT_202	[p12l329t426r388b449],
7	35669-35675	CD	NUMBER	35669-35675	dep	2	SENT_202	[p12l403t426r601b449],
8	.	.	O	.	_	0	SENT_202	[p12l403t426r601b449],

1	19	CD	NUMBER	19	num	3	SENT_203	[p12l1106t45r1137b67],
2	Davidson	NNP	PERSON	Davidson	nn	3	SENT_203	[p12l1172t44r1296b67],
3	MH	NNP	O	MH	_	0	SENT_203	[p12l1319t45r1374b72],
4	,	,	O	,	_	0	SENT_203	[p12l1319t45r1374b72],
5	Clark	NNP	PERSON	Clark	nn	7	SENT_203	[p12l1397t44r1465b67],
6	]	NNP	O	]	nn	7	SENT_203	[p12l1485t45r1519b73],
7	A	NNP	O	A	appos	3	SENT_203	[p12l1485t45r1519b73],
8	,	,	O	,	_	0	SENT_203	[p12l1485t45r1519b73],
9	Glass	NNP	ORGANIZATION	Glass	nn	10	SENT_203	[p12l1541t44r1609b67],
10	LM	NNP	ORGANIZATION	LM	appos	3	SENT_203	[p12l1632t45r1679b72],
11	,	,	O	,	_	0	SENT_203	[p12l1632t45r1679b72],
12	Kanumalla	NNP	O	Kanumalla	nn	14	SENT_203	[p12l1703t44r1843b67],
13	A.	NNP	O	A.	nn	14	SENT_203	[p12l1864t45r1890b67],
14	Statin	NNP	O	Statin	appos	3	SENT_203	[p12l1913t44r1988b67],
15	safety	NN	O	safety	dep	14	SENT_203	[p12l2009t44r2094b75],
16	:	:	O	:	_	0	SENT_203	[p12l2009t44r2094b75],
17	an	DT	O	a	det	18	SENT_203	[p12l2116t51r2147b67],
18	appraisal	NN	O	appraisal	dep	3	SENT_203	[p12l1171t81r1289b112],
19	from	IN	O	from	_	0	SENT_203	[p12l1302t81r1366b105],
20	the	DT	O	the	det	22	SENT_203	[p12l1379t81r1422b105],
21	adverse	JJ	O	adverse	amod	22	SENT_203	[p12l1436t81r1538b105],
22	event	NN	O	event	prep_from	18	SENT_203	[p12l1550t84r1626b105],
23	reporting	VBG	O	report	partmod	22	SENT_203	[p12l1638t81r1763b112],
24	system	NN	O	system	dobj	23	SENT_203	[p12l1777t84r1876b112],
25	.	.	O	.	_	0	SENT_203	[p12l1777t84r1876b112],

1	Am	VBP	O	be	_	0	SENT_204	[p12l1890t82r1933b104],
2	/	:	O	/	punct	3	SENT_204	[p12l1944t82r1954b110],
3	Cardiol	NNP	O	Cardiol	nsubj	8	SENT_204	[p12l1967t81r2059b105],
4	2006	CD	DATE	2006	num	3	SENT_204	[p12l2070t81r2147b110],
5	;	:	O	;	_	0	SENT_204	[p12l2070t81r2147b110],
6	97	CD	NUMBER	97	num	7	SENT_204	[p12l1171t121r1293b152],
7	(	CD	NUMBER	(	dep	3	SENT_204	[p12l1171t121r1293b152],
8	Suppl	NN	O	suppl	ccomp	1	SENT_204	[p12l1171t121r1293b152],
9	1	CD	NUMBER	1	num	10	SENT_204	[p12l1308t121r1341b151],
10	)	NN	O	)	dobj	8	SENT_204	[p12l1308t121r1341b151],
11	;	:	O	;	_	0	SENT_204	[p12l1308t121r1341b151],
12	532-543	CD	NUMBER	532-543	dep	10	SENT_204	[p12l1356t122r1480b145],
13	.	.	O	.	_	0	SENT_204	[p12l1356t122r1480b145],

1	This	DT	O	this	det	2	SENT_205	[p12l1303t232r1389b261],
2	work	NN	O	work	nsubjpass	4	SENT_205	[p12l1408t232r1515b261],
3	is	VBZ	O	be	auxpass	4	SENT_205	[p12l1534t232r1565b261],
4	licensed	VBN	O	license	_	0	SENT_205	[p12l1584t232r1744b261],
5	under	IN	O	under	_	0	SENT_205	[p12l1762t232r1881b261],
6	the	DT	O	the	det	8	SENT_205	[p12l1900t232r1965b261],
7	Creative	JJ	O	creative	amod	8	SENT_205	[p12l1985t232r2149b261],
8	‘”	NN	O	‘”	prep_under	4	SENT_205	[p12l1106t277r1274b292],
9	“	CD	NUMBER	“	dep	17	SENT_205	[p12l1106t277r1274b292],
10	"	``	O	"	punct	13	SENT_205	[p12l1106t277r1274b292],
11	“	JJ	O	“	amod	13	SENT_205	[p12l1106t277r1274b292],
12	"	''	O	"	punct	13	SENT_205	[p12l1106t277r1274b292],
13	“”	NN	O	“”	dep	9	SENT_205	[p12l1106t277r1274b292],
14	“	CD	NUMBER	“	dep	17	SENT_205	[p12l1106t277r1274b292],
15	"	``	O	"	punct	17	SENT_205	[p12l1106t277r1274b292],
16	“	NN	O	“	nn	17	SENT_205	[p12l1106t277r1274b292],
17	E	NN	O	e	dep	8	SENT_205	[p12l1106t277r1274b292],
18	"	''	O	"	punct	17	SENT_205	[p12l1106t277r1274b292],
19	"	``	O	"	punct	25	SENT_205	[p12l1106t277r1274b292],
20	‘	SYM	O	‘	dep	25	SENT_205	[p12l1106t277r1274b292],
21	"	``	O	"	punct	25	SENT_205	[p12l1106t277r1274b292],
22	Commons	NNP	O	Commons	nn	25	SENT_205	[p12l1304t280r1500b308],
23	Attribution-NonCommercial-No	NNP	O	Attribution-NonCommercial-No	nn	25	SENT_205	[p12l1516t279r2148b308],
24	Derivative	NNP	O	Derivative	nn	25	SENT_205	[p12l1104t326r1311b355],
25	Works	NNP	O	Works	dep	17	SENT_205	[p12l1318t326r1445b355],
26	3.0	CD	NUMBER	3.0	num	28	SENT_205	[p12l1453t327r1509b355],
27	Unported	NNP	O	Unported	nn	28	SENT_205	[p12l1516t326r1705b363],
28	License	NNP	O	License	dep	25	SENT_205	[p12l1712t326r1864b355],
29	.	.	O	.	_	0	SENT_205	[p12l1712t326r1864b355],

1	To	TO	O	to	aux	2	SENT_206	[p12l1872t327r1920b355],
2	view	VB	O	view	_	0	SENT_206	[p12l1927t326r2021b355],
3	a	DT	O	a	det	4	SENT_206	[p12l2027t334r2050b354],
4	copy	NN	O	copy	dobj	2	SENT_206	[p12l2057t334r2150b363],
5	of	IN	O	of	dep	12	SENT_206	[p12l1104t373r1147b401],
6	this	DT	O	this	det	7	SENT_206	[p12l1171t373r1247b401],
7	license	NN	O	license	pobj	5	SENT_206	[p12l1274t373r1416b407],
8	,	,	O	,	_	0	SENT_206	[p12l1274t373r1416b407],
9	visit	NN	O	visit	nn	11	SENT_206	[p12l1445t373r1531b401],
10	http://creativecommons.org/	NN	O	http://creativecommons.org/	nn	11	SENT_206	[p12l1559t373r2148b410],
11	licenses/by-nc-nd/3	NN	O	licenses/by-nc-nd/3	appos	7	SENT_206	[p12l1104t420r1546b457],
12	.0	CD	NUMBER	.0	dep	2	SENT_206	[p12l1104t420r1546b457],
13	/	:	O	/	punct	12	SENT_206	[p12l1104t420r1546b457],

1	The	DT	O	the	det	3	SENT_207	[p12l1715t551r1765b573],
2	Pharmacogenomics	NNP	MISC	Pharmacogenomics	nn	3	SENT_207	[p12l1778t551r2042b580],
3	lournal	NN	O	lournal	_	0	SENT_207	[p12l2053t551r2147b578],

